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BACKGROUND
In recent years technological innovations have increasingly developed and applied nanoma-
terials (NMs) which are structures that have at least one external dimension in the nanoscale 
(1-100 nm) (Stone et al. 2009). In this thesis the focus lies on nanoparticles (NPs) which are 
NMs with all three external dimensions (length, height, width) in the nanoscale (ISO/TS 
80004-2:2015). Due to their small size and relatively large surface area to volume ratio, NPs 
have physicochemical characteristics diff erent from those of the bulk material, such as diff er-
ent thermal, mechanical, electrical, chemical, catalytic and optical properties, which makes 
engineered NPs so interesting for applications (Auff an et al. 2009, Kango S. 2013). For exam-
ple, bulk gold is considered to be inert but gold NPs are very eff ective catalysts (Auff an et al. 
2009). Due to their specifi c properties, engineered NPs off er numerous interesting opportuni-
ties in many sectors of society including medicine, agriculture and food technology.
Since NPs are incorporated more and more in a variety of consumer products, it is likely that 
the general public may be exposed to NP-containing products such as personal care products, 
food and food packaging materials, textiles and medicine. In order to assess whether exposure 
to these NPs may pose a human health risk, NPs should be assessed for their safety. Insight 
into the potential human health risks posed by NPs is essential for sustainable development 
and safe use of innovative products based on these materials. To develop such insights, toxic 
properties (hazards) of NPs should be identifi ed and dose-response relationships established. 
Despite the fact that there are a number of publications concerning undesirable eff ects of NPs, 
various gaps still exist in the knowledge on the intrinsic hazards of NPs, the potential human 
exposures to NPs and the relationship between exposure and adverse health eff ects (risks) of 
NPs (Oberdorster et al. 2007, Dhawan et al. 2010, Hussain et al. 2015). Existing information 
on potential adverse health eff ects is mainly based on animal experiments, although in vitro 
studies with cell lines have recently added to the insight in potential hazards of NPs. NPs have 
been shown, for example, to induce cytotoxic, genotoxic, infl ammatory and oxidative stress 
responses in diff erent mammalian cell lines (Nel et al. 2006, Elsabahy et al. 2013, Watson et 
al. 2014).
Th ere is no doubt that the safety testing of all these materials requires a high number of exper-
imental animals given the large numbers and variety of NPs developed and applied. Testing 
all these NPs in animal bioassays is undesirable for scientifi c, ethical and societal reasons. 
Th ere is a strong societal demand to reduce the use of experimental animals for safety testing 
of chemicals, including NPs. In order to reduce in vivo testing, alternative methods for testing 
of chemicals are currently being developed and validated (Van der Jagt et al. 2004, Macharia 
Th euri et al. 2016). It is desirable that the safety and risk assessment of NPs would be largely 
based on studies using in vitro models instead of in vivo models as this would also reduce 
costs and time needed to test the large numbers of NPs. 
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Use of in vitro models may also help to defi ne structure activity relationships and facilitate 
read-across within classes of NPs. Previous research has indicated that NP toxicity can be re-
lated to a certain extent to their physicochemical properties (Fourches et al. 2010). Diff erent 
specifi c biological responses resulting from exposure to NPs, such as reduction in cell viabil-
ity, are shown to be aff ected by NP physicochemical properties, such as size, surface charge 
and surface area (Duran et al. 2015, Recordati et al. 2016). It would be of great value to get 
more insight in these relationships, not only to facilitate read across within classes of NPs, but 
also to be able to set priorities for safety testing and/or to develop safer NPs. 
AIM OF THE THESIS
Th e aim of the present thesis was to investigate the potential of in vitro alternative testing 
strategies to detect hazards of NPs, focusing on toxicokinetic as well as toxicodynamic end-
points. Toxicokinetic studies focused on translocation of NPs across in vitro models of the 
placental barrier, while toxicodynamic studies were directed at two endpoints that represent 
potential hazards of NPs that have not been well characterized yet: developmental toxicity 
and immunotoxicity. Th e model NPs and in vitro model systems used in the present thesis are 
described in more detail in the following sections.  
NANOPARTICLES
Th e next sections provide background information about the diff erent types of NPs that have 
been used in this thesis. A fi rst group of model NPs consisted of polystyrene NPs (PS-NPs). A 
second group of model NPs consisted of metal and metal oxide NPs. 
Polystyrene NPs (PS-NPs)
During the last decades, NPs made of polymers like polystyrene are increasingly used in food 
packaging due to their functionality, light weight, ease of processing and low costs (Arora et 
al. 2010). PS-NPs are also used in industrial applications, including sensors and drug deliv-
ery systems (Phosphorex , Simon et al. 2008, Arora and Padua 2010, Lee et al. 2014, Chiu et 
al. 2015). At present it is unknown whether humans are exposed to such PS-NPs due to e.g. 
migration into food and drinks (Chaudhry et al. 2008). It is also not clear whether such a 
migration would have a consequence for the safety of the food.  
Fluorescent PS-NPs are oft en used as model NPs in nanotoxicological studies to investigate 
interactions between NPs and cells because of their commercial availability, high quality, easy 
detection by means of fl uorescence measurements and wide variety of available sizes and sur-
face chemistries (surface charges) (Varela et al. 2012). PS-NPs have been reported to enter dif-
ferent cell types like renal cells (Monti et al. 2015), macrophages (Xia et al. 2008), hepatocytes 
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(Johnston et al. 2010), gastric cells (Forte et al. 2016) and lung cells (Geys et al. 2006, Yacobi et 
al. 2008, Salvati et al. 2011, Deville et al. 2015). Results from these studies have shown that the 
in vitro internalisation of NPs depends on several factors like cell type, NP size, surface charge 
as well as the presence or absence of serum in the cell culture medium. Evaluation of studies 
with PS-NPs with diff erent size (50 and 100 nm) and charge (negative and positive) in an in 
vitro intestinal cell model, suggests that ingested PS-NPs, depending on their size and charge, 
could potentially translocate across the intestinal barrier (Walczak et al. 2014). 
Although polystyrene itself is considered to be inert, several studies have found toxic eff ects 
of PS-NPs. Aft er internalisation in human gastric adenocarcinoma epithelial cells, PS-NPs of 
44 and 100 nm aff ected gene expression, and caused infl ammatory responses and morpho-
logical alterations, especially for the smaller sized PS-NPs (Forte et al. 2016). In another study, 
20 nm carboxylated PS-NPs were taken up passively, stimulated IL-8 secretion, and induced 
oxidative burst in human monocytes while 1000 nm PS-NPs entered cells both passively and 
actively (Prietl et al. 2014). Th e eff ect of size has also been demonstrated by Bhattacharjee et 
al. who investigated polymer NPs of 45 and 90 nm. Th e 45 nm NPs showed a higher response 
in terms of cytotoxicity, ROS production and TNF-α release, compared to the 90 nm NPs 
(Bhattacharjee et al. 2012). Surface charge is another factor that could determine cytotoxicity 
of NPs (Bhattacharjee et al. 2010, Frohlich 2012). In the present thesis, aminated PS-NPs 
(positively charged) and carboxylated PS-NPs (negatively charged) were used. Th e present 
thesis studied whether these diff erences in surface charge would aff ect their toxicokinetic and 
toxicodynamic characteristics. 
Metal and metal oxide NPs
Th e other model NPs used in the present thesis were metal and metal oxide NPs. Several met-
al and metal oxide NPs are possible constituents of approved food additives. Food additives, 
such as titanium dioxide (TiO2) (E171), iron(III) oxide (Fe2O3) (E172), and silicon dioxide 
(SiO2) (E551) consist of metal oxide particles of variable sizes. Also metal NPs may be present 
in food additives, and for this silver (Ag) (E174) is an example. At present the specifi cations 
of these food additives do not exclude the presence of the compounds in their nanoform, and 
food additives are excluded from the regulation that states that all ingredients that are present 
in nano-form should be indicated in the list of ingredients as ‘nano’ (2011). In addition to the 
food-borne NPs, also some related metal oxide NPs were used in the present thesis. Th ese 
included manganese oxide (Mn2O3), copper oxide (CuO), chromium oxide (Cr2O3), cobalt 
oxide (Co3O4) and nickel oxide (NiO) NPs, to which humans may be exposed via products 
like paints, coatings, batteries, catalysts and construction materials (Siddiqui et al. 2012, Tav-
ares et al. 2014, Dang et al. 2015).
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Titanium dioxide (TiO2).
TiO2 is used in food as a colorant (E171), and as such may end up in food in the nanoform 
(Periasamy et al. 2015, Grande et al. 2016). Chewing gum and candies contain the highest 
amount of particulate TiO2. Of the chewing gum and candies many tested samples contained 
0.01 to 1 mg titanium per serving (Weir et al. 2012, Peters et al. 2014). TiO2 NPs are also 
used in glazes, paper, fi bers, plastics, pharmaceuticals, cosmetics, sunscreens and toothpastes 
due to their ability to confer opacity and whiteness (Weir et al. 2012). It has been shown that 
25-38% of the TiO2 of a food-grade TiO2 was present as NPs smaller than 200 nm (Weir et 
al. 2012). TiO2 NPs are normally present as a mixture of anatase and rutile crystal forms, of 
which the anatase form has been found to be more chemically reactive (Warheit et al. 2007). 
Concerns have been raised that TiO2 NPs may present a diff erent bioactivity than bulk TiO2 
and cause adverse eff ects to human health (Shi et al. 2013). It has been found that TiO2 NPs 
can induce genotoxicity, cytotoxicity, formation of reactive oxygen species (ROS) and induce 
cytokine production as demonstrated in vitro and in vivo (Gerloff  et al. 2012, Montiel-Davalos 
et al. 2012, Shi et al. 2013). Also exposure to a food grade TiO2 which included about 25% of 
the TiO2 as NPs <100 nm, has been found to cause a loss of microvilli of Caco-2BBe1 cells (Faust 
et al. 2014). Although TiO2 NPs have been studied extensively in recent years, a lot of issues 
concerning possible health eff ects still remain to be elucidated to support risk assessment and 
management (Shi et al. 2013).
Iron oxide (Fe2O3).
Fe2O3 is used in food products as coloring agent (E172), in paints and in the cosmetic and per-
sonal care industry, to add color to products like eye shadow, lipstick and mineral make-up. In 
recent years there has also been an increased interest for the use of Fe2O3 NPs for biomedical, 
magnetic, catalytic and electronic applications (Valdiglesias et al. 2016). New applications are 
for example drug delivery systems or magnetic resonance imaging contrast agents (Baetke et 
al. 2015). Together with these promising applications, concerns have been raised regarding 
the onset of unexpected adverse health eff ects following exposure. In vitro and in vivo studies 
report on several adverse eff ects of Fe2O3 NPs, such as a decrease in cell viability (Karlsson et 
al. 2009, Ying et al. 2010), increased ROS production (Alili et al. 2015), induction of apoptosis 
(Kim et al. 2013), cell cycle alterations (Wu et al. 2011), cell membrane disruptions (Rajiv et 
al. 2016), cytoskeleton modifi cations (Wu et al. 2008) and autophagy (Shi et al. 2015). How-
ever, a recent review concluded that the potential human health eff ects of Fe2O3 NPs remain 
unknown, since the currently available information on their potential toxicity is still scarce 
and contradictory, and human epidemiological studies do not exist (Valdiglesias et al. 2016). 
Silicon dioxide (SiO2).
SiO2 is used as an anti-caking additive in several food products (Chaudhry et al. 2008, Dek-
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kers et al. 2013). Coff ee creamers, instant soups and seasoning mixes are products that con-
tain the highest amount of nano-sized SiO2 (Dekkers et al. 2011). Analysis of isolated SiO2 
samples from commercial food products showed the presence of SiO2 NPs of about 10-50 nm 
in size (Athinarayanan et al. 2014). Also, it was demonstrated that 33% of the food additive 
SiO2 (E551) consisted of 10- to 200-nm spherical particles (Dekkers et al. 2011). Th e health 
risks of using nano-sized SiO2 particles as food additives are largely unknown. 
When food products containing SiO2 were tested in an in vitro digestion model, which sim-
ulated the conditions of the human gastrointestinal tract, it was found that SiO2 NPs (5-200 
nm) were still present in the intestinal content upon 4 hours and 15 minutes of incubation 
(Peters et al. 2012). Th is indicates that it is most likely that upon consumption of foods con-
taining SiO2, the gut epithelium is exposed to SiO2 NPs (5-200 nm) (Peters et al. 2012). SiO2 
NPs can translocate across the intestinal barrier, as demonstrated in a rat in vivo study in 
which 6.6-9.7% of SiO2 NPs of 20 and 100 nm were absorbed into the systemic circulation 
when orally administered at a single dose of 500 or 1000 mg/kg bw (Lee et al. 2014). 
Several in vitro and in vivo studies have shown adverse eff ects of SiO2 NPs. Yamashita et al. 
demonstrated that 70 nm SiO2 NPs reduced the growth of fetuses in pregnant mice upon 
intravenous injection, while the 300 and 1000 nm particles did not induce these eff ects (Ya-
mashita et al. 2011). In endothelial cells, 20 nm SiO2 NPs were shown to induce ROS produc-
tion which resulted in apoptosis via JNK/p53 dependent mitochondrial pathways (Liu et al. 
2010). Exposure of bone marrow-derived dendritic cells to SiO2 NPs (14 nm) induced partial 
maturation of the cells, activation of the infl ammasome and apoptosis in a substantial fraction 
of cells (Winter et al. 2011). Human lung normal fi broblast treated with high concentrations 
of isolated SiO2 containing NPs (10–50 nm), showed cellular damage, mitochondrial mem-
brane potential depletion, and ROS generation. Th e cell cycle distribution was altered and 
the expression of antioxidant enzymes and stress response proteins were modulated (Athina-
rayanan et al. 2014).
Silver (Ag).
Th e food additive silver (E174) is used as coloring agent to give a metallic appearance to for 
example cake decorating sweets. Silver NPs are used in food supplements, in the form of 
aqueous suspensions of Ag NPs that claim to enhance the body’s immune system and to have 
antimicrobial activity (Griﬃ  th et al. 2015). Furthermore, Ag NPs are used as antibacterial 
coatings in refrigerators and food packaging materials, wound dressings, clothes and deodo-
rants (Nanoparticle Products Inventory). In vitro studies report on various adverse eff ects 
of Ag NPs, including for example a decrease in cell viability (McShan et al. 2014), increased 
ROS production (Rahman et al. 2009), DNA damage (Huk et al. 2014), cell cycle alterations 
(Asharani et al. 2009), apoptosis (Foldbjerg et al. 2009) and inhibition of stem cell diff erenti-
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ation (Park et al. 2011). In vivo studies with Ag NPs have been done with rats (Vandebriel et 
al. 2014, Boudreau et al. 2016, Garcia et al. 2016) and mice (Su et al. 2013). In a 28-day repeat-
ed-dose toxicity study with rats, intravenously administration of Ag NPs induced suppression 
of the functional immune system (Vandebriel et al. 2014). Factors known to infl uence toxicity 
are concentration, dispersion, size and surface functionalization of the Ag NPs (Duran et al. 
2015, Recordati et al. 2016). 
Manganese oxide (Mn2O3).
Human exposure to Mn2O3 NPs is not so much via the food, but is more likely to take place as 
occupational exposure since Mn2O3 NPs are mainly used in industry, for example as compo-
site in wastewater treatment, as catalysts, sensors, electronic components or voltage sensitive 
material (Negahdary et al. 2015). So far, a limited number of studies investigating the eff ects 
of Mn2O3 has been performed. Some in vitro studies classifi ed Mn2O3 NPs as one of the most 
toxic metal oxide NPs and it has been hypothesized that oxidative stress can be a mechanism 
underlying their cytotoxicity (Zhang et al. 2012, Liu et al. 2013). Recently, 70 nm Mn2O3 NPs 
at a dose of 400 ppm in the diet were found to reduce sex hormone levels and sperm produc-
tion and caused testicular damage in Wistar adult male rats (Negahdary et al. 2015).
Copper oxide (CuO).
CuO NPs are used in catalysts, gas sensors, conductors, batteries and for applications in 
antimicrobial textiles, paints and plastics metallic coatings (Ren et al., 2009; Dastjerdi and 
Montazer, 2010; Delgado et al., 2011; Chang, Zhang et al. 2012). Exposure to CuO is mainly 
through inhalation (Ahamed et al. 2015). In vitro studies have shown that CuO NPs can 
cause cytotoxicity, DNA damage, ROS production, and infl ammatory and genotoxic eff ects 
(Karlsson et al. 2008, Karlsson et al. 2009, Perreault et al. 2012, Zhang et al. 2012). CuO NPs 
are reported to cause oxidative stress in cells (Karlsson et al. 2008, Zhang et al. 2012, Mitra et 
al. 2013).
Chromium oxide (Cr2O3).
Cr2O3 NPs are used as a pigment in paints, inks, and glasses. It is the colourant in “chrome 
green” and “institutional green” (Senapati et al. 2015).  Furthermore Cr2O3 NPs are used in a 
wide variety of applications such as: coating materials for thermal protection, wear resistance 
materials, solar energy application, digital recording system and electrochromic material 
(Abdullah et al. 2014, Meenambika et al. 2014). Exposure to Cr2O3 NPs is mainly through in-
halation (Senapati et al. 2015). In vitro studies have shown that in human lung epithelial cells, 
exposure to 30 nm Cr2O3 NPs caused DNA damage, which was investigated by the comet 
assay and the cytokinesis block micronucleus assay (Senapati et al. 2015). In L929 cells, 37 nm 
Cr2O3 NPs had signifi cant cytotoxic eff ects, induced ROS production and caspase-3 induc-
tion, indicating that exposure to Cr2O3 NPs induced apoptosis (Alarifi  et al. 2016).
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Cobalt oxide (Co3O4).
Co3O4 NPs fi nd applications in catalysts, sensors, magnetism, energy storage and in pigments 
(Papis et al. 2009). Since Co3O4 NPs are used in automotive exhaust catalysts, the NPs may 
get released into the air, and thus may be inhaled by humans (Verstraelen et al. 2014). In vitro 
studies have shown that exposure of HepG2 cells to Co3O4 NPs resulted in an induction of 
cytotoxicity and genotoxicity through ROS formation and oxidative stress (Alarifi  et al. 2016). 
In another study using human lymphocytes, a decrease in cell viability and an increase in cell 
membrane damage was observed aft er exposure to Co3O4 NPs. In addition chromosomal ab-
errations were observed in human lymphocytes exposed to 100 µg/ml Co3O4 NPs for 24 hours 
(Rajiv et al. 2016). One other study investigated both the in vitro eff ects of 60 nm Co3O4 NPs 
in normal PBMCs and the in vivo eff ects in Swiss mice that were subcutaneously injected by 
a three-days interval for 15 and 30 days with Co3O4 NPs (Chattopadhyay et al. 2015). Co3O4 
NPs induced signifi cantly the intracellular production of ROS and cytokines and apoptosis in 
normal PBMCs exposed in vitro. Th e in vivo results showed toxicity demonstrated by a sig-
nifi cant rise in lactate dehydrogenase (LDH), serum glutamate oxalate transaminase (SGOT) 
and creatinine level in the 200–1000 µg/kg bw treated groups (Chattopadhyay et al. 2015).
Nickel oxide (NiO).
While occupational nickel exposure is a known cause of pulmonary alveolitis, fi brosis, and 
cancer, the health risks of NiO NPs are not so well understood (Glista-Baker et al. 2014). 
NiO is an important industrial material used for solar cells, lithium-ion batteries, electronic 
components, as pigment for glasses, catalysts and ceramic materials (Song et al. 2008, Horie 
et al. 2011). Compared to bulk NiO, NiO NPs possess unique properties such as early oxida-
tion and melting phenomena, which can be used in industrial products promoting innovative 
applications (Song et al. 2008, Oukarroum et al. 2015). Possible exposure to NiO NPs can 
occur via inhalation (Shimada et al. 2009). In vitro studies have reported eff ects of NiO NPs 
exposure including cytotoxicity (Ada et al. 2010), oxidative stress (Horie et al. 2011), DNA 
damage (Kawanishi et al. 2002), apoptosis (Siddiqui et al. 2012) and induction of infl ammato-
ry cytokines (Morimoto et al. 2010). Some in vivo studies have demonstrated that NiO NPs of 
26 nm (Nishi et al. 2009, Morimoto et al. 2010), 27 nm (Ogami et al. 2009), and 20 nm (Horie 
et al. 2011) were able to induce infl ammatory eff ects aft er intratracheally instillation in rats. 
IN VITRO MODELS FOR THE STUDY OF TOXICOKINETICS OF NANOPARTI-
CLES
In the present thesis, fi rst the use of in vitro models for studies on the toxicokinetics of NPs is 
investigated. Toxicokinetics describe the uptake and fate of chemicals and NPs in the body as 
a result of absorption, distribution, metabolism, and excretion (ADME) processes, which to-
gether determine the internal exposure and the potential adverse health eff ect. Th e four main 
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routes via which NPs may enter the human body are oral, inhalation, dermal and systemic 
intravenous (IV) injection (Oberdorster et al. 2007, Krug et al. 2011). Several studies have 
indicated that translocation of NPs across the gut, lung and skin barriers is possible, enabling 
NP uptake upon oral, inhalation and dermal exposure, respectively (Landsiedel et al. 2012). 
Also, NPs have been shown to translocate across other barriers, such as the blood-brain bar-
rier and the placental barrier (Landsiedel et al. 2012). In order to estimate the in vivo internal 
exposure, several in vitro models have been used to study NP translocation across the lung, 
gut, skin, blood-brain and placental barrier (Mahler et al. 2012, Prow et al. 2012, George et al. 
2015, Poulsen et al. 2015). A detailed evaluation of the performance of such in vitro models is 
presented in chapter 2 of this thesis. 
Since part of the toxicodynamic studies of the present thesis were directed at testing the  pos-
sible developmental toxicity of NPs, an important toxicokinetic aspect studied in the present 
thesis was placental translocation of NPs. At present, research on placental translocation of 
nanomaterials and their eff ects on the placenta and the developing fetus is still in its infancy 
(Saunders 2009, Buerki-Th urnherr et al. 2012, Juch et al. 2013). Th e perfused isolated human 
placenta ex vivo model which maintains the complexity of the intact placenta, has oft en been 
used to study placental transfer (Saunders 2009). A drawback of the isolated ex vivo human 
placenta model is that experiments with this model are technically challenging and require 
large quantities of substances for testing. Th erefore, models using placental cells in an in vitro 
transwell system are being developed that may serve as in vitro alternatives for the isolated 
human placenta ex vivo model. Generally, these models are easier to handle and require less 
test material. Available human placental choriocarcinoma cell lines for such models include 
BeWo b30, Jar and JEG-3 cell lines, which have been applied to study placental translocation 
of a variety of drugs and compounds (Manley et al. 2005, Ikeda et al. 2011, Blazquez et al. 
2014). Th e BeWo b30 cell line is most commonly used in in vitro models of the placental 
barrier (Saunders 2009) and was also applied in the present thesis. Th is cell line  was derived 
from a human choriocarcinoma and can be grown on transwell inserts to form a cell layer that 
separates an apical from a basolateral compartment, representing the maternal and the fetal 
side, respectively. 
A few studies have applied the BeWo b30 transwell model to study translocation of NPs, in-
cluding PEGylated gold NPs of 10-30 nm (Myllynen et al. 2008), iron oxide and silica NPs of 
23-38 nm (Correia Carreira et al. 2013), dexamethasone loaded Poly lactic-co-glycolic acid 
(PLGA) NPs of 140-289 nm (Ali et al. 2013), rhodamine labelled silica NPs of 25 and 50 
nm (Sonnegaard Poulsen et al. 2013) and neutral PS-NPs of 50 and 100 nm (Cartwright et 
al. 2012). Th e 50 nm PS-NPs were translocated to a higher extent to the fetal compartment 
than the 100 nm PS-NPs, indicating that transport of PS-NPs in this in vitro model of the 
placental barrier is, like in the ex vivo placental model (Wick et al. 2010), dependent on the 
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size of the NPs (Cartwright et al. 2012). Th ese studies focused on the eff ect of size on the po-
tential translocation, while no studies have been performed on the eff ects of surface charge,
another important property of NPs driving their toxicokinetics. In the present thesis, we 
aimed therefore to assess the infl uence of surface charge on placental translocation. For this, 
the translocation of positively and negatively charged 50 nm PS-NPs was studied in the BeWo 
b30 placental model.
IN VITRO MODELS FOR THE STUDY OF TOXICODYNAMICS OF NANOPARTI-
CLES
In the present thesis toxicodynamic studies were directed at two endpoints that represent 
potential hazards of NPs that have not yet been well characterized. Th ese included develop-
mental toxicity and immunotoxicity.
Developmental toxicity of nanoparticles
Developmental toxicity refers to the adverse eff ects of compounds on developmental process-
es including the induction of structural abnormalities (malformations), growth retardation, 
death, and behavioural and functional abnormalities. To date, data on developmental toxicity 
of NPs are limited and remain insuﬃ  cient as a basis for risk assessment for pregnant women 
and their children (Powers et al. 2013, Hougaard et al. 2015). For NPs to reach the fetus, they 
fi rst need to translocate at the portal of entry to the systemic circulation and then traverse 
the placental barrier. NPs have been shown to be able to pass physiological barriers, such as 
that of the intestines and the placenta (Wick et al. 2010, Walczak et al. 2015), indicating that 
systemic exposure, including fetal exposure is feasible and that the fetus is hence a potential 
target of NPs. 
To assess possible adverse eff ects of NPs on the developing fetus, in vivo developmental toxici-
ty studies can be performed in for example rats (Ema et al. 2016, Garcia et al. 2016). However, 
because of economic and ethical constrains with in vivo studies, alternatives for in vivo toxic-
ity studies are being developed and validated (Jelinek et al. 1985, Fort et al. 2002, zur Nieden 
et al. 2004, Spielmann et al. 2006, Park et al. 2009, de Jong et al. 2011). Due to the complexity 
of the developmental process, it is a challenge to develop non-animal based methods that 
cover the whole developmental process (de Jong et al., 2011). Although the implementation 
of alternative methods for in vivo toxicity testing in regulatory frameworks is a relatively slow 
process, several in vitro tests that may function adequately in hazard assessment for develop-
mental toxicity are available. 
Currently, three in vitro developmental toxicity tests have been validated according to EC-
VAM’s (European Centre for the Validation of Alternative Methods) criteria: the whole em-
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bryo culture (WEC), the limb bud micromass (MM) and the embryonic stem cell test (EST) 
(Genschow et al. 2002, Augustine-Rauch et al. 2010). Of these three tests only the EST does 
not require pregnant animals to obtain embryonic tissue (de Jong et al. 2011). Th e EST uses 
pluripotent mouse embryonic stem cells, derived from the inner cell mass of blastocysts. Th e 
test is based on the capacity of murine embryonic stem (ES) cells (cell line D3) to diff erentiate 
into contracting myocardial cells under specifi c cell culture conditions (Campagnolo et al., 
2013). Th e treatment-induced inhibition of the formation of beating cardiomyocytes in em-
bryoid bodies (EBs) outgrowth is used as a toxicological endpoint to assess the embryotoxic 
potential of a compound (Buesen et al., 2004). Disturbances of ES cell diff erentiation follow-
ing a treatment indicate an embryotoxic potential, since embryotoxic compounds can inter-
fere with these diff erentiation processes (ECVAM 2012). Th e EST is relatively easy to carry 
out and the endpoints used in the assay do not require extensive knowledge on morphological 
development (de Jong, 2012). So far, some studies have used the diff erentiation assay of the 
EST to test NPs for in vitro developmental toxicity potencies, such as the studies testing amor-
phous silica NPs (Park et al. 2009), gold and cobalt ferrite NPs (Di Guglielmo et al. 2010), and 
oxidized single-wall carbon nanotubes (SWCNTs) (Pietroiusti et al. 2011). So far, the EST has 
never been applied to evaluate the eff ects of surface charge of NPs on embryotoxicity. Th e 
present thesis aims to study the embryotoxicity of diff erentially charged PS-NPs in the EST, 
which can be related to the toxicokinetic studies in the in vitro BeWo b30 placental transwell 
system using the same PS-NPs.
Immunotoxicity of nanoparticles
A second toxicodynamic endpoint of interest is the potential immunotoxicity of NPs. Giv-
en that immune responses are highly complex processes, in vitro models generally focus on 
specifi c sub-characteristics of this endpoint. Intestinal and colonic macrophages represent 
the largest population of mononuclear phagocytes in the body. Gut macrophages are part of 
the fi rst-line defence mechanisms, playing a major role in the innate immune response (Ma 
et al. 2003, Smith et al. 2011, Elsabahy and Wooley 2013). NP-induced macrophage cell death 
may decrease the innate immune response. NPs have been shown to induce infl ammato-
ry responses, like induction of proinfl ammatory cytokines and oxidative stress responses, in 
diff erent mammalian cell lines which may point at possible immunotoxicity (Nel et al. 2006, 
Elsabahy and Wooley 2013, Watson et al. 2014). NPs can interact with various components of 
the immune system and either enhance or inhibit its function (Elsabahy and Wooley 2013). 
For example ZnO NPs tested in primary and immortalized immune cells were observed to re-
lease Zn2+ from the ZnO NPs which triggered the production of ROS, resulting in autophagic 
death of immune cells (Johnson et al. 2015). Intravenous administration of Ag NPs to rats in 
a 28-day repeated-dose toxicity study induces suppression of the functional immune system, 
as observed by a reduction in KHL-specifi c IgG and a reduced thymus weight (Vandebriel 
13937-kloet-layout.indb   17 28/10/2016   09:28
18
Chapter 1
et al. 2014). Further, NPs have been reported to attract macrophages and neutrophils that 
in response can produce ROS (Krug et al. 2011). Activation of cytokine production, such as 
TNF-α, by macrophages upon exposure to NPs may lead to infl ammatory reactions. 
In this thesis, eff ects of NPs on RAW264.7 cells were characterized, assessing cell viability, 
mitochondria related parameters and release of TNF-α. RAW264.7 cells are macrophages 
and can be considered an in vitro model for this important cell type in the innate immune 
function. Focus was on mitochondria-related parameters, as previous research indicated that 
mitochondria play an important role in NP-induced toxicity and ROS production (Shvedova 
et al. 2012, Bhattacharjee et al. 2013). Th e NPs chosen for these studies were the metal oxide 
NPs. Endpoints studied included cell viability, oxidative stress, mitochondrial permeability 
transition pore (MPTP) opening, ATP levels and TNF-α production. Th e MPTP opening 
refers to a change in the inner mitochondrial membrane permeability (Bonora et al. 2014). 
An increase in MPTP opening results in a rapid loss of mitochondrial membrane potential, 
a decrease in ATP production and fi nally in the loss of cell integrity (Ly et al. 2003). Th e 
production of ROS within cells (oxidative stress) can be a main cause leading to cell death 
(Elsaesser et al. 2012). Th e NPs’ ability to generate oxidative stress can be due to their high 
surface reactivity (Krug et al. 2011), the presence of transition metal ions in the case of metal 
oxides (Kim et al. 2014), or the fact that they can interact with the mitochondrial membrane 
and disrupt the electron transport chain (Bhattacharjee et al. 2012).
PHYSICOCHEMICAL CHARACTERIZATION
It is important to note that the assessment of toxicokinetics and -dynamics of NPs using in 
vitro assays is more complex than with regular chemicals. Factors like size, shape, composi-
tion, surface modifi cations, surface charge, interactions with salts, proteins and other macro-
molecules can have a major infl uence on the kinetics and dynamics of NPs  (Oberdorster et 
al. 2005, Bouwmeester et al. 2011, Landsiedel et al. 2012). Surface charge has an eff ect on the 
potential for aggregation and agglomeration of the NPs, infl uencing the uptake and translo-
cation of NPs by organisms (Graf et al. 2012). Due to their high surface energy, NPs adsorb 
biomolecules upon contact with biological environments, forming the so-called protein coro-
na (Cedervall et al. 2007). Th e formation of the protein corona can infl uence the biodistribu-
tion and clearance (toxicokinetics) of NPs as well as their possible interactions with cellular
macromolecules and cells, indicating that it can also infl uence their toxicity and pathophysi-
ology (Meissner et al. 2009, Tenzer et al. 2013). 
Not only the NP material, size and surface properties have been shown to play a role in de-
termining the composition of the protein corona, also exposure time and the type of phys-
iological fl uid (e.g. human or murine, plasma or serum) are critical aspects (Fadeel 2012, 
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Westmeier et al. 2016). Th is implies that when developing and validating possible in vitro 
alternative model systems for testing kinetics and dynamics of NPs, their characterisation in 
the actual medium or matrix in which they are tested and the relevance of this medium for 
the in vivo situation is of utmost importance (Gunsolus et al. 2016). Th erefore, in the present 
thesis, the NPs were characterized in the medium used for the respective assay using dynamic 
light scattering (DLS), zeta potential and scanning electron microscopic (SEM) techniques.
OUTLINE OF THE THESIS
As outlined above the aim of the present thesis was to investigate the potential of in vitro 
testing strategies to detect hazards of NPs, focusing on toxicokinetic as well as toxicodynamic 
endpoints. Model NPs used for the studies included PS-NPs with diff erent surface charges, 
and metal (oxide) NPs, of which some are possible constituents of specifi c food additives. Th e 
work is presented in seven chapters. Th e present chapter, chapter 1, provides an introduction 
and background information on the work discussed in this thesis. 
Chapter 2 presents a review about the performance of in vitro models for studies on toxicoki-
netics of NPs. Th e chapter describes models that mimic the diff erent barriers of the human 
body, with a focus on the lung, gut, skin and placental barrier, thus providing an overview of 
the state-of-the-art of using in vitro model systems to characterize the translocation of NPs 
across these diff erent barriers. 
In chapter 3 the BeWo b30 model for placental transfer was selected to study the role of 
NP charge on their placental translocation, using PS-NPs with positive and negative charge. 
Th e BeWo b30 model was used to get an initial qualitative impression about the capacity of 
PS-NPs to translocate across the placental barrier, which can be used to defi ne priorities for 
further in vivo studies on placental translocation of NPs and developmental toxicity.
Chapter 4 investigated whether the same PS-NPs as tested in chapter 3 for placental trans-
location, are able to cause in vitro developmental toxicity in the ES-D3 cell diff erentiation 
assay of the EST. Th is study also focussed on the eff ect that charge may have on the in vitro 
developmental toxicity. Combining the results from Chapter 3 and 4 allows the integration 
of kinetic considerations with the in vitro developmental toxicity assay to improve the pre-
diction of the in vivo hazards as done previously by Li et al. (Li et al. 2015, Li et al. 2015) for 
a series of azoles. 
In chapter 5, toxic eff ects of a series of metal (oxide) NPs were tested in macrophage RAW264.7 
cells in order to obtain insight in the eff ect of these NPs on cells that present a model for the 
innate immune response. In these macrophage RAW264.7 cells the eff ects of the metal (oxide) 
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NPs was characterized on cell viability, TNF-α production and mitochondria-related para-
meters like formation of reactive oxygen species (ROS), mitochondrial permeability transi-
tion pore (MPTP) opening, and intracellular ATP, since previous research has indicated that 
mitochondria play an important role in NP-induced toxicity (Park et al. 2008, Sharma et al. 
2011, Shvedova et al. 2012, Bhattacharjee et al. 2013).
In chapter 6 we used the in vitro RAW264.7 model to characterize the eff ect of surface charge 
and size of NPs in this in vitro model system using Ag NPs with two diff erent sizes (20 and 
50 nm) and with three diff erent surface coatings (chitosan, bovine serum albumin, polyvi-
nylpyrrolidone). Th e eff ects of these Ag NPs on cell viability, TNF-α production, formation 
of ROS, mitochondrial permeability transition pore (MPTP) opening, and intracellular ATP 
were measured. All together the results of the work presented in this thesis will contribute to 
the further development and use of in vitro testing strategies for the safety testing of NPs and 
provide insight into selected potential hazards of the tested NPs.
Chapter 7 discusses the fi ndings described in the thesis and presents suggestions for future 
research.
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ABSTRACT   
Th e increasing use of nanoparticles in products likely results in increased exposure of both 
workers and consumers. Because of their small size, there are concerns that nanoparticles 
unintentionally cross the barriers of the human body. Several in vivo rodent studies show 
that, dependent on the exposure route, time, and concentration, and their characteristics, 
nanoparticles can cross the lung, gut, skin, and placental barrier. Th is review aims to evaluate 
the performance of in vitro models that mimic the barriers of the human body, with a focus 
on the lung, gut, skin, and placental barrier. For these barriers, in vitro models of varying 
complexity are available, ranging from single- cell-type monolayer to multi-cell (3D) models. 
Only a few studies are available that allow comparison of the in vitro translocation to in vivo 
data. Th is situation could change since the availability of analytical detection techniques is no 
longer a limiting factor for this comparison. It was concluded that to further develop in vitro 
models to be used in risk assessment, the current strategy to improve the models to more 
closely mimic the human situation by using co-cultures of diff erent cell types and microfl uid-
ic approaches to better control the tissue microenvironments are essential. At the current state 
of the art, the in vitro models do not yet allow prediction of absolute transfer rates but they do 
support the defi nition of relative transfer rates and can thus help to reduce animal testing by 
setting priorities for subsequent in vivo testing.
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INTRODUCTION
Nanoparticles have attractive and novel properties compared with their bulk counterparts 
and are therefore used in an increasing number of consumer products (Nanotechnologies 
2014). Examples are zinc oxide and titanium dioxide nanoparticles in sunscreens and silver 
nanoparticles in food packaging material, textiles, and cosmetics, but many more have been 
identifi ed (Bouwmeester et al. 2014). Th e increasing use of nanoparticles in products likely re-
sults in increasing exposure of both workers and consumers. Because of the unique properties
of nanoparticles that are related to their small size, concerns arise that nanoparticles would 
unintentionally cross the barriers of the human body, which would result in internal exposure 
to nanoparticles potentially leading to adverse eff ects. 
Several in vivo studies have been performed to assess the distribution of nanoparticles aft er 
inhalation, oral exposure, skin exposure, and intravenous injection (Balasubramanian et al. 
2010, Braakhuis et al. 2014a, Creutzenberg et al. 2012, De Jong et al. 2008, Elder et al. 2006, 
Geraets et al. 2012, Kreyling et al. 2009, Leite-Silva et al. 2013, Ma-Hock et al. 2012, Oberdor-
ster et al. 2004, Semmler et al. 2004, Takenaka et al. 2001, van der Zande et al. 2012, 2014). 
Th ese studies show that, depending on the exposure route, time, concentration, as well as on 
their characteristics, nanoparticles can cross the lung, gut, skin, and placental barrier.
Information  on  the  kinetics  of  nanoparticles  in  the human body is essential for risk assess-
ment purposes, because of their potency to accumulate. Th e overall resultant of absorption, 
distribution, metabolism, and excretion (ADME), i.e. internal exposure, will determine target 
tissue doses and will be critical for the ultimate systemic adverse health eff ects (Geraets et al. 
2014). Even in cases of low absorption of nanoparticles, the oft en chronic nature of the expo-
sure (inhalatory, oral or dermal) might result in internal accumulation of the nanoparticles 
potentially reaching levels that might give rise to health concerns (van Kesteren et al. 2014). 
Th e current risk assessment of nanoparticles (and chemicals) mainly relies on in vivo studies 
using animal models (EFSA 2011). While these in vivo studies provide unique information on 
the distribution of nanoparticles in a whole organism, the number of animal studies should 
be reduced as much as possible for several reasons (Hartung et al. 2013). First, the use of 
animals is ethically debatable. Secondly, animal models do not fully simulate the physiology 
of humans. Lastly, given the great number of and variety in diff erent nanoparticles, it is im-
possible and economically not feasible to test all of them through in vivo studies. Th erefore, 
in vitro models have been developed to study the translocation of nanoparticles (Hartung et 
al. 2013) and estimate the in vivo internal exposure. However, before such in vitro models can 
reliably be used in risk assessment of nanoparticles, they need to be well described and vali-
dated (Kandarova and Letasiova 2011, Worth and Balls 2004) using in vivo data (Genschow 
et al. 2002).
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To obtain reliable NP kinetic data from in vitro or in vivo studies, robust analytical detection 
methods should be used in the experiments. Over the last couple of years, the quality of 
NP characterization methods used in kinetic studies has been improved, but much is to be 
gained here. Th erefore, the current state of the knowledge on analytical detection methods 
was reviewed and directions for further improvement and incorporation in in vitro or in vivo 
studies were proposed.
Th is review aimed to evaluate the existence and performance of in vitro models that mimic 
the barriers of the human body. Where possible the observed translocation in vitro was com-
pared to the in vivo translocation to compare to what extent the in vitro results mimic the in 
vivo situation. In addition, the placental barrier was included that protects the unborn foetus 
from exposure via the maternal circulation. For an overview on the status of alternatives for 
regulatory toxicology in general, we refer to the 2014 JRC Science and Policy Report by Worth 
et al. (2014). First the diff erent in vitro models that are currently in use to study the transfer 
of nanoparticles via inhalation, oral uptake, skin uptake, and placental uptake were described. 
In vitro models that are used only to assess the toxicity of nanoparticles, but not to measure 
translocation, are excluded from this review. Aft er defi ning the in vitro models available to 
study transfer across the diff erent barriers, the results of the in vitro models were compared 
with available in vivo data and discuss their predictive value. Finally, recommendations were 
given for the future development of relevant in vitro models.
Introduction to the lung barrier
Th e main function of the lungs is to transport oxygen from the atmosphere into the blood-
stream and to release carbon dioxide from the bloodstream into the atmosphere. During in-
halation, air travels from the mouth or nose through the nasopharynx, oropharynx, larynx, 
and trachea. Th e trachea divides into two main bronchi, which branch to the left  and right 
lungs and subsequently subdivide into a system of bronchi and bronchioles until the alveoli 
where the gas exchange takes place. Th e airways are lined by ciliated respiratory epithelium, 
which is covered by a mucus layer. Th e mucociliary movement is an important clearance 
mechanism, especially to remove inhaled (nano)particles. Deeper in the airways, the clear-
ance is slower, given the increased pathway length and decreased mucous velocity (Geiser 
and Kreyling 2010). Nanoparticles, especially those that dissolve readily such as ZnO, may be 
able to translocate the mucus layer and reach the epithelial cells and thus cause local damage 
(Frieke Kuper et al. 2015, Landsiedel et al.2014a, Vandebriel and De Jong 2012). Th ey may 
also be able to cross the epithelial barrier and reach underlying interstitium with its blood and 
lymph vasculature.
Th e alveoli are lined by a single epithelial layer under which is an interstitium with extracel-
lular matrix, blood capillaries, and stromal cells. Th e epithelial layer is covered by surfactant 
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at the alveolar luminal side. Alveolar type I cells form the structure of the alveolar wall. Th ese 
cells are very thin to improve the gas exchange. In addition, type I cells have tight junctions to 
prevent chemicals and particles from entering the bloodstream. Besides type I cells, alveolar 
type II cells secrete pulmonary surfactant to lower the surface tension. Finally, for clearance 
of particles and pathogens from the lungs, alveolar macrophages are present (Klein et al. 2011, 
Möller et al. 2010).
To cross the lung–blood barrier, nanoparticles must deposit in the alveolar region. Th e depo-
sition of inhaled particles depends on the morphology of the lungs, the respiratory  condi-
tions,  and  the  physicochemical  properties of the particles. Th e most important physico-
chemical properties of inhaled particles that infl uence deposition are (agglomerate) size, size 
distribution, density, shape, charge, and hygroscopicity (Braakhuis et al. 2014b, Carvalho et 
al. 2011, Pilcer and Amighi 2010). When the agglomerate size of nanoparticles is <100 nm but 
>10 nm, a considerable part will deposit in the alveolar region (about 30 % of the particles) 
(Asgharian et al. 2009, ICRP 1994, Oberdorster 1989). Below 30 nm, the deposition shift s 
from the alveoli more towards to tracheobronchial region (Braakhuis et al. 2014b).
Once deposited in the alveoli, nanoparticles can be cleared  from  the  lungs  by  alveolar 
macrophages.  However, single nanoparticles and agglomerates of <100 nm are less eﬃ  ciently 
phagocytized by alveolar macrophages compared  with  microparticles  or  large  agglomerates 
of >1 µm (Bakand et al. 2012, Muhlfeld et al. 2008, Phalen et al. 2010). Aft er uptake of the par-
ticles, macrophages can move gradually upward by the mucociliary escalator, are subsequent-
ly swallowed, and enter the gastrointestinal tract. If not cleared by phagocytosis, nanoparticles 
can be taken up by the alveolar epithelium and reach the pulmonary interstitium from which 
they are transported to the local lymph nodes, or reach the blood circulation (Borm et al. 
2006). Translocated particles may subsequently reach organs where they can be taken up and 
might cause damage (Braakhuis et al. 2014b).
Introduction to the intestinal barrier
Th e primary functions of the human gastrointestinal (GI) tract are related to the digestion 
and absorption of nutrients and electrolytes, and to water homeostasis. Th e GI tract is respon-
sive to internal stimuli as well as to (microbe) stimuli from the lumen content. Th e GI epithe-
lial layer forms a tight, but selective barrier: nutrients are absorbed eﬃ  ciently, while microbes, 
for example, are not. Anatomically the gut wall can be divided into the mucosa, submucosa, 
muscularis externa, and serosa. At the lumen site, the gut wall consists of a mucosa, which 
is a combined mucus and cell epithelial layer. Th e composition of the mucus and the type of 
cells is variable along the GI tract and refl ects the specialized function of each region. Th e 
submucosa is a layer of connective tissue that contains lymphatic and blood vessels as well as 
ganglion and nerve cells. In the next layer, the muscularis externa, the main smooth muscles 
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of the gut are found. Th e thickness of the muscle layer varies. Th e serosa is a squamous epi-
thelium (mesothelium) which sits on connective tissue and is continuous with the abdominal 
peritoneum.
Th e small intestine is the site where most of the chemical and mechanical digestion takes 
place and where almost all of the absorption of nutrients and electrolytes is carried out. Th e 
wall of the small intestine is lined with absorptive mucosa. Th e mucosal surface is extended 
by the presence of crypts and villi. Th e most common epithelial cell is the enterocyte, its major 
function being to absorb nutrients. Th e second cell type is the mucus-secreting goblet cell, the 
mucus acts as a lubricant and protects the mucosa from irritation. Lastly, the gut-associated 
lymphoid tissue (GALT) includes several specialized cells including Peyer’s patches, M cells, 
and intraepithelial lymphocytes, which are part of the intestinal immune system.
Following ingestion, translocation of particles into and across the gastrointestinal mucosa can 
occur via four diff erent: (1) via endocytosis, through enterocytes, (2) via the M cell-rich layer 
of Peyer’s patches (small intestinal lymphoid aggregates), (3) via persorption, where particles 
can trans- locate through a ‘hole’ left  in the epithelium when enterocytes shed from the villous 
tip, and (4) via the paracellular route, where nanoparticles pass across tight junctions of the 
epithelial cell layer (Powell et al. 2010). While the exposure of the gastrointestinal mucosa to 
engineered nanoparticles might pose yet unresolved heath issues, it is important to realize 
that people in the Western world are daily exposed to sub-micrometre-sized mineral particles 
(Powell et al. 1996, 2010). Th ese particles have been observed to be composed of aluminosili-
cates, titanium dioxide, and a small percentage of non-aluminium-containing silicates such as 
silica (SiO2) and magnesium trisilicate (talc) (Dekkers et al. 2011, Powell et al. 1996).
Introduction to the skin barrier
Th e skin is a barrier towards loss of water and ingress of microorganisms, UV radiation, and 
potentially harmful chemicals. Although the permeability of skin is an order of magnitude 
less than that of the intestinal epithelial cell layer, due to its large surface of almost 2 m2  and 
likelihood of dermal exposure in everyday life, the skin can pose an important absorption 
route for nanoparticles. Th e barrier function of the skin is generally attributed to its upper 
layer, the stratum corneum. Th e stratum corneum consists of stacked layers of corneocytes, 
enucleated fl attened cells that are surrounded by impermeable cornifi ed envelope and em-
bedded in organized lipid bilayers. Th ere are three potential routes by which a penetrant can 
diff use across the stratum corneum: (1) across the lipid bilayers (intercellular route; Fig. 1a), 
(2) across the corneocytes and lipid bilayers (intracellular route; Fig. 1b), and (3) along hair 
follicles and sweat glands (Fig. 1c).
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Th e intracellular route is thermodynamically unfavourable due to the highly impermeable 
cornifi ed envelope of the corneocytes. For most chemicals, the route across lipid bilayers 
represents the main diff usional pathway. Th e stratum corneum lipids are organized in two 
coexisting lamellar phases: a long periodicity phase with a repeat distance of around 13 nm 
and a short periodicity phase with a repeat distance of around 6 nm (Baroli 2010). Th e space 
between the tail–tail and head–head domains of the lipid bilayers (Fig. 1) restricts the size of 
a NP that is able to penetrate across the stratum corneum (Baroli 2010, Cevc and Vierl 2010). 
Another restriction factor for the penetration of nanoparticles across the intracellular route 
is high diff usion resistance for particles larger than 5 nm (Watkinson et al. 2013). Th us, theo-
retically for nanoparticles larger than approximately 5 nm the route along hair follicles might 
represent the predominant penetration route.
Th is view, however, can be challenged in the case of a compromised skin barrier, which can 
occur due to intrinsic and environmental factors. For instance, one of the main features of a 
common infl ammatory skin disease, atopic dermatitis (AD), is a damaged skin barrier (Kezic 
et al.2014). Furthermore, exposure to skin irritating chemicals such as detergents and or-
Figure 1. A schematic illustration of the skin and main penetration routes, insert showing the lipid bi-
layers between corneocytes. Route A: across the lipid bilayers (intercellular route); Route B: across the 
corneocytes and lipid bilayers (intracellular route); Route C: along hair follicles and sweat glands
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ganic solvents in the work place as well as in everyday life can also lead to increased skin 
permeability (Kezic and Nielsen 2009). Data on percutaneous penetration of nanoparticles 
are scarce. Recently, Labouta et al. 2011a, b showed that in contrast to intact skin barrier, the 
skin compromised by toluene allows for penetration of nanoparticles of 15 nm into viable 
skin (Labouta et al.2011b).
Introduction to the placental barrier
Th e human placenta is a unique organ, structurally complex, highly eﬃ  cient, and metabol-
ically and biosynthetically active (Aye and Keelan 2013). Th e placenta is responsible for the 
(bidirectional) transfer of substances between the maternal and foetal circulations including 
carbon dioxide, oxygen, water, nutrients, hormones, vitamins, and also xenobiotics includ-
ing drugs and toxic compounds (Desforges and Sibley 2010). In early pregnancy, the human 
placenta is primarily composed of cytotrophoblasts, which continually fuse to form multinu-
cleate syncytiotrophoblasts as pregnancy progresses. Th e syncytiotrophoblast consists of two 
polarized plasma membranes: a maternal-facing microvillous plasma membrane (MVM) and 
a basal plasma membrane (BM) oriented towards the foetal circulation (Kulvietis et al. 2011, 
Lager and Powell 2012) (Fig. 2).
Figure 2.  Schematic illustration of the placental barrier as a cross section of a human placental vil-
lus. Th e placental barrier consists of two layers: the syncytiotrophoblast and cytotrophoblast, the latter 
forming a discontinuous layer. Th e basal plasma membrane (BM) of the syncytiotrophoblast is oriented 
towards the foetal circulation, while  the maternal-facing microvillous plasma membrane (MVM) faces 
the maternal blood compartment
Th e rate-limiting barrier in the human placenta for the permeation  of  substances  between 
maternal  blood  and foetal capillaries is the syncytiotrophoblast (Young et al. 2003). Once 
in the cytoplasm of the syncytiotrophoblast, molecules destined for the foetus exit from the 
syncytiotrophoblast via the foetal facing basal plasma membrane (BM) (Desforges and Sibley 
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2010). At term, the placental diameter varies between 200 and 220 mm (Benirschke et al. 
2006). Th e diff usion distance between the maternal and foetal circulations varies between 4 
and 5 µm, while in the fi rst trimester the distance varies between 50 and 100 µm (Aye and 
Keelan 2013, Benirschke et al. 2006). Passage across the placenta can occur via simple diff u-
sion, pinocytosis, receptor-mediated uptake, and both active and facilitated transport (Aye 
and Keelan 2013). Th e syncytiotrophoblast plasma membranes express numerous transport-
ers which may be regulated by foetal, maternal and placental signals (Lager and Powell 2012). 
Th e anatomy and physiology of the human placenta is diff erent from the rodent placenta. Th e 
main diff erence is that in humans the syncytiotrophoblasts arise from fusion of cytotropho-
blast cells and form a syncytium with no lateral cell membranes. In rodents, three trophoblast 
layers are present between maternal blood and foetal blood capillaries. 
Overview of currently used in vitro models to study translocation of nanoparti-
cles
Many diff erent in vitro models have been developed to study the translocation of nanopar-
ticles. Most in vitro barrier models culture cells on Transwell inserts, which consist of a per-
meable membrane separating an apical and a basolateral compartment. Cells are seeded and 
cultured on the inserts to form a barrier (upon confl uence of the cells) between the two com-
partments. Depending on the cell type selected, the Transwell model can be used to study 
lung, gastrointestinal, or placental transfer.
Transwells can be used to quantify both uptake of nanoparticles into the cells from the apical 
compartment and eﬄ  ux from the cells to the basolateral compartment as a measure of trans-
location (Fig. 3). Fluorescent polystyrene nanoparticles are the most commonly employed 
because of their easy detection.
Skin in vitro models are not based on Transwell inserts, because these cell culturing models 
Figure 3.  Two-compartment cell culture system contains a permeable cell culture insert, separating two 
compartments in a Transwell. Cells are seeded and cultured on the inserts to form a barrier between the 
two compartments
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lack the principal barrier, the stratum corneum. Th erefore, ex vivo skin models are mostly 
used for the in vitro assessment of nanoparticles translocation. Also for the other barriers, 
especially for the placental barrier and to a lesser extent for the lung and intestinal barrier, ex 
vivo models are available to test the translocation of nanoparticles.
Table 1 presents an overview of in vitro barrier models currently used to study the transloca-
tion of nanoparticles aft er inhalation, oral intake, dermal exposure, and across the placenta.
Lung in vitro models
Th e most frequently used lung epithelial cells lines are A549, Calu-3, H441, and 16HBE14o-. 
Of these cell lines, Calu-3, H441, and 16HBE14o- form tight junctions, but A549  do  not 
(Lehmann  et  al.  2011,  Chowdhury  et  al. 2010, Geys et al. 2006, Hermanns et al. 2004, 
George et al. 2015). In in vitro translocation studies, primary rat alveolar cells have also been 
frequently used (Fazlollahi et al. 2011, Geys et al. 2009, Yacobi et al. 2008).
Besides  diff erences  in  cell  types,  in  vitro  lung  barrier models diff er in whether they 
are submerged or cultured at the air–liquid interface. Submerged models have the advan-
tage of being technically simple. However, the culture medium can alter the properties of 
the nanoparticles, and subsequently their uptake and eff ects. Air–liquid models mimic more 
realistically the inhalation exposure; therefore, many air–liquid models have been developed 
recently (Blank et al. 2006, Brandenberger et al. 2010, Frohlich et al. 2013, Herzog et al. 2013, 
Holder and Marr 2013, Lenz et al. 2009, 2013, Raemy et al. 2011, Rothen-Rutishauser et al. 
2009, Savi et al. 2008, Xie et al. 2012). Disadvantages are the complexity of the system to 
maintain constant temperature and humidifi cation, and the high costs in comparison with 
submerged models.
In  recent  years,  co-culture  models  containing  more than one cell type are used to mimic 
the lung barrier more closely compared with monocultures (Klein et al. 2011). Most  models 
use  lung  epithelial  cells  as  a  basis,  those being either primary cells or immortalized cell 
lines. To obtain  co-culture  models,  diff erent  cell  types  are  added to the basic model. Th e 
fi rst type of co-culture models includes, in addition to epithelial cells, endothelial cells to 
mimic the alveolar-capillary barrier (Bermudez et al. 2002, Chowdhury et al. 2010, Hermanns 
et al. 2010, Hermanns et al. 2004, Papritz et al. 2010). Th is type of model can be extended by 
the addition of alveolar macrophages, mast cells, and/or type II alveolar cells. Th e second type 
of models does not include endothelial cells, but adds dendritic cells and macrophages to the 
epithelial cell layer (Brandenberger et al. 2010, Muller et al. 2010, Rothen-Rutishauser et al. 
2008, Rothen-Rutishauser et al. 2005). Th is type of model can also be completed with type II 
alveolar cells. Th e third type of models includes, in addition to the epithelial cells, fi broblasts 
instead of endothelial cells, which can be extended by adding dendritic cells.
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A limited number of nanoparticles have been studied to test translocation across the in vitro 
lung barrier. Th ese include polystyrene nanoparticles, titanium dioxide nanoparticles, quan-
tum dots, cerium dioxide nanoparticles, gold nanoparticles, silica nanoparticles, diesel parti-
cles, and single-walled carbon nanotubes (Table 1). Th e translocation rate of nanoparticles is 
higher in models with cells that do not form tight junctions compared with cells that do (Geys 
et al. 2006, Hermanns et al. 2004, George et al. 2015). Probably, the higher translocation rate 
is a consequence of paracellular transport, which will not occur in a healthy lung but might 
occur in a damaged or infl amed lung. Th e  pore size of the permeable membrane of the in-
serts also infl uences the translocation rate of nanoparticles: the larger the pore size, the high-
er the translocation rate (Geys et al. 2006). Th erefore, for each single type of nanoparticles, 
the translocation across the diff erent types of inserts should be tested without cells to assess 
whether the nanoparticles are not withheld by the insert itself.
Ex vivo tissues as model for the lung are not addressed here. Th e precision-cut lung slices 
(PCLS) taken from human and rodent lungs have been used to study translocation and toxic-
ity of nanomaterials. Th e use of PCLS for translocation of nanoparticle-mediated drug deliv-
ery has recently been reviewed by Paranjpe and Muller-Goymann (Paranjpe and Muller-Goy-
mann 2014).
Gut in vitro models
Orally ingested nanoparticles are exposed to continuously changing conditions while tran-
siting through the gastrointestinal tract, which infl uences their nature and characteristics 
(Bellmann et al. 2015). In vitro GI models aim to mimic the gastrointestinal environment 
as closely as possible, to generate physiologically relevant results. Th ese models focus either 
on the aspects of dynamically changing GI conditions during digestion by simulation of the 
transit of nanoparticles along the GI tract from the mouth towards the large intestine (diges-
tion models), or on mimicking translocation and uptake behaviour (in vitro human intestinal 
epithelium models) (Lefebvre et al. 2014).
Human digestion models can fi rst be simple and static, and mimic only gastric or small in-
testinal conditions, in which materials are incubated with simulated gastric fl uids, simulated 
small intestinal fl uids or buff ers at static pH values (Mwilu et al. 2013, Minekus et al. 2014). 
More complex static models oft en include most of the relevant GI conditions, i.e. the oral, gas-
tric, small intestinal (and large intestinal conditions) (Oomen et al. 2003, Van de Wiele et al. 
2007, Versantvoort et al. 2005). Recently, these models have been used to assess the fate of 60-
nm silver nanoparticles, and nanometre-sized silica (synthetic amorphous silica) nanopar-
ticles during digestion (Peters et al. 2012, Walczak et al. 2013). In contrast to static models, 
more complex dynamic models simulate successive changes in conditions (i.e. pH, secretion 
of digestive fl uids) and transit times (Helbig et al. 2013, Kong and Singh 2010, Minekus et 
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al. 1995, Wickham et al. 2009, Zangenberg et al. 2001). Such a dynamic computer controlled 
model was used to study the behaviour of engineered nanoclay materials (Newsome 2014).
Translocation and uptake of nanoparticles can be addressed by cellular models that can also 
be divided in relatively simple models or more complex ones (Lefebvre et al. 2014). Amongst 
the variety of cell models that are available in vitro, intestinal Caco-2 cells (human epithelial 
colorectal adenocarcinoma cells) are the most commonly used cell type (Miret et al. 2004) in 
nanoparticle translocation studies. Caco-2 cells are regarded as model cells for enterocytes, 
the most abundant epithelial cell type in the intestine. Several examples can be found in the 
literature where  monocultures  of  Caco-2  cells  have  been  used  to study the in vitro trans-
location of nanoparticles, (mainly polystyrene, but also silicon, silver, and organic nanoparti-
cles) (Bhattacharjee et al. 2013, des Rieux et al. 2007, des Rieux et al. 2005, Mahler et al. 2009, 
Natoli et al. 2012, Nkabinde et al. 2012, Walczak et al. 2014).
A potential drawback of Caco-2 monolayers is the lack of a mucus layer (at least in con-
ventional models), which can, however, be introduced by co-culturing Caco-2 cells with 
HT29-MTX cells (human colon adenocarcinoma mucus-secreting cells) (Behrens et al. 2002, 
Mahler et al. 2009, Scaldaferri et al. 2012, Walczak et al. 2014). Th e mucus layer consists of 
mucin glycoproteins that form viscoelastic gels, and it is thinner in the small intestine com-
pared with the large intestine. Th ough this makes the small intestine a prominent place for 
nanoparticle uptake, the mucus layer also represents a hindrance allowing selective passage of 
materials. Th e mucus can entrap nanoparticles (and thus reduce their translocation) because 
it poses a physical barrier due to its thickness, density, negative charge, and constant renewal 
(Cone 2009, Crater and Carrier 2010, Szentkuti and Lorenz 1995). In addition, mucus has  a 
protective  function  for  bio-relevant  fl uids present in the lumen of the gut, and direct expo-
sure of Caco-2 cells (without a mucus layer) to lumen content stimulants reduces the barrier 
function of Caco-2 cells models (Ingels et al. 2002). Th is is probably due to the lack of mucus 
layer making the Caco-2 cells much more sensitive to direct exposure to the low pH and high 
osmolality of the buff ers (Westerhout et al. 2014).
To further increase the complex anatomy of the human gut epithelium, human intestine mi-
crofold (M) cells are introduced in epithelial monolayers. While M cells in total compose less 
than 1 percent of the small intestine epithelial cell layer, they are responsible for the uptake 
and translocation of relatively larger particles (Antunes et al. 2013, Bouwmeester et al. 2011, 
des Rieux et al. 2007, des Rieux et al. 2005, Kerneis et al. 1997, Martinez-Argudo et al.2007, 
Walczak et al. 2014). Recently, in vitro digestion models have been linked to in vitro gut epi-
thelial models to study fi rst the digestion of nanoparticles and next the bioavailability of the 
digested particles in the intestines (Walczak et al. 2015) (see Table 1).
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      Several  ex  vivo  gut  models  have  been  developed  to study the translocation of chem-
icals. Diff erent approaches are used ranging from in situ perfusion (intestinal loop) models 
to models in which part of the gut epithelium is excised from animals and maintained in, for 
example, Ussing chambers for a limited period of time. Th ese models have recently been re-
viewed by Lefebvre et al. (2014). Th ese authors summarize studies in which the translocation 
of mainly organic nanoparticles have been evaluated, only a limited number of studies used 
polystyrene or titanium nanoparticles that have also been used in vitro (see Table 1).
Skin in vitro models
For the determination of dermal absorption of chemicals, several guidelines have been estab-
lished by prescribing the type of skin membrane, species, and experimental protocol (OECD 
2004). However, specifi cally for nanoparticles, there are no such guidelines and critical evalu-
ation of the current models is missing. Skin in vitro models diff er in the type of the skin mem-
brane (full thickness skin vs. dermatomed skin), species (human vs. animal skin), vehicle and 
type of the diff usion cell, which hampers comparison and interpretation of the results.
Figure 4.  In vitro diff usion chamber to test bioavailability of nanoparticles across the skin barrier.
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In contrast to the lung, intestinal and placental barrier, no Transwells are used for percu-
taneous penetration studies. Th e reported in vitro studies on percutaneous penetration of 
nanoparticles have been performed by using either a Franz static cell or a fl ow-through dif-
fusion cells. In both systems, the skin membrane is clamped between two chambers, one of 
which contains a vehicle supplemented with the investigated chemical (donor chamber) and 
the other one a receptor fl uid from which the penetrated chemical will be sampled (Fig. 4) (Ja-
kasa and Kezic 2008). In several studies, human reconstructed skin models have been applied 
although there were concerns regarding a less well-developed barrier in these models and the 
absence of the follicular penetration route that might play an important role for translocation 
of nanoparticles (Labouta et al. 2011a, b). In in vitro assays, usually a cryopreserved skin is 
used, which might, however, lead to changes of the skin barrier and shrinkage of the hair 
follicles (Labouta et al. 2011a). 
Although human skin is regarded as a gold standard, a large number of studies on percutane-
ous penetration of nanoparticles use diff erent animal models including mice, rat, and pig skin 
(Labouta and Schneider 2013). However, structural and morphological diff erences between 
human and animal skin, especially concerning the density of the hair follicles, thickness of the 
skin layers, skin lipid composition, and structure, could certainly aff ect the NP percutaneous 
penetration (Labouta and Schneider 2013). Another problem encountered by using hairy an-
imals is damage of the skin barrier due to hair clipping.
Placenta in vitro models
Models  for  studying  transplacental  transport  have  long been based on the perfused isolated 
human placenta studied in ex vivo study designs. Th e perfused isolated human placenta ex 
vivo model presents a directly relevant alternative that maintains the complexity of the in-
tact placenta (Saunders 2009). Transport studies in the ex vivo intact placenta are technically 
challenging and require large quantities of substances to be tested. Th erefore, models using 
representative placental cell lines in Transwell study designs are being developed as in vitro 
alternatives. Most commonly used human placental cell lines are the BeWo, Jar, and JEG-3 
cell lines, which have been applied to study transplacental transfer of a variety of drugs and 
compounds. Th e most popular cellular model consists of the BeWo cell line, representing a 
choriocarcinoma-derived placental cell line that  strongly  resembles cytotrophoblastic cells. 
Th e BeWo b30 subclone can be grown on Transwell inserts to form confl uent cell layers, en-
abling the quantifi cation of both uptake into the cells from the apical compartment (maternal 
side) and eﬄ  ux from the cells to the basolateral compartment (foetal side) (Buerki-Th urnherr 
et al. 2012). In some studies these models have been validated by comparison of the transport 
rate across the Transwell cellular BeWo b30 layer and the transport rates detected in ex vivo 
placental models for the same compounds (Li et al. 2013, Poulsen et al. 2009).
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Although the type and nature of the nanoparticles studied in in vitro placental models are 
diff erent and the number of studies is limited, some general observations can be made. 
Nanoparticles can be transported across the placental barrier, where their size and type of 
nanoparticles infl uence the eﬃ  ciency of the transport. Furthermore, in contrast to drugs and 
other xenobiotic bulk chemicals, transport of several nanoparticles across the placental bar-
rier appears to be highly variable. Th e latter conclusion can be derived from the observation 
that for the nanoparticles studied so far the amount (%) of the nanoparticles transported 
across the BeWo b30 cell layer varies from 0.6 to 29 % in 6 h (Table 1). Comparison of this 
transport rate to that reported in  the BeWo model  for  several  chemicals  mounting  up to 
30 % in 2 h reveals that the transport of nanoparticles across the BeWo cell layer, just as that 
of chemicals, may be limited or signifi cantly depending on the type of nanoparticles. Th is im-
plies that a validated in vitro model to quantify the potential transport of nanoparticles across 
the placental barrier would be of high value to set priorities for further in vivo testing, thereby 
avoiding in vivo testing of all newly developed nanoparticles.
General remarks on currently used in vitro models to study translocation of 
nanoparticles
Currently used in vitro models to study translocation of nanoparticles are mostly based on 
cell culturing on Transwell inserts or on the use of ex vivo tissues. Transwell inserts can diff er 
in the type of plastic they are made of and in the pore size of the permeable membrane. Th ese 
diff erences between the Transwell inserts infl uence the translocation rate (Cartwright et al. 
2012, Geys et al. 2006). Transwell inserts with a larger pore size give increased translocation 
rates  compared  with  inserts  with  smaller pore sizes. In addition, some types of plastic of 
the Transwell inserts  yield decreased translocation due  to nanoparticle adsorption on the 
material surface. Th erefore, for each single type of nanoparticles, the translocation across the 
diff erent types of inserts should be tested without cells to assess whether the nanoparticles are 
not withheld by the insert itself.
Next to this, diff erent cell types are used, which clearly infl uences the translocation and the 
mechanism of translocation. When cell types lack the formation of tight junctions, nanopar-
ticles can easily pass between the cells resulting in a higher translocation rate compared with 
cell types that do form tight junctions. To prevent paracellular transport, epithelial cells form-
ing tight junctions are preferred. As already discussed, the incorporation of a mucus layer 
in gut epithelial models decreases the translocation (Walczak et al. 2014). Th is mucus layer 
might be a very important barrier for nanoparticles in vivo because of electrostatic repul-
sion (for negatively charged nanoparticles) and mucus entrapment (for positively charged 
nanoparticles) (Husain et al. 2001, Lai et al. 2007, Norris et al. 1998, Szentkuti and Lorenz 
1995). Similarly, such a mucus layer might also be essential for in vitro lung barrier models, 
since nanoparticles fi rst come in contact with the pulmonary surfactant if they are deposited 
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in the lungs. Lastly, the use of specifi c cells types in co-culture on top of an epithelial layer can 
alter the translocation rate of the nanoparticles. For instance, alveolar macrophages in lung 
models can decrease the translocation rate by uptake of nanoparticles, while M cells in intes-
tinal models can enhance translocation. Th e addition of these specifi c cell types can improve 
the in vitro models by more closely mimicking the in vivo situation in which, for example, the 
lungs are protected from particles via phagocytosis by alveolar macrophages.
Some reported in vitro models use primary cells, while others use immortalized cell lines. 
On one hand, primary cells have a more diff erentiated phenotype compared with cell lines. 
On the other hand, the isolation of primary cells is oft en experimentally challenging: the cells 
dediff erentiate aft er isolation, diff er from batch to batch, and proliferate to a limited extent. 
Cell lines are easy to work with, well characterized and more homogenous, but they show only 
few  characteristics  of  diff erentiated  cells.  Overall they only poorly represent the in vivo sit-
uation (Hartung et al. 2002, Klein et al. 2011). In in vitro lung translocation studies, primary 
rat alveolar cells have been frequently used (Fazlollahi et al. 2011, Geys et al. 2009, Yacobi et al. 
2008). Recent, biologically complex human intestinal tissues have been cultured using human 
(induced) pluripotent stem cells, resulting in human intestinal organoids that have secretory 
and absorptive functions (Brugmann and Wells 2013). Comparable systems have now been 
modifi ed into mature epithelial, functional and polarized monolayers grown on Transwell 
membranes, which are suitable for translocation studies (VanDussen et al. 2014).
Ex vivo models maintain the complexity of the physiological barriers (Saunders 2009). How-
ever, transport studies in ex vivo models are technically challenging, time consuming, and can 
require large amounts of the test substance.
Advances in the fi eld of miniaturized and microfl uidic devices have recently led to the con-
cept of organ-on-a-chip models (Bhatia and Ingber 2014, Huh et al. 2012, Moraes et al. 2012, 
van der Meer and van den Berg 2012), which can be seen as hybrid devices combining cells 
and microfabricated structures aiming to recapitulate the dynamic physical,  cellular,  and 
functional  features  of  human  tissues (Ardavin et al. 2001, Huh et al. 2010. 2013, Schimek et 
al. 2013, Wagner et al. 2013). Th ese devices fi rst provide a high control on the cell microenvi-
ronment (e.g. physical and chemical parameters) together with dynamic culture conditions, 
since they are embedded in a microfl uidic format (Whitesides 2006). Furthermore, these de-
vices can include active elements, which allow exposing cells to  mechanical  stimuli  and 
surface  strains,  by  stretching the substrate on which they are grown (Sinha et al. 2015). Th ese 
approaches mostly rely on 3D cell culture conditions, which are acknowledged to better mim-
ic the in vivo conditions compared with conventional monolayer models (Harink et al. 2013).
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Over the years, examples of organ-on-a-chip models in the literature have diversifi ed and, 
for instance, include gut (Kim and Ingber 2013), lung (Huh et al. 2007, 2010, Nalayanda et 
al. 2010), or even blood–brain barriers (Griep et al.2013, Huh et al. 2013, Wolff  et al. 2015). 
Th ese models can be of particular interest to the fi eld of nanotoxicology. Huh et al., for in-
stance, have developed a complex lung-on-a-chip model,  which  recapitulates  movements 
associated with breathing that is accompanied by cyclic stretching of cells (Huh et al. 2010). 
Th is device has been applied for NP testing, showing that breathing motion is essential for 
such nanotoxicological assays. Th e same group, using the same principle, later proposed a 
gut-on-a-chip model integrating peristaltic motion associated with digestion. Interestingly, 
exposed to a combination of dynamic culture and mechanical strain, Caco-2 cells were pro-
ducing mucus and microvilli features were formed (Kim and Ingber 2013). Finally, organ-
on-a-chip devices are amenable to parallelization and automation; they are easily coupled to 
virtually any detection technique, and diff erent organ models can even be combined on one 
device (Wagner et al. 2013) to eventually mimic the whole body/organism. Th e availability 
of such complex and in vivo-like models is expected to facilitate the implementation of the 
3R’s legislation regarding animal experimentation (Marx et al. 2012, van de Stolpe and den 
Toonder 2013).
Accuracy of current in vitro translocation models compared to in vivo data
In vitro translocation studies show mostly limited transport of nanoparticles across the lungs, 
gut, skin, and placenta. In the sections below, we discuss the comparison between in vitro 
data and available in vivo data. We included in vivo studies that measured the bioavailability 
of similar nanoparticles compared to their in vitro counterparts. However, most in vivo data 
come from separate studies in which not exactly the same type of nanoparticle is used: for 
instance, the nanoparticles diff er in size. Another marked diff erence is that the in vitro models 
are composed of cells (oft en cell lines) with a human origin, while the in vivo models mostly 
are rodents. Th erefore, we fi rst compared data from studies using nanoparticles of the same 
chemical composition although they sometimes diff ered for other characteristics. In Table 
2, we included studies that used exactly the same nanoparticles in both an in vivo and an in 
vitro design.
Lung barrier
Th e translocation rate between in vitro lung barrier models and in vivo inhalation studies 
diff ers depending on the tested nanoparticles (Table 2). In addition, some studies determined 
the cellular uptake and not the translocation rate of nanoparticles. Th e information on their 
localization can also be used in the comparison between in vitro and in vivo data.
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For the most frequently used polystyrene nanoparticles, the translocation rate, both in vitro 
and in vivo, is very low 1 day aft er exposure. Depending on the pore size of the inserts, the 
translocation amounts to 0–6 % in vitro against 0.05–2 % in vivo. However, one in vivo study 
shows accumulation over time of polystyrene nanoparticles in the thymus (Sarlo et al. 2009), 
which cannot be demonstrated in an in vitro lung model. One in vitro study reported a size 
dependent translocation rate (Yacobi et al. 2008), which is in line with the size-dependent 
distribution shown aft er oropharyngeal aspiration (Sarlo et al. 2009). Also for gold nanopar-
ticles, the in vitro translocation rate ranges from 0.5 to 5.2 % (Brandenberger et al. 2010). 
For comparison this can be compared to the in vivo translocation to the liver of 0.7 to 2.8 
%; clearly, this is an underrepresentation of the complete systemic availability (Sadauskas et 
al. 2009, Sung et al. 2011, Takenaka et al. 2006, Yu et al. 2007). For cerium dioxide, quantum 
dots, silica, and titanium dioxide nanoparticles, diff erent translocation rates are found in vi-
tro and in vivo. For cerium dioxide, the uptake rate in vivo is very low, and only about 10 % 
of the inhaled cerium dioxide was detected in the lungs (Geraets et al. 2012), while 80 % of 
the particles was internalized in cells in vitro (Raemy et al. 2011). Aft er inhalation exposure, 
quantum dots could be detected in the liver and kidney at relatively high amounts of 15 and 
5 %, respectively (Ma-Hock et al. 2012). However, in vitro, no translocation of quantum dots 
across primary rat alveolar epithelial cells was observed (Fazlollahi et al. 2011, Geys et al. 
2009). Silica nanoparticles were able to translocate across monolayers of Calu-3, NCI-H292, 
and A549 cells in vitro (George et al. 2015), but were not detected in tracheobronchial lymph 
nodes aft er inhalation exposure (Arts et al. 2007). However, the silica content was not mea-
sured in any other tissue or organ besides the lung and lymph nodes, so there might have 
been some in vivo translocation to the blood, liver, and other organs. Finally, titanium dioxide 
nanoparticles were internalized by A549 epithelial cells, monocyte-derived macrophages, and 
monocyte-derived dendritic cells in vitro (Muller et al. 2010, Rothen-Rutishauser et al. 2008), 
while the in vivo studies showed that most nanoparticles retained in the alveolar space in the 
lung-lining fl uid directly aft er exposure, and were found later mostly inside alveolar macro-
phages (Creutzenberg et al. 2012, Geiser et al. 2005, Oberdorster et al. 1994).
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Th e above-mentioned studies did not test exactly the same nanoparticles for the in vitro and 
in vivo set-ups. Arai et al. (2014) did test the same silver nanoparticles in vitro and in vivo. 
However, they did not measure the in vitro NP translocation but the presence of silver mate-
rial in cells. Th ey concluded that, in vivo, silver ions appear to translocate from the lungs to
other tissues rapidly. In vitro, Ag from AgNO3 binds to metallothioneins, whereas Ag nanopar-
ticles accumulate in lysosomes (Arai et al. 2014). Multi- walled carbon nanotubes (MWCNTs) 
were jointly tested in vitro and in vivo. However, this study focused on the development of 
pulmonary fi brosis and did not measure tissue distribution or translocation. Th e results did 
show, however, that MWCNTs are taken up by alveolar macrophages both in vivo and in vitro 
(Taylor et al. 2014).
Intestinal barrier
Several in vivo oral studies have been performed, but only a very limited number of those in 
vivo studies can directly be compared to in vitro studies. Here, we focus only on studies that 
evaluated the uptake of food-relevant nanoparticles such as silica and titanium dioxide. In 
addition, studies that used model materials such as polystyrene are discussed, as polystyrene 
nanoparticles have also been used in vitro (Table 1).
Some studies investigated the in vitro and in vivo translocation of titanium dioxide across the 
gut epithelium. Six hours aft er a single oral administration of 130-nm TiO2, titanium could 
be detected in gut tissues, but due to the low concentrations, it could not be quantifi ed (Brun 
et al. 2014). Janer et al. (2014) did not observe any increase in tissue concentration in vivo 24 
h aft er a single dose of 100 mg/kg TiO2 of 18 nm, while very low translocation was observed 
in vitro (Janer et al. 2014). In another study, rats were exposed to 5 mg/kg of diff erent types 
of TiO2 nanoparticles (mean particle size 40 nm, 40–50 nm, 120 nm and up to 5 µm), and 
up to 96 h post-administration, no translocation of titanium was detected to blood, several 
organs and urine. Also, no translocation was observed in vitro (MacNicoll et al. 2015). In rats 
exposed for 30 days to 200 mg/kg body weight (bw) 75-nm TiO2  nanoparticles, no increased 
titanium levels were detected in blood, liver kidney and spleen, while eff ects on liver and 
other organs have been reported (Wang et al. 2013). Titanium nanoparticles were also orally 
administered to rats, with a dose of 1 or 2 mg/kg TiO2 nanoparticles with a primary size of 
20–60 nm (large agglomerates were present) for 5 days (Tassinari et al. 2014). Only a limit-
ed number of tissues were collected; interestingly, in spleen elevated Ti concentrations were 
found in the high dose  group.  Detailed  analysis  revealed  the  presence  of 130-nm (sp ICP-
MS) or 200–400 nm (SEM-EDX) materials in spleens (Tassinari et al. 2014).
Like  titanium  dioxide,  silica  is  commonly  used  as food additives. Th erefore, the oral up-
take of silica nanoparticles was studied aft er 28 and 90 days of exposure to food-grade  syn-
thetic  amorphous  silica.  Limited  uptake was observed: only aft er 90-day exposure to 2500 
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mg/kg bw elevated Si levels were found in spleen (van der Zande et al. 2014). More studies are 
available that focussed on model polystyrene nanoparticles, and they generally highlight the 
dependence of uptake and accumulation of polystyrene  nanoparticles  on  several  factors, 
including  their size, surface charge, and type of coating material (Araujo et al. 2014, Hillery 
et al. 1994, Hillyer and Albrecht 2001, Hussain and Florence 1998, Hussain et al. 1997, Jani et 
al. 1989). In general, smaller polystyrene nanoparticles were taken up across the GI tract to a 
higher extent than the larger ones (Jani et al. 1990); the non-ionic more than the carboxylated 
ones (Jani et al. 1989) and 407 poloxamer-coated more than 188 poloxamer-coated nanopar-
ticles (Hillery and Florence 1996, Hussain et al. 1997).
Th e estimated oral bioavailability of 50-nm polystyrene nanoparticles varied between stud-
ies from 0.2 to 1.7 % (Walczak et al., submitted) to 6.6 % (Jani et al. 1990). Strikingly, much 
higher bioavailability (23 %) was reported for 500-nm polystyrene nanoparticles (Hussain et 
al. 1997), while  their  1-µm-size counterpart’s  nanoparticles  had  a lower uptake (2 × 10−6  % 
detected in lymph fl uid) (Seifert et al. 1996). Also, the amounts of polystyrene nanoparticles 
associated with intestinal tissues that were reported by Walczak (between 0.38 and 0.74 % 
depending on the type of polystyrene nanoparticles, calculated as a sum of the small- and 
large intestinal walls), were lower than the ones reported by others for 60-nm nanoparti-
cles (between 1.5 and 10 %, depending on the type (i.e. surface chemistry) of polystyrene 
nanoparticles used) (Hillery and Florence 1996, Hillery et al. 1994). Comparison of the oral 
in vivo bioavailability (0.2 and 1.7 %) (Walczak 2015), with the in vitro translocation values 
(1.6 to 12.3 %) of the same 50-nm polystyrene nanoparticles (Walczak et al. 2014), shows 
lower uptake values in the in vivo model. Th erefore, the in vitro model used by Walczak et al. 
appears to overestimate the in vivo translocation.
Skin barrier
In the literature, various in vitro assays (based on ex vivo skin tissue) have been used to de-
termine percutaneous penetration of nanoparticles. However, the scarcity of in vivo human 
data hampers proper evaluation of these models. Th e vast majority of in vitro studies focused 
on TiO2 and ZnO  nanoparticles found in sunscreens. Most, although not all in vitro studies 
fi nd that these nanoparticles do not penetrate beyond the superfi cial layers of the stratum 
corneum (Cross et al. 2007, Mavon et al. 2007, Wu et al. 2009, Zvyagin et al. 2008). One of 
the disadvantages of in vitro assays is that exposure duration is limited to 24 h, although 
long-term exposures would be closer to the real-life situation. Wu et al. (2009) compared in 
vitro and in vivo penetration of nanoscale TiO2  (4 nm and 60 nm) in two animal models 
(hairless mice and pigs). Aft er in vitro dermal exposure, TiO2 nanoparticles were not de-
tected beyond the stratum corneum. However, in vivo, 30-day dermal exposure to the same 
nanoparticles in hairless mice revealed, that in contrast to short-term in vitro exposure, TiO2 
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nanoparticles do reach viable skin layers (Wu et al. 2009). Furthermore, aft er 60-day dermal 
exposure, TiO2 nanoparticles could penetrate through the skin, reach diff erent tissues and 
induce diverse pathological lesions in several major organs (Wu et al. 2009). Deeper, although 
minimal, penetration into epidermal layers has also been found for ZnO nanoparticles in an 
in vivo study in human volunteers (Leite-Silva et al. 2013). In a parallel in vitro–in vivo study, 
Monteiro- Riviere et al. (2011) investigated the penetration of TiO2 and ZnO nanoparticles in 
UVB-damaged porcine skin. Under both conditions, TiO2 and ZnO NP predominantly resid-
ed in the stratum corneum, although small amounts of TiO2 and ZnO were also detected in 
the viable skin layers. On the other side, not all in vivo studies report penetration of nanopar-
ticles beyond the stratum corneum (Monteiro- Riviere et al. 2011). For instance, Zvyagin et al. 
found in an in vivo study with human skin no penetration of ZnO (26–30 nm) into the viable 
layers (Zvyagin et al. 2008). Th is is consistent with the fi ndings reported by Mavon et al. show-
ing no penetration of TiO2  into the viable epidermal layers of human skin either in vivo or in 
vitro (Mavon et al.2007). Obviously, the discrepancy in the results cannot be explained solely 
by the diff erences between in vitro and in vivo data but also by the characteristics of the used 
nanoparticles (size, coating), exposure duration and sensitivity of the detection methods.
Another frequently investigated NP is silver, which is used on a large scale in medicinal and 
consumer products. Larese et al. found in an in vitro study with human skin that smaller 
silver nanoparticles (30 nm) can penetrate across the stratum corneum into the upper layers 
of the epidermis (Larese et al. 2009). Th is is consistent with in vivo data obtained in human 
volunteers (George et al. 2014) showing that silver nanoparticles could penetrate as deep as 
the reticular dermis. Zhu et al. showed, using a highly sensitive detection method, that the 
penetration depth of Ag nanoparticles could exceed the stratum corneum thickness (Zhu et 
al. 2015).
Placental barrier
As described above, the transport eﬃ  ciency of nanoparticles across the human placenta is 
likely to be diff erent from that in rodents (Wick et al. 2010). To study the translocation over 
the human placental barrier, dual recirculation human placental (ex vivo) perfusion models 
are used. In such a design the translocation of 50, 80-, 240-, or 500-nm polystyrene was stud-
ied, under highly controlled conditions (i.e. translocation of a marker compound) (Wick et 
al.2010). Aft er a single administration, 50-, 80-, and 240-nm polystyrene nanoparticles were 
observed in the foetal circulation (foetal to maternal ratios 0.4; 0.4; 0.1, respectively), while 
the 500-nm polystyrene nanoparticles were retained in the placenta (Wick et al. 2010). In 
vitro similar results were found, where the translocation rate of 50-nm polystyrene nanopar-
ticles was larger compared with 100-nm nanoparticles (Cartwright et al., 2012). Myllynen et 
al. perfused ex vivo human placentas with 10-, 15-, and 30-nm PEGylated gold nanoparticles 
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(for up to 6 h) and did not observe  any  PEGylated  gold  nanoparticles  in  the  foetal part of 
the placenta (Myllynen et al. 2008). In vitro, they observed internalization of PEGylated gold 
nanoparticles of 10 nm in BeWo cells up to 48 h aft er exposure (Myllynen et al. 2008).
In rodents, fl uorescent polystyrene nanoparticles were administered via the extraembryonic 
tissue. Th e embryos were ex vivo incubated for 12 h with 20-, 100-, and 500- nm carboxylated 
and 200-nm amino-conjugated/terminated polystyrene nanoparticles. Th e 20-nm carboxyl-
ated nanoparticles were distributed in the embryonic and extraembryonic germ layers of ec-
toderm, mesoderm, and endoderm. Th e 100 and 500-nm carboxylated polystyrene nanopar-
ticles accumulated in extraembryonic tissue. Interestingly, the 200-nm amino-conjugated 
particles can pass into the embryos (Tian et al. 2009). For 5-nm gold nanoparticles, 0.018 % of 
the administered dose (118 µg/kg bw intravenous) administered to rats at day 19 of gestation 
was detectable in the embryo (Takahashi and Matsuoka 1981).
In  addition,  studies  with  silica  nanoparticles  showed that 70 nm, but not 300 or 1000 nm 
reached the brain and liver of the foetus aft er i.v. administration to the mother (Yamashita et 
al. 2011), while there was limited transport of 25-nm silica nanoparticles in vitro (Sonnegaard 
Poulsen et al. 2013). In the same study of Yamashita et al. 63-nm TiO2 nanoparticles were 
detected by TEM in brains and livers of foetuses (Yamashita et al. 2011). In another study, 
surface modifi ed 28–30-nm iron oxide nanoparticles were administered (intraperitoneal) to 
mice from gestation days 9–16. Nanoparticles with a positive zeta potential in water [coated 
with hydrophilic polyethyleneimine (PEI)] were detected in the livers of foetuses 1 day aft er 
dosing of the dams, while negatively charged nanoparticles (coated with acrylic acid) could 
not be found in the foetuses (Di Bona et al. 2014). In vitro, iron oxide nanoparticles were able 
to cross a BeWo cell layer (Correia Carreira et al. 2013).
Based on these studies, it can be concluded that nanoparticles  can  pass  the  placenta  of 
rodents  and  humans (ex vivo). Th is translocation is size- and surface charge- dependent. 
Although there are few studies available to compare the in vitro translocation to the in vivo 
or ex vivo translocation, for polystyrene nanoparticles, size-dependent translocation has been 
observed both ex vivo and in vitro. However, for gold nanoparticles and iron oxide nanopar-
ticles the in vitro translocation was higher compared with the ex vivo or in vivo translocation, 
while for silica nanoparticles it was lower.
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ANALYTICAL TECHNIQUES TO QUANTIFY AND CHARACTERIZE NANOPAR-
TICLE TRANSLOCATION IN VITRO AND IN VIVO
Meaningful interpretation and comparison of the results obtained using diff erent in vitro ex-
periments and extrapolation to in vivo data require reliable characterization of the nanopar-
ticles and their aggregates, as well as matrix-based infl uences on the nanoparticles. Th erefore, 
appropriate analytical techniques should be applied to determine the nanoparticle size distri-
bution, composition, and concentration in the experimental samples.
Widely used methods to detect nanoparticles in liquid dispersions are dynamic light scat-
tering (DLS), centrifugal liquid sedimentation (CLS) (Braun et al. 2011, Cascio et al. 2015, 
Murdock et al. 2008, Nickel et al. 2014, Powers et al. 2006) and nanoparticle tracking analysis 
(NTA) (Filipe et al. 2010, Vasco et al. 2010). Th ese methods allow determining an average 
size or size distribution related to the measured intensity signal. NTA is able to count and size 
nanoparticles in aqueous media at µg/L to mg/L concentrations (Filipe et al. 2010, Vasco et 
al. 2010). Both DLS and NTA are highly dependent on the polydispersity of  the  nanoparticle 
suspension  and  material  properties of the particles since the scattered light of the indivi-
dual particles must be suﬃ  ciently strong for detection. CLS is more robust since particles are 
size-separated before their actual detection and sizing. Transmission and scanning electron 
microscopy (TEM, SEM) are techniques to visualize nanoparticles (Dudkiewicz et al. 2011, 
Zhang et al. 2012). If pure nanoparticle dispersions are analysed, EM is currently the only 
technique that reliably covers the entire size range down to 1 nm. In cells or tissues, the min-
imal particle size that can be detected is around 20 nm, depending on the electron density of 
the nanoparticles (De Jong et al. 2010). Furthermore, EM distinguishes size aggregates and 
primary particles. Other imaging techniques are atomic force microscopy (AFM) (Brown et 
al. 2013) and particle- induced  X-ray  emission  (PIXE)  spectroscopy  (Lozano et al. 2012, 
2013).
Elemental information about the sample can also be obtained by atomic spectrometry meth-
ods such as inductively  coupled  plasma optical emission spectrometry (ICP-OES) (Elzey et 
al. 2012) and ICP mass spectrometry (ICP-MS) (Krystek 2012, Krystek et al. 2013), especially 
in single particle mode (sp ICP-MS) (Laborda et al. 2014, Pace et al. 2011, Peters et al. 2014a). 
From these studies it becomes clear that he smallest particle sizes that now can be determined 
are around 20 nm for silver and gold nanoparticles. For TiO2 and SiO2, nanoparticles size 
detection limits are around 50 and 200 nm; however, recent experiments suggest that the size 
detection limit may become lower in the next few years. Another promising possibility is to 
combine size-specifi c techniques, that separate particles from each other, such as hydrody-
namic chromatography (HDC) or fi eld-fl ow fractionation (FFF) with atomic spectroscopy 
techniques, that characterize particles, such as ICP-MS (Bednar et al. 2013, Hassellov et al. 
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2008, Peters et al. 2014b, Striegel and Brewer 2012, Von der Kammer et al. 2011). Currently, 
asymmetric fl ow fi eld-fl ow fractionation (AF4) is the most successfully used variant of FFF 
(Zattoni et al. 2014). In in vitro testing, AF4 coupled to ICP-MS becomes a powerful tool to 
investigate, for example, time-dependent uptake of medium-sized silver nanoparticles (Krys-
tek et al. 2015). Laser ablation (LA)-ICP-MS has been used to quantify gold nanoparticles in 
single cells (Wang et al. 2014).
Most of the detection methods described above generally require sample preparation proce-
dures. However, only little information concerning sample preparation techniques is available 
in the literature (Szakal et al. 2014). Aqueous media containing nanoparticles only need lim-
ited sample preparation; samples may be sonicated or tip-sonicated to suspend materials and 
proteins such as bovine serum albumin (BSA), or detergents such as sodium dodecylsulphate 
(SDS) may be added to stabilize nanoparticle suspensions (Jensen et al. 2011). For other ma-
trices, matrix removal or nanoparticle isolation from the matrix can be achieved by physical 
processes such as centrifugation, fi ltration, column techniques or cloud point extraction, or 
by chemical or enzymatic destruction of the matrix (Loeschner et al. 2014, Peters et al. 2014a, 
b).
As mentioned not only size, but also, surface chemistry and charge, and composition of the 
so-called protein corona have been shown to signifi cantly aff ect the translocation of nanopar-
ticles. Th e nanoparticle surface charge (or zeta potential) is routinely determined, but a cor-
rect interpretation might be hampered by interactions of the matrix with these measurements. 
More details analysis of the surface of the nanoparticles, for example, by matrix-assisted laser 
desorption/ionization  time-of-fl ight mass spectrometry (MALDI-TOF) should be consid-
ered (Walczak et al.2014). Methods for the assessment of protein composition range from 
simple gel electrophoreses experiments to a full characterization of the biomolecules that are 
present using mass spectrometry-based techniques (Lesniak et al. 2010, Lundqvist et al. 2008, 
Tedja et al. 2012).
Overall, diff erent techniques are available to determine the nanoparticle size distribution, 
composition and concentration in experimental samples. Attention should be paid to the lim-
its of the chosen techniques and to adequate sample preparation; this should be incorporated 
in studies reporting translocation data.
Conclusions on comparison of in vitro translocation models with in vivo data
While comparing the in vitro translocation to in vivo data, we noticed that very few studies 
tested exactly the same nanoparticles in in vitro and in in vivo settings. It seems that most 
studies are performed either in vitro or in vivo. Th erefore, we focused our comparison on the 
nanoparticle chemical composition although the nanoparticles studied sometimes diff er in 
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other particle characteristics such as size. Interestingly, this approach revealed that for some 
nanoparticles, the in vitro translocation is similar to the in vivo translocation. Examples are 
the translocation of polystyrene and gold nanoparticles in in vitro lung barrier models, and 
the translocation of titanium dioxide and silver nanoparticles in in vitro skin models. Howev-
er, for other nanoparticles, major diff erences seem to exist between the in vitro translocation 
rate and the in vivo translocation.
Th ese diff erences in translocation may be caused by the many diff erences existing between 
the in vitro barrier models and the in vivo study designs. First of all, the in vitro models 
mostly use an acute exposure of maximum 24 h and a short post-exposure time, while, for 
example, in vivo inhalation studies vary from 1 h to 13 weeks of inhalation exposure, 5 days 
a week, 6 h per day with post-exposure periods of up to 1 year. Th e relative short in vitro 
exposure durations might imply that only a fraction the nanoparticles that have been taken 
up (intracellularly) has been translocated. Longterm exposures are not conceivable in an in 
vitro set-up, although this would be a more realistic exposure scenario. Second, exposure 
concentrations between the in vitro and in vivo studies diff er. In in vitro experiments, high 
particle concentrations are sometimes used to be able to detect the nanoparticles in the baso-
lateral compartment. Th ese high concentrations might increase the agglomeration state of the 
nanoparticles and damage the epithelial barriers resulting in a diff erent translocation mech-
anism compared with the in vivo situation. Clearly also in vivo dose selection can be criti-
cal, as it has been shown in rats that exposure to high concentrations to silica nanoparticles 
cause gelation (agglomeration) of silica nanoparticles in the gut (van der Zande et al. 2014). 
Th ird, in vitro models have a single basolateral compartment, while in vivo, nanoparticles can 
translocate to various tissues and organs. In the in vitro set-up, saturation might occur while 
under in vivo conditions nanoparticles can continue translocating, since they are taken up in 
organs and removed from the blood. On the other hand, this distribution of nanoparticles 
to various tissues can hamper translocation studies in vivo. Fourth, current in vitro models 
are almost all static, while in vivo exposure is dynamic. Fift h, nanoparticles adsorb proteins 
and/or phospholipids in biological fl uids such as serum or lung-lining fl uid (Landsiedel et al. 
2014b). Th ese proteins or phospholipids form a corona around the particles that aff ects their 
uptake and bioavailability (Lesniak et al. 2012). Th e proteins that are encountered in in vitro 
models, for example in foetal calf serum, are completely diff erent from the proteins in vivo 
(i.e. rodent or human). Sixth, many in vitro lung models are submerged, which might  alter 
the  nanoparticle characteristics and  thus the translocation rate, while most in vivo studies 
rely on inhalation exposure.
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CONCLUSIONS
Th e aim of this review was to evaluate the performance of in vitro models that mimic diff erent 
physiological barriers found in the human body by comparing—when possible— the in vitro 
translocation of nanoparticles to their in vivo translocation across the lung, gut, skin, and pla-
cental barriers. For all these barriers, a great variety of in vitro models are available to evaluate 
the translocation of nanoparticles, ranging  in  complexity  from  single-cell-type  monolayer 
to multi-cell (3D) models. Many studies that use in vitro models on inserts focus on the 
toxicity of nanoparticles, do not include their translocation, and were thus not included in 
this review. Clearly, for a correct interpretation of the observed toxicity, the translocation (or 
systemic availability, internal concentration) is a crucial parameter. In recent years, the avail-
ability of analytical detection methods to quantify and characterize the nanoparticles in in 
vitro settings has improved considerably, which provides highquality data that are valuable in 
studying the relationship between physiochemical  properties of the nanoparticles and their 
translocation. Th e improved analytical chemical detection methods also contributed to an 
increase in in vivo uptake data (bioavailability) of nanoparticles.
Here, while comparing the in vitro translocation to in vivo data, we noticed that very few 
studies tested exactly the  same  materials  in  both  settings.  Comparing  data obtained using 
nanoparticles of the same chemical composition, we found that for some nanoparticles, the 
in vitro translocation is similar to the in vivo bioavailability. Examples are the translocation 
of polystyrene and gold nanoparticles in in vitro lung barrier models, and that of titanium 
dioxide and silver nanoparticles in in vitro skin models that are both in line with the in vivo 
data. However, for other nanoparticles, major diff erences were found between the in vitro and 
the in vivo translocation rate. As discussed in the sections above, many diff erences exist in 
the experimental set-up between in vitro and in vivo study design that probably account for 
the poor  correlation  between these two types of studies. Especially, the changes in the phys-
icochemical characteristics of the nanoparticles caused by the presence of lung-lining fl uid, 
mucus, serum protein, and lipoproteins that form a corona should be taken into account, 
as these dramatically alter their recognition, uptake and translocation (Lesniak et al. 2012, 
Treuel et al. 2013).
Risk assessment of nanoparticles (as is true for chemicals in general) still heavily relies on 
in vivo studies using experimental animals. However, the latter must be reduced as far as 
possible, for numerous reasons. Th erefore, there is an urgent need to validate existing in vitro 
models using data from animal models, although these animal models do not fully simulate 
the physiology of humans. How can we establish an in vitro barrier model that has value 
for the risk assessment of nanoparticles for humans? Ideally, in vitro models refl ect the key 
mechanisms of corresponding in vivo end points, which cannot always be accomplished and 
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may not be required if in vitro models reliably detect nanoparticles that are of concern in vivo 
(Landsiedel et al. 2014b). Th e predictive value of in vitro models can be better assessed by 
testing exactly the same nanoparticles simultaneously in both in vitro and in vivo assays. If the 
ranking of the tested nanoparticles from the lowest translocation rate to the highest translo-
cation rate is the same in both cases, the in vitro models provide information on the internal 
exposure, which is critical for the ultimate systemic adverse eff ects. Th en, the in vitro models 
can be considered as suitable for the risk assessment of nanoparticles and will in addition help 
to reduce animal testing by setting priorities for subsequent in vivo testing.
A crucial factor for both translocation studies is the sensitivity of the analytical technique 
used for the quantifi cation of the translocation. While this is of importance also for in vivo 
studies, in vitro studies are more vulnerable for poorly performing methods. Th e observed 
low translocation rates combined with the relatively short exposure durations in vitro pose 
great analytical challenges. Th e absence of acute in vitro translocation should always be inter-
preted in  relation  to  the  sensitivity  of  the  detection  technique (both in terms of concentra-
tion and nanoparticle size). Th e introduction of in vitro models that allow chronic exposures 
are promising in that a chronic exposure better refl ects the real-life human exposure.
In vitro models with a high predictive value do not necessarily have to be complex, but can 
consist of a single cell type, as long as they give a similar ranking of nanoparticles as obtained 
in the in vivo situation. However, the mechanism in these models might be completely diff er-
ent from the in vivo situation. To obtain more insight into the mechanisms behind nanopar-
ticle uptake and translocation, in vitro models should be further developed to become phys-
iologically very close to the in vivo human conditions. Such in vitro models must be more 
complex because the human lung, gut, skin, and placental barrier consist of multiple cell 
types, which are exposed to a low concentration of nanoparticles. A physiologically realistic 
model will increase the confi dence in the NP testing outcome, but it will also be elaborate and 
expensive to develop and maintain.
When in vitro models are available that either have a high human predictive value or are phys-
iologically similar to the human situation, experimental data can be used to develop in silico 
models that will eventually be able to predict the human in vivo bioavailability of nanoparti-
cles from their in vitro translocation rate. Th e (improved) in vitro models still needs valida-
tion, most likely using animal data, clearly alternative approaches need to be developed for 
this (making use of available human data).
We conclude that the current in vitro models to study the translocation of nanoparticles do 
not (yet) allow correlating to the reported in vivo translocation because of many diff erences 
between the in vitro and in vivo study designs. However, the use of in vitro models is very 
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promising since they are currently further improved to mimic the in vivo situation more 
closely by, for example, using co-cultures of diff erent cell types and implementing them in 
a microfl uidic format. When these models are further validated by testing exactly the same 
nanoparticles in an in vivo set-up as in the in vitro model, then, they can be used to determine 
the internal exposure (bioavailability) of nanoparticles and to set priorities for nanoparticles 
testing.
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ABSTRACT 
To obtain insight in translocation of nanoparticles across the placental barrier, translocation 
was studied for one positively and two negatively charged polystyrene nanoparticles (PS-NPs) 
of similar size in an in vitro model. Th e model consisted of BeWo b30 cells, derived from 
a human choriocarcinoma grown on a transwell insert forming a cell layer that separates 
an apical from a basolateral compartment. PS-NPs were characterized with respect to size, 
surface charge, morphology and protein corona. Translocation of PS-NPs was not related to 
PS-NP charge. Two PS-NPs were translocated across the BeWo transwell model to a lower ex-
tent than amoxicillin, a model compound known to be translocated over the placental barrier 
to only a limited extent, whereas one PS-NP showed a slightly higher translocation. Studies 
on the eff ect of transporter inhibitors on the translocation of the PS-NPs indicated that their 
translocation was not mediated by known transporters and mainly dependent on passive dif-
fusion. It is concluded that the BeWo b30 model can be used as an eﬃ  cient method to get 
an initial qualitative impression about the capacity of NPs to translocate across the placental 
barrier and set priorities in further in vivo studies on translocation of NPs to the fetus. 
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INTRODUCTION 
Nanoparticles (NPs) are incorporated in a variety of consumer products, such as electronics, 
clothing, food, cosmetics and medicines. Consequently, there is an increasing potential for 
workers and consumers to be exposed to various NPs. Due to their small size and relatively 
large surface area compared to volume, NPs have physico-chemical characteristics diff erent 
from the bulk material (Auff an et al. 2009). Although these novel characteristics drive the 
development of numerous applications in many fi elds of technology and medicine, they may 
also have unforeseen (adverse) health eff ects (Oberdorster 2004, Stampfl  et al. 2011). It is 
known that size and surface functionalization are major factors that infl uence kinetics, in-
cluding rate of uptake, distribution, and excretion of NPs, and thereby their possible toxicity 
(Oberdorster et al. 2005, Sager et al. 2009, Park et al. 2011, Bhattacharjee et al. 2013). In order 
to bypass in vivo toxicity testing of every type of NP, eﬃ  cient in vitro research methods with 
prognostic potential would be of great value. Th erefore, suitable in vitro methods are needed 
that can be used to predict the in vivo kinetics of NPs in order to predict in vivo internal ex-
posure. At present, research on transplacental transfer of nanomaterials and their eff ects on 
the placenta and the developing fetus is still in its infancy (Saunders 2009, Buerki-Th urnherr 
et al. 2012, Juch et al. 2013). However, the fetus may be exposed to NPs upon translocation 
across the placenta, (Menjoge et al. 2011).
Th e aim of the present study was to obtain insight in translocation of NPs across the placental 
barrier by studying translocation of positively and negatively charged polystyrene NPs (PS-
NPs) across an in vitro model. Th e model consisted of BeWo b30 cells, derived from a human 
choriocarcinoma, grown on a transwell insert forming a cell layer that separates an apical 
compartment from a basolateral compartment. When grown on transwell inserts, BeWo b30 
cells retain functional adenosine triphosphate binding cassette (ABC) transporters specifi c to 
the apical and basolateral membranes, such as P-glycoprotein (Pgp), breast cancer resistance 
protein (BCRP) or multidrug resistance-associated protein 1 (MRP-1) (Utoguchi et al. 2000, 
Atkinson et al. 2003, Ceckova et al. 2006, Evseenko et al. 2006, Milane et al. 2009, Mitra et 
al. 2010, Wick et al. 2010). Furthermore, these cells express placental diff erentiation mark-
ers, such as human chorionic gonadotrophin (HCG) (Takeuchi et al. 1990) and the major 
cytochrome P450 isoforms (CYP1A1 and 1A2) present in placenta (Avery et al. 2003). In our 
previous studies the BeWo b30 transwell model was shown to be useful to study placental 
translocation of drugs and nutrients, and translocation of these compounds across the BeWo 
b30 layer in the transwell model appeared to correlate with their translocation in an ex vivo 
human placental model (Li et al. 2013). 
In the present study the BeWo b30 transwell model was used to study possible placental trans-
location of NPs. Th e model NPs selected for this study were 50 nm PS-NPs with positive or 
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negative charge. PS-NPs are used in various products like food packaging, drug delivery sys-
tems, sensors, paints and electronics spacers in LCD displays (Phosphorex , Simon et al. 2008, 
Arora et al. 2010, Lee et al. 2014, Chiu et al. 2015). PS-NPs were characterized by measuring 
their size and polydispersity index (PDI) by dynamic light scattering (DLS), their surface po-
tential (as an indication of surface charge) by ζ-potential measurements, their protein corona 
by SDS-PAGE and their morphology by scanning electron microscopy (SEM).
MATERIALS AND METHODS 
Chemicals
Fluorescent red PS-NPs were obtained from Magsphere Inc. (Cat nr: AMFR050NM, CA-
FR050NM). Fluorescent Yellow-Green carboxylated 50 nm microspheres were obtained from 
Polysciences (Cat nr. 16661-10). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT), fl uorescein, antipyrine, amoxicillin, β-mercaptoethanol and Dulbecco's mod-
ifi ed Eagle's medium (DMEM) (Cat nr. D5071 and D5671) were purchased from Sigma-Al-
drich (Zwijndrecht, the Netherlands). Penicillin-streptomycin, L-glutamine, trypsin-EDTA, 
fetal calf serum (FCS), phosphate-buff ered saline (PBS), and Hank’s balanced salt solution 
(HBSS) were obtained from Invitrogen (Breda, the Netherlands). Laemmli Sample Buff er, 
Precision Plus Protein Dual Color Standards marker, Bio-Safe Coomassie Stain G-250 and 
Mini-PROTEAN TGX Gels were obtained from Bio-rad (Veenendaal, the Netherlands). 
Cell culture
Th e choriocarcinoma BeWo cell line (clone b30) was kindly provided by the Institute of Pub-
lic Health of the Faculty of Health Sciences (University of Copenhagen, Denmark) with per-
mission from Dr. Alan Schwartz (Washington University, St. Louis, MO) and confi rmed to be 
mycoplasma negative. Cells were cultured at 37°C with 5% CO2 in a humidifi ed atmosphere 
in DMEM supplemented with 10% (v/v) heat inactivated FCS, 1% (v/v) penicillin-streptomy-
cin and 1% (v/v) L-glutamine. Cells were subcultured every 3 to 4 days when reaching 80% 
confl uency using trypsin-EDTA aft er rinsing with PBS. 
Particle characterization 
Th e size (hydrodynamic diameter) of the PS-NPs was determined by dynamic light scattering 
(DLS) using a Cobolt Samba 300mW DPSS laser at a wavelength of 532 nm as a light source. 
Measurements were performed on freshly prepared NP solutions at 10 μg/ml in nanopure 
water and in cell culture medium containing 10% FCS. For each sample, twenty measure-
ments were made and the detector intensity data (measured with an ALV/SO SIPD Single 
Photon Detector with ALV Static and Dynamic Fiber optics) were processed with an AL-
V5000/60X0 external correlator and ALV-5000/E soft ware (all from ALV-GmbH, Germany). 
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Data were analysed with the  Aft erALV soft ware and mean diameter and polydispersity index 
(PDI) were determined for each PS-NP sample. Additionally the ζ-potential of the PS-NPs 
was measured at a concentration of 100 µg/ml using the Malvern Zetasizer 2000 (Malvern 
Instruments, UK). Th ree independent measurements, each containing 5 sub-measurements, 
were used to establish the average ζ-potential and standard deviation (SD) for each sample. 
Morphology of the PS-NPs was characterised by scanning electron microscopy (SEM). To 
this end suspensions of the PS-NPs (20 µg/mL) in water were studied using SEM. Of each sus-
pension 20 μl was deposited on a nickel-coated polycarbonate fi lter, which was mounted on 
an aluminium specimen holder. Th e droplets were left  to dry. Subsequently the fi lters with PS-
NPs were coated with a 5 nm layer of chromium with an Emitech K575X turbo sputter coater. 
Th e high resolution fi eld emission gun scanning electron microscope (FEG-SEM) used in this 
study was a Tescan MIRA-LMH FEG-SEM (Tescan, Brno, Czech Republic). Th e microscope 
was operated at an accelerating voltage of 15 kV, working distance (WD) of 10 mm and spot 
size of 5 nm. Th e mean diameter ± SD of 50-500 particles is given.
Protein corona detection 
For the protein corona characterization, methods were adapted from previous similar stud-
ies (Lundqvist et al. 2008, Lesniak et al. 2010). Briefl y, PS-NPs were suspended in DMEM 
cell culture medium containing 10% FCS at a concentration of 1.66 mg/ml and incubated 
for 24 hours at 37°C. Th e samples were centrifuged 40 min at 18000 rcf at 15°C to pellet the 
NP-protein complexes. Th e pellet was resuspended in 1 ml PBS, transferred to a new tube and 
centrifuged again. Th is washing procedure was repeated three times to eliminate non-fi rmly 
bound proteins, using a new tube in every wash step to avoid artifacts from proteins bound 
to the tube wall. Finally, aft er the last centrifugation, the supernatant was removed and the 
pellets were resuspended carefully with 70 µl of a 1:1 (v/v) mixture of PBS and 2x Laemmli 
Sample Buff er containing 5% β-mercaptoethanol. Next, the samples were boiled for 5 min 
at 98°C to denature the proteins and unbind the proteins from the PS-NPs and then cooled 
down immediately on ice. Samples were again centrifuged 40 min at 18000 rcf at 15°C to sep-
arate the PS-NPs from proteins desorbed from their surface. Of the supernatant containing 
the desorbed proteins 20 µl was loaded on the gel. In this way the amount of protein loaded 
in each lane was normalized for the weight of the diff erent PS-NPs in the sample. A second 
gel was loaded with samples that were normalized for amount of protein in each lane. As we 
could not measure the protein content because of interference of β-mercaptoethanol which 
was present and required in all samples, an indirect measurement of total protein present in 
the samples was used. To this end the acquired gel image of the fi rst gel was digitally anal-
ysed for the pixel intensity of each whole lane. We thus obtained an estimate of the amount 
of protein loaded in each sample. Th e pixel intensity of all lanes was expressed relative to the 
pixel intensity of the lane with the lowest pixel intensity. Th is resulted in a factor by which the 
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samples should be diluted in order to load the same amount of protein in all lanes of the sec-
ond gel. One-dimensional polyacrylamide gel electrophoresis was performed using standard 
methods on the Bio-Rad Mini-Protean system, at 90 V for about 80 min, until the proteins 
neared the end of the gel (Mini-PROTEAN TGX Gel, 12% polyacrylamide 1 mm). A marker 
sample was included on each gel. Th e gels were washed in 40% methanol in water containing 
10% acetic acid for 15 min and subsequently stained with Bio-Safe Coomassie Stain G-250 for 
1.5 hours. Aft erwards, the gels were washed extensively and stored overnight in distilled wa-
ter. Gels were scanned using the Odyssey scanner (Li-cor ISO 9001) and analysed by further 
quantifi cation of the band intensity of the lanes with the Odyssey soft ware (Li-cor Bioscienc-
es). Experiments were repeated three times. 
MTT assay
BeWo b30 cells were seeded at 1x104 cells/well in 100 µl culture medium in 96-well plates 
and incubated at 37°C and 5% CO2 for 24 hours, followed by exposure to 100 µl of PS-NP 
solutions with concentrations ranging from 0 µg/ml to 100 µg/ml. Aft er 24 hours 10 µl of 
MTT solution in PBS (5 mg/ml) was added to the medium to reach a fi nal concentration of 
0.5 mg/ml MTT. Aft er 1.5 hours incubation, the MTT solution was removed and 100 µl/well 
pure DMSO were added to lyse the cells and to dissolve the formazan crystals. Th e plates were 
shaken for 10 minutes protected from light and subsequently absorbance was measured at 
562 and 620 (background) nm using a SpectraMax M2 Microplate Reader (Molecular De-
vices LLC, Sunnyvale, CA USA). For each PS-NP concentration cellular MTT reduction to 
formazan is expressed as percentage of the corresponding DMEM control reading (0 µg/ml). 
Th e absence of possible interference of particle fl uorescence with the absorbance readings 
was confi rmed by reading the absorbance of wells with diff erent concentrations of NPs aft er 
adding MTT and this indicated there was no interference of the particles with the absorbance 
readings. 
Translocation studies 
Originally transwell membranes are coated with placental collagen before seeding the BeWo 
b30 cells (Bode et al. 2006). However, previous studies showed that this collagen coating in-
hibits NP transfer across the permeable membrane (Cartwright et al. 2012). Th erefore, no 
collagen coating was used in the translocation studies. Th is will present a model presenting 
the highest possible translocation and thus preventing underestimation of the translocation. 
BeWo b30 cells were seeded at a density of 100.000 cells/cm2 on 12-well transwell inserts 
containing a polycarbonate membrane (0.4 µm pore size and a surface area of 1.12 cm2) 
(Corning, NY, product number 3401) with daily refreshment of the medium as described 
by (Poulsen et al. 2009). At day 6 post-seeding the BeWo b30 cell layers were washed twice 
with prewarmed (37oC) HBSS without phenol red aft er which transepithelial electrical resis-
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tance (TEER) measurements were performed just before exposure using a Millicell ERS-2 
Volt-Ohm Meter (Millipore, USA). Cell layers showing TEER values >160 ohm cm2 were 
chosen for translocation experiments, as these were values reported by others indicating a 
intact barrier (Liu et al. 1997, Li et al. 2013). Aft er TEER measurement, HBSS was removed 
and replaced by exposure medium. 
Translocation of the two reference compounds amoxicillin and antipyrine (both at fi nal con-
centration 100 µM) was assessed by adding apically 0.5 ml of the test compound dissolved in 
HBSS and basolaterally 1.5 ml of HBSS. In order to ensure the quality of the BeWo model, 
we always include both antipyrine and amoxicillin in our transport studies, using the circum-
stances (HBSS without protein) as used in our validation study (Li et al., 2013). In that study, 
(Li et al., 2013) showed that the transport of antipyrine and amoxicillin is not aff ected by the 
presence of proteins in the medium. At selected time points a sample of 0.2 ml was taken 
from the basolateral compartment and replaced by an equal volume of HBSS. At the end of 
each experiment 0.2 ml was also taken from the apical compartment. Subsequently cells were 
washed three times with HBSS without phenol red, TEER values were determined to check 
for an intact barrier. If the TEER value aft er the translocation study was not lower than before 
the translocation study, the experiment was considered valid, and the membrane with cells 
was dissected and transferred to an Eppendorf tube containing 250 µl 65% (v/v) methanol to 
determine the amount of compound accumulated in the cells using HPLC.  
Translocation of PS-NPs in time was tested by adding 0.5 ml of the freshly prepared vor-
texed PS-NP dilutions in phenol red free DMEM supplemented with 10% FCS to the apical 
compartment. At selected time points, samples of 100 µl were taken from the apical and ba-
solateral compartments and at the end of the incubation the membranes with BeWo b30 cell 
layers were washed three times with HBSS (37 °C) without phenol red and TEER values were 
measured to check cell layer integrity. Th en membranes were dissected and transferred to 
an Eppendorf tube containing 400 µl cold nanopure water. Samples were sonicated in order 
to lyse the cells and samples of 100 µl were taken and added to a 96 wells plate to measure 
fl uorescence for PS-NP quantifi cation. PS-NP quantifi cation was done by fl uorescence mea-
surements using a calibration curve (Magsphere PS-NPs: λex=540, λem=630, Polysciences PS-
NPs λex=485, λem=530) using a SpectraMax M2 Microplate Reader (Molecular Devices LLC, 
Sunnyvale, CA USA).
Th e role of specifi c transporters in the translocation of PS-NPs was tested by performing the 
translocation experiments in the presence or absence of the transporter inhibitors verapam-
il (inhibitor of PgP), KO143 (inhibitor of human breast cancer resistance protein; BCRP), 
MK571 (inhibitor of multidrug resistance-associated protein 1; MRP-1), chlorpromazine (in-
hibitor of caveolin-mediated endocytosis) or methyl-β-cyclodextrin (MβCD) (inhibitor of 
clathrin-mediated endocytosis). Table S1 presents an overview of the diff erent transporter 
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inhibitors used, their transporter specifi city, their concentrations generally used in literature 
to study transporter inhibition and relevant references. All inhibitors were diluted from a 250 
times concentrated stock solution in DMSO in cell culture medium, except for MβCD which 
was diluted from a 250 times concentrated stock solution in PBS. Transporter inhibitors were 
also added to the basolateral compartment containing 1.5 ml culture medium, using the same 
concentrations as applied in the apical compartment. Subsequently, the plate was incubated in 
a humidifi ed atmosphere with 5% CO2 at 37 °C. Aft er 24 hours, samples of 100 µl were taken 
and PS-NPs were quantifi ed by fl uorescence measurements in the same way as previously 
described. 
High performance liquid chromatography analysis
To determine the transport rate of amoxicillin and antipyrine, the collected samples were 
quantifi ed using High Performance Liquid Chromatography (HPLC) as was described by (Li 
et al. 2013). 
Data analysis
Th e apparent permeability coeﬃ  cients (Papp; cm/s) were calculated according to: 
Papp= (dQ / dt) / (A x C0)
In which dQ/dt is the transport velocity [nmol/s or µg/s] in the initial phase when appearance 
in the basolateral chamber is linear in time, A - the surface area of the membrane insert [cm2] 
and C0 - the initial concentration of the compound in the donor chamber (nmol/ml or µg/ml) 
(Artursson et al. 1991). 
Statistical analysis
Each experiment was repeated at least three or four times and the results are shown as mean ± 
standard deviation (SD). Statistical analyses were performed using GraphPad Prism® version 
5, using a one-way analysis of variance ANOVA test and post hoc Tukey test to determine sig-
nifi cant diff erences between the groups. Groups were considered signifi cantly diff erent when 
p<0.05.
RESULTS
Physico-chemical characterization of the PS-NPs
Th is study included three types of PS-NPs, one 50 nm positively charged PS-NP and two 50 
nm negatively charged PS-NPs. Th e two 50 nm negatively charged PS-NPs were included 
because previous studies of our group revealed that these are translocated to a diff erent extent 
across a Caco-2 monolayer (Walczak et al. 2014). Several physico-chemical properties of the 
nanoparticles were characterized.
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Figure 1. SEM pictures of A) 50 nm negatively charged PS-NP (Polysciences), B) 50 nm negatively 
charged PS-NP (Magsphere) and C) 50 nm positively charged PS-NP (Magsphere).
Table 1. DLS data of 50 nm PS-NPs with positive or negative charge in nanopure water and in medium 
with 10% FCS.
Nanoparticle Medium Mean size in nm (SD) Polydispersity Index (PDI)
50 nm positively charged  
PS-NP (Magsphere)
Nanopure water 56.5 (3.02) 0.09
DMEM+FCS 82.7 (30.91) 0.49
50 nm negatively charged 
PS-NP (Magsphere)
Nanopure water 50.4 (1.74) 0.19
DMEM+FCS 69.0 (10.1) 0.49
50 nm negatively charged 
PS-NP (Polysciences)
Nanopure water 52.4 (0.1) 0.21
DMEM+FCS 57.6 (11.7) 0.50
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SEM pictures of the PS-NPs (Figure 1) confi rm the spherical shape of the particles and their 
diameter of around 50 nm, although smaller particles can be observed in all samples. Au-
tomatic diameter measurements of these desiccated PS-NPs show that their sizes range be-
tween 15-75 nm with a mean value at 31.6 nm, 35 nm and 50.6 nm for the negatively charged 
(Polysciences), negatively charged (Magsphere) and positively charged (Magsphere) PS-NPs 
respectively (Table S2).
Th e hydrodynamic diameters of the hydrated NPs were measured by dynamic light scattering 
(DLS) in nanopure water and in the culture medium containing 10% FCS as used for the 
translocation experiments (Table 1). Th e measured sizes of the PS-NPs in nanopure water 
were close to the sizes reported by the manufacturer. Upon addition of the positively charged 
PS-NPs to DMEM with 10% FCS, their size increased 1.5-fold. Th e measured sizes of the 
negatively charged PS-NPs (Magsphere) and negatively charged PS-NPs (Polysciences) in 
DMEM with 10% FCS increased slightly by 1.4 and 1.1 fold, respectively (Table 1). It is of 
interest to note that DLS analysis of medium with 10% FCS alone revealed that proteins from 
the FCS appear to form particles of comparable sizes as the NPs (Figure S1). Formation of 
protein complexes in the nm range have been reported before (Liu et al. 2013). Th us, DLS 
measurements of NPs in medium containing 10% FCS may be hampered by the protein ag-
gregates of comparable size. 
Th e surface charges of the positively and negatively charged PS-NPs were measured in nano-
pure water and in DMEM with 10% FCS by determining the zeta potential (Table 2). Positive-
ly charged PS-NPs had a zeta potential of +51.0 mV in nanopure water. Negatively charged 
PS-NPs of Magsphere and Polysciences have a zeta potential of -55.5 mV and -58.3 mV re-
spectively in nanopure water. In medium with 10% FCS all NPs get a similar slightly negative 
Table 2. Zeta potential of 50 nm PS-NPs with positive or negative charge in nanopure water and in me-
dium with 10% FCS, and zeta potential measured with medium with 10% FCS.
Nanoparticle Medium Mean Zeta (mV) SD
50 nm positively charged  PS-NP (Magsphere) Nanopure water 51 4.5
DMEM+FCS -12.0 1.2  
50 nm negatively charged PS-NP (Magsphere) Nanopure water -55.5 6.7
DMEM+FCS -11.1 0.9
50 nm negatively charged PS-NP (Polysciences) Nanopure water -58.3 2.7
DMEM+FCS -10.9 0.2
None DMEM+FCS -9.16 1.3
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charge. Th is may be explained by the fact that the majority of particles present in these sam-
ples are protein aggregates from the 10% FCS so that the zeta potential may refl ect the overall 
charge of the protein aggregates rather than those of the PS-NPs (Table 2). Alternatively the 
similar charges in the presence of FCS may be ascribed to the protein corona dominating the 
overall charge.
Protein corona detection
Figure 2A shows a representative picture of the SDS-PAGE gel with proteins  desorbed from 
the diff erent PS-NPs aft er their incubation in medium with 10% FCS. Each lane contains the 
amount of protein obtained from the same amount of PS-NP and thus, given the similar size 
of the PS-NPs, presents the amount of protein desorbed from a presumably similar surface 
area of the PS-NPs. Proteins desorbed from the protein corona of NPs are present in lanes 
2-4. Figure 2B shows a protein gel prepared to contain the same amount of protein in each 
lane. Th e band intensities of the lanes containing NPs were further quantifi ed using the Od-
yssey soft ware and graphs thus obtained are also presented in Figure 2. Th ese results reveal 
diff erences in the amount but not the nature of the proteins in the corona of the three diff erent 
PS-NPs (Figure 2A+B lanes 2-4). 
From the 50 nm positively charged PS-NPs (lane 3) only a small amount of protein corona 
was obtained. Th e control (lane 5) shows the DMEM sample without nanoparticles which was 
treated by the same experimental procedure as NP samples. Hardly any protein is detected in 
this control, which corroborates that the proteins which are detected in the other samples are 
coming from the protein corona of the PS-NPs. Lane 6 shows the proteins present in the me-
dium containing 10% FCS and comparison of this pattern to that of the PS-NPs reveals that 
not all medium proteins contribute to the protein corona to the same relative extent at which 
they are present in the medium, indicating at least some preferential binding of proteins to 
the NPs.
Cell viability studies
Before testing the transplacental translocation of the PS-NPs, the concentration of the PS-NPs 
to be tested in the BeWo b30 transwell translocation studies were chosen based on results 
from cell viability studies. Th e cell viability of BeWo b30 cells upon 24 hours exposure to 
increasing PS-NP concentrations was determined using the MTT assay. Only cells exposed to 
the positively charged PS-NPs showed a decrease in MTT reduction, an eff ect that becomes 
statistically signifi cant at concentrations of 20 µg/ml and higher (Figure 3), whereas no eff ect 
was found upon exposure to the negatively charged PS-NPs. Based on these results the con-
centration of PS-NPs to be tested in the translocation studies was chosen at 10 µg/ml.
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Figure 2. SDS-PAGE gel showing the desorbed protein corona of diff erent PS-NPs with the lanes con-
taining: in gel A) the amount of protein corresponding to the same surface area of the PS-NPs and those 
in gel B) a similar amount of total protein. Lanes: 1) marker; 2) 50 nm negatively charged (Magsphere); 
3) 50 nm positively charged (Magsphere); 4) 50 nm negatively charged (Polysciences); 5) Control: me-
dium sample without NPs which followed the same experimental procedure as the NP-samples; 6) Me-
dium. Th e right part of the fi gure shows the banding pattern of lanes 2-4 and 6.
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Figure 3. Eff ects of three diff erent PS-NPs on cell viability of BeWo b30 cells as determined with the 
MTT assay. BeWo b30 cells were exposed for 24 hours to increasing concentrations of 50 nm positively 
charged PS-NP (Magsphere)  (open triangle) or 50 nm negatively charged PS-NP (Magsphere) (closed 
circle) or 50 nm negatively charged PS-NP (Polysciences) (open square) PS-NPs. Data are expressed as 
percentage of the negative control and presented as the mean ± SD of n=3 independent biological repli-
cates. Th e * indicates p<0.05 for a signifi cant diff erence with the other two types of PS-NPs (n=3).
Placental translocation of model compounds
In order to calibrate the BeWo b30 model system and provide points for comparison the 
translocation of two model compounds antipyrine and amoxicillin was determined. Th ese 
compounds are known to be translocated across the placenta and also across the BeWo cell 
layer in vitro at respectively high or low rate (Akbaraly et al. 1985, Li et al. 2013). Table 3 
shows the apparent permeability coeﬃ  cients for antipyrine and amoxicillin amounting to 53 
x 10-6 cm/s for antipyrine and 5.1 x 10-6 cm/s for amoxicillin indicating that the translocation 
of these two model compounds varies by one order of magnitude. Previously it was reported 
that for a series of model compounds including antipyrine and amoxicillin a good correlation 
(r2=0.95) exists between their relative transport in the BeWo b30 transwell model and their 
transport in an ex vivo placental perfusion model (Li et al. 2013) and that also in the ex vivo 
placental transport model antipyrine and amoxicillin showed a diff erence in transport rate of 
about one order of magnitude (Akbaraly et al. 1985).
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Table 3. Apparent permeability (Papp) coeﬃ  cients across BeWo b30 cell barrier of the reference com-
pounds antipyrine and amoxicillin, and the PS-NPs. Data presented are the mean ±SD of n=3 indepen-
dent biological replicates.
Mean Papp value ± SD (cm/s)
Antipyrine 53 x 10-6 ± 5.6 x 10-6
Amoxicillin 5.1 x 10-6  ± 0.52 x 10-6
50 nm positively charged  PS-NP (Magsphere) 0.3 x 10-6 ± 0.05 x 10-6
50 nm negatively charged PS-NP (Magsphere) *ND
50 nm negatively charged PS-NP (Polysciences) 13 x 10-6  ± 1.1 x 10-6
*ND: not detected, so no Papp coeﬃ  cient derived.
Placental translocation of PS-NPs
Th e time-dependent translocation of the three PS-NPs to the basolateral compartment was 
determined using an apical concentration of 10 µg/ml PS-NP (Figure 4). Upon 24 hours in-
cubation the negatively charged PS-NPs from Magsphere were not detected in the basolateral 
compartment . For the other two PS-NPs a time dependent increase in the basolateral com-
partment was observed (Figure 4). Th e apparent permeability coeﬃ  cient of the positively 
charged PS-NPs from Magsphere was the lowest (Papp value of 0.3 x 10-6 cm/s), followed by 
that of the negatively charged PS-NPs from Polysciences (Papp value of 13 x 10-6 cm/s). In the 
absence of cells, PS-NP translocation across the insert was much higher which corroborates 
that the BeWo b30 cell layer acts as a barrier. 
 Comparison of the apparent permeability coeﬃ  cients of the PS-NPs that were translocated 
with that of the reference compound amoxicillin, known to be translocated over the placental 
barrier to only a limited extent, reveals that translocation of the positively charged PS-NPs of 
Magsphere is 17 fold lower than that of amoxicillin, whereas the translocation of the negative-
ly charged PS-NPs from Polysciences was 2.5 fold higher than that of amoxicillin (Table 3).
Compartmental distribution of PS-NPs in the presence of transporter inhibitors
To investigate the possible role of specifi c transport mechanisms in the translocation of the 
PS-NPs across BeWo b30 cell layers, the distribution of the NPs over the three compartments 
(apical, basolateral and intracellular) was assessed in the presence or absence of inhibitors 
of endocytosis or of specifi c ABC transporters. Results obtained are presented in fi gure 5. 
For the positively charged PS-NPs, the presence of MK571, an inhibitor of MRP-1, slightly 
but signifi cantly (p<0.01) decreased the amount of PS-NPs in the apical compartment from 
71.5 to 67.8 % and signifi cantly increased (p<0.01) the amount of PS-NPs in the basolateral 
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compartment from 7.5 to 11.5 % (fi gure 5A), indicating a 1.5 fold increased translocation 
across the BeWo b30 cell layer. TEER measurements performed aft er the distribution studies 
showed that the barrier integrity of the BeWo b30 cell layer was not aff ected, indicating that 
the increased translocation did not result from a compromised cell layer. Co-exposure to the 
positively charged PS-NPs and the BCRP- or PgP-inhibitors KO143 and verapamil, respec-
tively, did not show an eff ect on the distribution of these PS-NPs (fi gure 5A). For the nega-
tively charged 50 nm PS-NPs from Polysciences, none of the inhibitors showed a signifi cant 
eff ect on the distribution of these particles in the BeWo transwell model (Figures 5B) and 
the lack of intracellular signal indicates no intracellular localization. In addition, the clathrin 
and caveolin inhibitors (5 µM chlorpromazine or 1 µM MβCD, respectively) used to inhibit 
clathrin- and caveolin- mediated endocytosis, did not show an eff ect on translocation or dis-
tribution of any of the PS-NPs.
Figure 4. Time dependent translocation across the BeWo b30 cell layer of 50 nm positively charged PS-
NPs of Magsphere (open triangle), 50 nm negatively charged PS-NPs of Magsphere (open square)  and 
50 nm negatively charged PS-NPs of Polysciences (closed square) with starting concentration of 10 µg/
ml. Papp values (Table 3) were calculated from the linear part of the curve. Results presented are the 
mean ± SD of n=3 independent biological replicates.
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Figure 5. Eff ect of specifi c transporter inhibitors (Table S1) on the distribution of A) 50 nm positively 
charged PS-NPs of Magsphere; B) 50 nm negatively charged PS-NP of Polysciences in the BeWo tran-
swell model, 24 hours aft er adding 0.5 ml of a 10 µg/ml PS-NP solution to the apical compartment. Re-
sults presented are the mean ± SD of n=4 independent biological replicates. Th e * indicates a diff erence 
(p<0.01) compared to the situation without inhibitors.
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DISCUSSION 
To obtain insight in passage of NPs across the placental barrier, translocation of one positively 
and two diff erent types of negatively charged PS-NPs across an in vitro model of the placen-
tal barrier was studied. Th e two negatively charged PS-NPs were included because previous 
studies within our group revealed they were translocated to a diff erent extent across a Caco-2 
monolayer, a model for intestinal translocation (Walczak et al. 2014). Th e model in the pres-
ent study consisted of cells of the BeWo cell line (clone b30) grown on a transwell insert, and 
forming a cell layer that separates an apical compartment from a fetal compartment. 
Th e characterization of the PS-NPs was done by measuring the size and polydispersity index 
(PDI) by dynamic light scattering (DLS), the ζ-potential (as an indication of surface charge) 
by ζ-potential measurements, the protein corona by SDS-PAGE and shape and the num-
ber-based size distribution by scanning electron microscopy (SEM). Th e results obtained re-
veal that in the presence of 10% FCS in cell culture medium, measurement of ζ-potential may 
be hampered by the presence of free protein particles as the ζ-potential of medium without 
or with PS-NPs present, resulted in the same negative ζ-potential. Alternatively the similar 
charges of the diff erently charged NPs in the presence of FCS may be ascribed to their protein 
corona dominating the underlying PS-NP’s charge. SDS-PAGE analysis of this protein corona 
revealed that there were diff erences in mainly the amount but not in the nature of the proteins 
in the corona of the diff erently charged PS-NPs. Th e proteins desorbed from the PS-NPs were 
to a large extent a refl ection of what was detected in the medium containing 10% FCS. Th is 
result was somewhat diff erent from a previous study that reported that surface properties of 
PS-NPs signifi cantly aff ected the composition of the protein corona (Lundqvist et al. 2008). 
In this latter study using diff erent commercially available PS-NPs and mass spectrometry 
instead of SDS-PAGE, a fraction (about 35%) of the proteins in the corona were specifi cally 
detected on the positively charged PS-NPs or on the negatively charged PS-NPs, the others 
being similar.
In the present study it appeared that in spite of similar size (SEM and DLS), ζ-potential and 
type of proteins in the protein corona, the diff erently charged NPs displayed a remarkable 
diff erence in cytotoxicity, with only the PS-NPs with an original positive charge inducing 
cytotoxicity. Th e relatively higher cytotoxicity of positively as compared to negatively charged 
NPs was reported before for tri-block copolymer NPs (Bhattacharjee et al. 2012) but also for 
other type of NPs like gold NPs (Liu et al. 2013) and silicon NPs (Bhattacharjee et al. 2013). 
Th us for interaction with the cells, the original diff erence in charges or surface chemistry of 
the particles as prepared and measured in water, is apparently still of infl uence. Th e higher 
cytotoxicity of positive NPs might be due to a stronger interaction with cells compared with 
negative NPs, because of the electrostatic attraction towards the negatively charged cell mem-
brane (Kim et al. 2009).
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Translocation of the diff erent PS-NPs across the BeWo cell layer was not found to be relat-
ed to PS-NP charge. A remarkable diff erence in translocation was found between the two 
50 nm negatively charged PS-NPs from diff erent manufacturers. For the PS-NPs from Poly-
sciences, the apparent permeability coeﬃ  cient was slightly higher than that of amoxicillin, 
with a Papp value of 13 x 10-6 cm/s (table 3). When testing the negatively charged PS-NPs 
from Magsphere, no PS-NPs could be detected in the basolateral compartment upon adding 
a concentration of 10 µg/ml in the apical compartment and 24 hours incubation. A 30-fold 
diff erence was found in translocation of the same types of negatively charged PS-NPs across 
a Caco-2 monolayer in a similar transwell model system (Walczak et al. 2014). Since none 
of the characterized parameters, including size, ζ-potential and protein corona revealed re-
markable diff erences between the two negatively charged NPs, the diff erence may originate 
from the chemical groups on the surface of the NPs generating the negative charge. Although 
both PS-NPs are reported by the respective manufacturers to contain carboxylic groups from 
vinylic co-monomers, including acrylic acid, methacrylic acid and itaconic acid, further de-
tails on the chemical characteristics of the NP surface remained unknown. In this respect it 
is of interest that variation in steric shielding of the charge on a surface moiety due to subtle 
diff erences in the chemical structure of the charge bearing moiety may aff ect the cellular up-
take and toxicity of fl uorescent tri-block copolymer nanoparticles (Bhattacharjee et al. 2011). 
In this previous study it was demonstrated that three diff erent positively charged tri-block 
copolymer nanoparticles showed diff erent cellular uptake and toxicity in spite of a similar 
overall size and ζ-potential, and that only a diff erent shielding of the charge due to subtle 
diff erences in the charge generating surface moiety infl uenced the cellular uptake and toxicity 
(Bhattacharjee et al. 2011). Th is factor may explain the diff erent translocation rates of the two 
negatively charged 50 nm PS-NPs in this study, given the diff erent carboxylic groups that have 
been used in the production of these diff erent PS-NPs. 
Th e translocation studies presented in this study revealed that the PS-NPs were translocated 
across the BeWo b30 transwell model to only a limited extent. We compared these results 
to reports in the literature studying the translocation of NPs across the placental barrier. A 
few studies also applied the BeWo b30 transwell model studying translocation of PEGylated 
gold NPs of 10-30 nm (Myllynen et al. 2008), iron oxide and silica NPs of 23-38 nm (Cor-
reia Carreira et al. 2013), dexamethasone loaded PLGA NPs of 140-289 nm (Ali et al. 2013), 
rhodamine labelled silica NPs of 25 and 50 nm (Sonnegaard Poulsen et al. 2013) and poly-
styrene NPs of 50 and 100 nm (Cartwright et al. 2012). Th ese studies generally report that 
the NPs are translocated across the BeWo cell layer aft er a few hours of incubation to the 
basolateral compartment albeit in relatively small amounts. Th e results of the present study 
are in line with these observations, and suggest that translocation of NPs across the in vitro 
placental barrier cannot be excluded. Literature data obtained in ex vivo human placental 
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perfusion models also report the potential of NPs to cross the placental barrier (Wick et al. 
2010, Menjoge et al. 2011, Grafmuller et al. 2013, Sonnegaard Poulsen et al. 2013) and are in 
line with this conclusion.
In order to investigate the role of specifi c transporters in the translocation of the PS-NPs 
across the BeWo b30 cell layer, translocation studies were also performed in the absence and 
presence of transporter inhibitors. Th e presence of PgP, BCRP, MRP-1 has been confi rmed in 
the BeWo b30 cells (Atkinson et al. 2003, Ceckova et al. 2006, Evseenko et al. 2006, Milane et 
al. 2009, Mitra and Audus 2010, Wick et al. 2010) but inhibitors of PgP and BCRP at a con-
centration of 50 and 2.5 µM, respectively, showed no eff ect on translocation of PS-NPs across 
the BeWo b30 cell layers. MK571 (24 µM), an inhibitor of MRP-1, signifi cantly increased the 
basolateral translocation of positively charged PS-NP by 1.5 fold but did not infl uence the 
translocation of the negatively charged PS-NPs so in general the translocation of the PS-NPs 
tested appeared to occur preferentially by passive diff usion. 
In vitro models are attractive for high throughput testing of various NPs. However, it should 
be kept in mind that in vitro models like the BeWo b30 transwell model applied in the current 
study have their limitations (Nikitina et al. 2013). For example, given that the physiology of 
the placental barrier in vivo varies in time, it is diﬃ  cult to classify the BeWo cell layer in a rep-
resenting specifi c stage of pregnancy.  Furthermore, the BeWo transwell model is a simplifi ed 
placental barrier compared to the complex in vivo placental barrier since it lacks the multi-
ple layers of diff erent cell types (cytotrophoblasts and syncytiotrophoblasts) and extracellular 
matrix including collagen, known to constitute the in vivo placental barrier. Th is implies that 
extrapolation of in vitro results to the in vivo situation should acknowledge uncertainties in 
the predictions made (Mathiesen et al. 2014). To this end we have included the model com-
pounds amoxicillin and antipyrine, known to be translocated across the placental barrier to 
respectively only a limited or large extent (Akbaraly et al. 1985, Li et al. 2013) to enable qual-
itative interpretation of the results. Th is comparison revealed that for positively charged PS-
NPs translocation was 17 fold lower and for negatively charged PS-NPs from Polysciences 2.5 
fold higher than that of amoxicillin, while for the negatively charged PS-NPs from Magsphere 
no translocation was found under the same test conditions.
In conclusion, the translocation studies of PS-NPs in the present study and the comparison of 
the data with translocation data of model compounds, for which the model has been validated 
with an ex vivo placental model, reveal that the in vitro BeWo b30 model can be used as a fast 
method to get an initial qualitative impression about the capacity of NPs to translocate across 
the placental barrier and set priorities for further in vivo studies on translocation of NPs to 
the fetus. 
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SUPPLEMENTARY MATERIALS CHAPTER 3
Table S1. Transporter inhibitors used in the PS-NP distribution studies.
Transporter inhibitor Target
Concentration 
used in present 
study (µM)
Reference
Methyl-β-cyclodextrin Caveolin 1 (Bhattacharjee et al. 2013)
Chlorpromazine Clathrin 5 (dos Santos et al. 2011)
Verapamil PgP 50 (Ushigome et al. 2000)
KO143 BCRP 2.5 (Brand et al. 2008) (Ceckova et al. 2006)
MK571 MRP-1/MRP-2 24 (Brand et al. 2008)
Table S2. Automatic diameter measurements of PS-NPs using Scandium SIS image analysis soft ware 
(Olympus Soft  Imaging Solutions GmbH, Germany). Th e mean diameter ± SD and range of 50-500 
particles is given (in nm).
 Nanoparticle Mean SD Range 
50 nm negatively charged PS-NP (Polysciences) 31.6 13.6 15 - 70
50 nm negatively charged PS-NP (Magsphere) 35.0 15.3 15 - 70
50 nm positively charged  PS-NP (Magsphere) 50.6 9.3 25 - 75
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Figure S1. Dynamic light scattering of A) 50 nm positively charged PS-NP (Magsphere),  B) 50 nm 
negatively charged PS-NP (Magsphere), C)  50 nm negatively charged PS-NP (Polysciences) freshly 
dispersed at 10 µg/ml in cell culture medium or nanopure water; for comparison the scattering of the 
cell culture medium alone is also shown (medium control). 
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 ABSTRACT
Knowledge on the relation between physicochemical characteristics of nanoparticles (NPs) 
and their toxicity would be of great help for setting priorities for NP toxicity testing. Th e 
present study aimed to assess the role of surface charge of NPs on in vitro developmental tox-
icity, by determining the eff ects of positively or negatively charged polystyrene nanoparticles 
(PS-NPs) in the embryonic stem (ES-D3) cell diff erentiation assay. Th e results show that the 
negatively charged PS-NPs did not aff ect ES-D3 cell diff erentiation, whereas the positively 
charged PS-NPs showed a concentration-dependent inhibition of ES-D3 cell diff erentiation, 
indicating that the eff ects of NPs on ES-D3 cell diff erentiation may depend on their surface 
charge. In order to assess whether NP-induced eff ects on ES-D3 cell diff erentiation may be 
related to other physicochemical properties, we performed a literature search on the reported 
potencies of NPs in these models. Th is analysis shows that the potency of NPs may depend on 
size, surface charge or coating, but that currently available data are too limited to indicate a 
clear relation between physicochemical characteristics and their in vitro developmental toxic-
ity. Th e results also reveal that additional experimental data, as presented in the present study, 
may help to further advance the fi eld.
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INTRODUCTION 
Th e rapid increase of nanotechnology has several benefi ts for society, yet there is an increas-
ing concern that exposure to nanoparticles (NPs) may result in signifi cant adverse eff ects 
(Oberdorster et al. 2007, Gebel et al. 2013). NPs have been shown to be able to pass physio-
logical barriers, such as that of the intestines and the placenta (Braakhuis et al. 2015). Th is 
indicates that systemic exposure, including fetal exposure, is feasible and that the fetus is a 
potential target for NPs. To assess possible adverse eff ects of NPs on the developing fetus, in 
vivo developmental toxicity studies can be performed in for example rats or mice. However, 
because of economic and ethical constrains with in vivo studies, alternatives for in vivo tox-
icity studies are being developed and validated (Jelinek et al. 1985, Fort and Paul 2002, zur 
Nieden et al. 2004, Spielmann et al. 2006, Park et al. 2009, de Jong et al. 2011). 
One of the in vitro alternative assays for developmental toxicity testing is the embryonic stem 
cell test (EST) which has been validated by the European Centre for the Validation of Alterna-
tive Methods (ECVAM). In particular the diff erentiation assay of the EST has been shown to 
be useful in assessing relative developmental toxicity potencies of chemicals and NPs (Gen-
schow et al. 2004, de Jong et al. 2011, Pietroiusti et al. 2011, Li et al. 2015). In this assay, the 
chemical- or NP-induced inhibition of blastocyst-derived mouse embryonic stem (ES-D3) 
cells developing into contracting cardiomyocytes, is used as an in vitro endpoint of develop-
mental toxicity (de Jong et al. 2009, Campagnolo et al. 2013). Considering the large variety of 
NPs that have not been tested yet for their developmental toxicity, knowledge on the relation 
between physicochemical characteristics of NPs, such as size or surface charge, and their tox-
icity would be of great help for setting priorities for NP toxicity testing. 
To increase our knowledge on the relation between physicochemical properties of NPs and 
their developmental toxicity potential, the present study aimed to assess the role of surface 
charge in the in vitro developmental toxicity potential of NPs. To this end, we assessed the 
eff ects of one 50 nm positively charged polystyrene NP (PS-NP) and two 50 nm negatively 
charged PS-NPs on the viability and diff erentiation of ES-D3 cells. Further, we made an over-
view of the available literature on NP-induced eff ects on ES-D3 cell diff erentiation, in order 
to assess whether also other physicochemical characteristics may relate to the in vitro devel-
opmental toxicity potential of NPs.
METHODS 
Materials 
WST-1 Cell Proliferation Reagent was purchased from Roche (Woerden, Th e Netherlands). 
Phosphate buff ered saline (PBS), non-essential amino acids, penicillin–streptomycin and 
13937-kloet-layout.indb   107 28/10/2016   09:29
108
Chapter 4
L-glutamine were obtained from Invitrogen (Breda, Th e Netherlands). Non-enzymatic cell 
dissociation solution, 0.1% gelatine, murine leukemia inhibiting factor (LIF) and β-mercap-
toethanol were purchased from Sigma–Aldrich (Zwijndrecht, Th e Netherlands). AdvanceS-
TEMTM Low Osmo DMEM was obtained from Hyclone (Hyclone; Logan, USA) and foetal 
calf serum (FCS) was obtained from ATCC (USA). 
Nanoparticles
Th is study included three diff erent PS-NPs, one 50 nm positively charged PS-NP and two 
50 nm negatively charged PS-NPs. Positively and negatively charged fl uorescent red PS-NPs 
were obtained from Magsphere Inc. (California, USA) (Cat nr: CAFR050NM, AMFR050NM 
respectively). Negatively charged fl uorescent Yellow-Green carboxylated 50 nm PS-NPs were 
obtained from Polysciences (Warrington, USA) (Cat nr. 16661-10). All the PS-NPs used had 
an average particle size of 50 nm as indicated by the manufacturers’ specifi cation. 
Particle characterization
Th e size (hydrodynamic diameter) of the NPs was determined by dynamic light scattering 
(DLS) using a Cobolt Samba 300mW DPSS laser at a wavelength of 532 nm as a light source. 
Measurements were performed on freshly prepared NP solutions at 100 μg/ml in nanopure 
water and in cell culture medium containing 20% FCS. For each sample, twenty measurements 
were made and the detector intensity data (measured with an ALV/SO SIPD Single Photon 
Detector with ALV Static and Dynamic Fiber optics) were processed with an ALV5000/60X0 
external correlator and ALV-5000/E soft ware (all from ALV-GmbH, Germany). Data were 
analysed with the Aft erALV soft ware and mean diameter and polydispersity index (PDI) were 
determined for each NP sample. Additionally, the ζ-potential of the NPs was measured at a 
concentration of 100 µg/ml using the Malvern Zetasizer 2000 (Malvern Instruments, UK). 
Cell culture
Th e murine ES-D3 cell line was purchased from ATCC (Wesel, Germany). Th e cells were 
maintained in cell culture fl asks (Corning, the Netherlands) that were pre-coated with 0.1% 
gelatin, using AdvanceSTEMTM Low Osmo DMEM, supplemented with 20% FCS, 2 mM 
L-glutamine and 50U/50µg penicillin-streptomycin and leukemia inhibiting factor (LIF 1000 
U/ml), in a humidifi ed atmosphere at 37°C and 5% CO2. LIF serves to keep the embryonic 
stem cells in the pluripotent state, by inhibiting their diff erentiation. Cells were subcultured 
every 2 to 3 days using non-enzymatic cell dissociation solution to detach the cells when 
reaching 60-80% confl uence. Experiments were performed using ES-D3 cells between pas-
sages 4 and 18.
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Assessment of cell viability 
To assess the eff ects of the PS-NPs on cell viability, ES-D3 cells were seeded at 2 x 104 cells/
ml (one-day exposure) or 1 x 103 cells/ml (fi ve-day exposure) in 100 μL culture medium in 
96-well plates (Greiner bio-one) in the absence of LIF and incubated at 37°C and 5% CO2 for 
24 hours to allow cell adherence. Th en the cells were exposed to 100 μL of PS-NPs at con-
centrations up to 100 μg/ml and subsequently incubated for one or fi ve days at 37°C and 5% 
CO2 in a humidifi ed atmosphere. Culture medium was used as a negative control and 200 µM 
CuSO4 was used as a positive control. Aft er incubation, 20 μL WST-1 reagent was added to 
each well and the plates were incubated for another 3 hours. Th en absorbance was measured 
at 450 nm and 620 nm (background) using a SpectraMax M2 Microplate Reader (Molecular 
Devices LLC, Sunnyvale, CA USA). Th e cell viability was expressed as percentage of the neg-
ative control, with the control set at 100% viability. 
Diff erentiation assay with ES-D3 cells
Th e potential of PS-NPs to inhibit ES-D3 cell diff erentiation was evaluated using the ES-D3 
cell diff erentiation assay using culture medium without LIF. In this assay, the eff ect of chemi-
cals or NPs is assessed on the diff erentiation of ES-D3 cells into contracting cardiomyocytes. 
Similar to other studies (van Dartel et al. 2009, van Dartel et al. 2009, van Dartel et al. 2011), 
we exposed diff erentiating ES-D3 cells during day 3-10 of the 10-day diff erentiation process. 
On day 0, droplets of 20 μl ES-D3 cell suspension (3.75 x 104 cells/ml) in the absence of PS-
NPs were placed as hanging drops on the inner side of the lid of a 96-well plate. Sterile lids 
of Eppendorf tubes were placed on each corner of the plate to prevent contact of the drops 
with the plate. Th e wells of the 96-well plate were fi lled with 250 μl PBS and the plate was 
sealed with Micropore tape (3M, Neuss, Germany) to prevent evaporation of the hanging 
drops. Plates were incubated for three days at 37°C and 5% CO2 in a humidifi ed atmosphere 
to allow for the formation of embryonic bodies (EBs). Th ese EBs were transferred aft er 3 days 
to non-tissue culture treated Petri dishes (Greiner, diameter 6 cm) with 5 ml of medium in 
the absence (negative control) or presence of PS-NPs. On day 5, the EBs were transferred to 
a 24-well plate (Corning) with 1 ml of medium in the absence or presence of PS-NPs, plating 
one EB per well. On day 10, the number of wells containing contracting cardiomyocytes was 
determined by visual inspection using a light microscope. Tests were accepted for further 
analysis if at least 21 of the 24 wells of the negative control contained contracting cardiomy-
ocytes. For each test compound, three independent assays were performed, at concentrations 
ranging from 0.1 to 50 μg/ml. For each concentration, the fraction of the EBs that diff erenti-
ated into contracting cardiomyocytes was determined, with a value of 1 implying that all EBs 
in one 24-well plate diff erentiated into contracting cardiomyocytes.
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Data analysis
For each study, three independent experiments were performed. In each cell viability study, 
three technical replicates were used for each condition. Data are shown as mean ± standard 
deviation (SD) of all data points and plotted in graphs using GraphPad Prism® version 5. Con-
centration-response analysis was performed using GraphPad Prism® version 5.
Literature search on reported eff ects of NPs in the ES-D3 diff erentiation assay
A literature search was performed to obtain an overview of the eff ects of NPs on ES-D3 cell 
diff erentiation, in order to assess whether the NP-induced inhibition of ES-D3 cell diff eren-
tiation may be related to specifi c physicochemical characteristics. For this literature search 
the following search terms were used in Pubmed and Scopus databases: mouse embryonic 
stem cell, ES-D3, embryonic stem cell test, EST, ES-D3 cell diff erentiation assay, nanoparticle, 
nanomaterial, in vitro, developmental toxicity. 
RESULTS
Physicochemical characterization of the NPs
Th is study included three diff erent PS-NPs, one 50 nm positively charged PS-NP and two 50 
nm negatively charged PS-NPs. Th e hydrodynamic diameters of the NPs were measured by 
DLS in nanopure water and in the culture medium containing 20% FCS (Table 1). Th e mea-
sured sizes of the PS-NPs in nanopure water were close to the sizes reported by the manufac-
turer. Upon addition of the PS-NPs to DMEM with 20% FCS, a slight increase in size was ob-
served (Table 1). Th e PDI increased upon addition of the PS-NPs to DMEM with 20% FCS as 
compared to the PDI in water, indicating that the size distribution became wider. Background 
DLS values of DMEM with 20% FCS and water are 19.9 and 0 nm respectively (Table 1).
Table 1. Dynamic light scattering (DLS) (n=3) and zeta potential (n=3) results.
NP Diameter in nm ± SD (PDI) Zeta potential (mV) ± SD
In water DMEM with 20% 
FCS
In water DMEM with 20% 
FCS
50 nm positively charged  PS-NP 
(Magsphere)
56.5 ± 3.0 (0.09) 66.6 ± 2.4 (0.34) 51.0± 4.5 -8.7 ± 0.2
50 nm negatively charged PS-NP 
(Magsphere)
50.4 ± 1.7 (0.19) 60.9 ± 5.4 (0.33) -55.5 ± 6.7 -7.8 ± 0.9
50 nm negatively charged PS-NP 
(Polysciences)
52.4 ± 0.1  (0.21) 55.7 ± 4.8 (0.32) -58.3 ± 2.7 -9.7 ± 1.1
None 0 19.9 ± 1.2 (0.46) 0  -9.2 ± 1.3
13937-kloet-layout.indb   110 28/10/2016   09:29
111
Assessment of the potenti al developmental toxicity of positi vely and negati vely charged polystyrene nanoparti cles 
using the embryonic stem cell diﬀ erenti ati on assay
4
Th e surface charges of the positively and negatively charged PS-NPs were measured in nano-
pure water and in DMEM with 20% FCS by determining the zeta potential (Table 1). Positive-
ly charged PS-NPs had a zeta potential of +51.0 mV in nanopure water. Negatively charged 
PS-NPs of Magsphere and Polyscience had a zeta potential of -55.5 mV and -58.3 mV, respec-
tively, in nanopure water. In DMEM with 20% FCS all NPs got a slightly negative charge of -8 
to -9 mV, similar to the charge measured for DMEM with 20% FCS without PS-NPs (Table 1).
Eff ects of PS-NPs on ES-D3 cell viability and ES-D3 cell diff erentiation
To evaluate the eff ects of the PS-NPs on ES-D3 cell viability, the WST-1 assay was performed 
on ES-D3 cells exposed for one day or fi ve days to the PS-NPs (Figure 1). Th e positively 
charged PS-NPs caused a concentration-dependent decrease in cell viability, which was more 
prominent aft er the 5-day exposure than aft er the 1-day exposure (Figure 1A), indicated by 
EC50 values of 2.0 and 71 µg/ml, respectively. For both negatively charged PS-NPs no eff ect 
on cell viability was observed up to the highest concentrations tested (100 μg/ml) (Figure 1B 
and 1C). 
To study the in vitro developmental toxicity of the PS-NPs, their eff ect on the diff erentia-
tion of ES-D3 cells into contracting cardiomyocytes was evaluated (Figure 1). Th e positively 
charged PS-NPs showed a concentration-dependent inhibition of the diff erentiation of ES-D3 
cells into beating cardiomyocytes, with an EC50 of 1.2 µg/ml, whereas both the negatively 
charged PS-NPs did not aff ect the diff erentiation of the ES-D3 cells up to the highest concen-
tration tested (50 μg/ml) (Figure 1B and 1C). 
Th e results indicate a clear eff ect of NP charge on both viability and diff erentiation of the 
ES-D3 cells. Th e results for the negatively charged PS-NPs do not seem to point at a hazard 
for developmental toxicity of these NPs. Th e results for the positively charged PS-NPs may in-
dicate a possible hazard for developmental toxicity. Since cell diff erentiation was inhibited at 
concentrations that also inhibited cell viability upon a 5-day exposure, NP-induced inhibition 
of ES-D3 cell diff erentiation may be due to cytotoxic eff ects.
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Figure 1. Concentration-dependent eff ects of A) 50 nm positively charged PS-NPs (Mag-
sphere), B) 50 nm negatively charged PS-NPs (Magsphere) C) 50 nm negatively charged PS-
NPs (Polysciences) on ES-D3 cell viability (1-day exposure: ● with solid line; 5-day exposure: 
▲ with solid line) and ES-D3 cell diff erentiation into beating cardiomyocytes (○ with dotted 
line). Cell viability data are expressed as percentage of the negative control and cell diff eren-
tiation data are expressed as the fraction diff erentiated EBs of the total EBs for that exposure 
condition. Data are presented as the mean ± SD of n=3 independent biological replicates.
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Reported eff ects of other NPs on ES-D3 cell diff erentiation
In order to obtain further insight in the role of physicochemical characteristics of NPs on 
their potential developmental toxicity, we performed a literature search on the NP-induced 
inhibition of ES-D3 cell diff erentiation into contracting cardiomyocytes. Table 2 presents an 
overview of the literature data obtained, showing the EC50 values for the inhibition of ES-D3 
cell diff erentiation, including EC50 values for cell viability, as well as the NP physicochemical 
properties.
For silicon dioxide NPs and silver NPs, diff erent sizes have been tested in the ES-D3 cell dif-
ferentiation assay. For silicon dioxide NPs, the two largest particles (80 and 400 nm) did not 
inhibit ES-D3 cell diff erentiation up to the highest concentration tested (100 µg/ml), whereas 
the two smallest particles (10 and 30 nm) inhibited ES-D3 cell diff erentiation with EC50 val-
ues of 59 and 29 µg/ml, respectively (Table 2). For silver NPs all four sizes (7, 20, 80 and 113 
nm) inhibited ES-D3 cell diff erentiation, and the smaller the NPs, the higher their potency, 
except for the two largest particles, which showed a similar potency (Table 2). For other NPs, 
the eff ect of coating on the in vitro developmental toxicity has been assessed. Table 2 shows 
that the coating of NPs had an eff ect on the toxicity of cobalt ferrite and titanium dioxide NPs, 
but not on zinc oxide NPs. Th is literature search also indicated that the present study is the 
only study so far that has assessed the eff ect of NP charge on the in vitro developmental tox-
icity of NPs, showing that positively charged PS-NPs are more potent than negatively charged 
PS-NPs. Th e review also reveals however that the eff ect of surface charge may vary with the 
type of NPs investigated, since the silicon dioxide, silver and titanium dioxide NPs that were 
reported to inhibit ES-D3 cell diff erentiation were negatively charged, while the negatively 
charged PS-NPs of the present study did not aff ect ES-D3 cell diff erentiation. 
A comparison of eff ect concentrations on the inhibition of ES-D3 cell diff erentiation with ef-
fect concentrations on the decrease of ES-D3 cell viability reveals that for various NPs (cobalt 
ferrite NPs, gold NPs, silicon dioxide NPs and titanium dioxide NPs) ES-D3 cell diff erentia-
tion is already inhibited at concentrations that do not yet aff ect cell viability, whereas for other 
NPs (PS-NPs, silver NPs and zinc oxide NPs), ES-D3 cell diff erentiation is only inhibited 
at concentrations that also aff ect cell viability. Th ese diff erences between NPs may point to 
diff erences in modes of action underlying their inhibition of ES-D3 cell diff erentiation. In 
summary, the review shows that, in spite of the limited available data, smaller NPs may be 
more potent than larger NPs made of the same core material and that NP coating and surface 
charge can aff ect the NP-induced decrease of ES-D3 cell viability and inhibition of ES-D3 cell 
diff erentiation, albeit in an NP-type specifi c way.
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DISCUSSION
Th e present study aimed to assess the role of NP surface charge on the in vitro developmental 
toxicity potential of NPs as measured in the ES-D3 cell diff erentiation assay. Th e results show 
that the positively charged PS-NPs caused a concentration-dependent inhibition of ES-D3 
cell diff erentiation while the two negatively charged PS-NPs did not show any eff ect, indi-
cating that NP charge may play an important role in NP-induced developmental toxicity. 
In order to obtain insight whether also other physicochemical characteristics of NPs may 
relate to their in vitro developmental toxicity potency, we performed a literature search on 
the reported eff ects of NPs on ES-D3 cell diff erentiation. Th is analysis indicated that besides 
surface charge, also size and coating are important NP characteristics that may determine the 
developmental toxicity potential of NPs.
Eff ect concentrations of the positively charged PS-NPs in the ES-D3 cell diff erentiation assay 
were close to cytotoxic concentrations as measured in cell viability studies (Figure 1A), which 
indicates that the inhibition of the ES-D3 cell diff erentiation may be caused by non-specifi c 
eff ects. Similar eff ects have also been found for silver NPs and zinc oxide NPs (Table 2). In the 
validation study of the EST, most developmental toxicants that were selected based on pos-
itive developmental toxicity eff ects in in vivo studies appeared to cause inhibition of ES-D3 
cell diff erentiation at concentrations that also caused cytotoxicity (Marx-Stoelting et al. 2009). 
Th erefore, the positively charged PS-NPs tested in the present study may present a develop-
mental hazard in vivo, even though the mode of action underlying this developmental toxicity 
may be related to cytotoxicity.
Knowledge on the relation between physicochemical characteristics of NPs, such as size or 
surface charge, and their toxicity would be of great help for setting priorities for NP toxicity 
testing. Although the experiments in the present study show that positively charged PS-NPs 
are more toxic than negatively charged PS-NPs, it appeared that this may not be generalizable 
to other NPs, following from the fact that the negatively charged PS-NPs of the present study 
did not aff ect ES-D3 cell diff erentiation, while silicon dioxide, silver and titanium dioxide NPs 
that were reported to inhibit ES-D3 cell diff erentiation were also negatively charged (Table 2). 
Th e reported surface charges of these NPs were measured in either nanopure water or phos-
phate buff er. Th is implies that the negative charge did not arise from serum proteins which 
may aff ect the NP charge, as observed in the present study when NP charge was measured in 
medium with FCS. To obtain better insight in the role of NP surface charge on developmental 
toxicity more studies are needed that assess the eff ects of NPs with diff erent charge that are 
made of the same core material. Th e eff ect of surface charge on the potential to aff ect cell 
viability has been demonstrated before in other cell lines for tri-block copolymer NPs (Bhat-
tacharjee et al. 2012), gold NPs (Liu et al. 2013) and silicon NPs (Bhattacharjee et al. 2013), 
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generally showing higher cytotoxicity for positively charged NPs compared to negatively 
charged NPs. Whether this implies that positively charged silicon dioxide, silver and titanium 
dioxide NPs would show more potent eff ects on ES-D3 cell viability and diff erentiation than 
reported for their negative counterparts in literature (Table 2) remains to be investigated. 
Our literature search showed that for two diff erent types of NPs (silicon dioxide NPs and 
silver NPs), it has been shown that the eff ects on ES-D3 cell viability and diff erentiation were 
found at lower concentrations for relatively small NPs than for larger NPs of the same core 
material, indicating the role of NP size in their eff ects on ES-D3 cell viability and diff erenti-
ation. Th e smaller the diameter of a spherical NP the higher the surface area which is oft en 
accompanied by increased chemical reactivity with cells (Nel et al. 2009). It has also been re-
ported that cellular uptake of NPs is dependent on their size, showing a higher cellular uptake 
for relatively small NPs (Kreyling et al. 2009, Dos Santos et al. 2011), indicating that the intra-
cellular concentration of small-sized NPs may be higher than the intracellular concentration 
of the larger sized NPs, which may also explain their higher toxic potency. However, when 
comparing toxic potencies of NPs of diff erent sizes, it must be taken into account that when 
expressing exposure on a mass-basis (µg/ml) the number of NPs is larger for small-sized NPs 
than for large-sized NPs at the same concentration. Th is may need to be accounted for when 
comparing the toxicity potencies of NPs of diff erent sizes. 
Our analysis of the available literature also indicated that the in vitro developmental toxicity 
potency of NPs may also largely depend on the coating applied. However, from the available 
data it cannot be concluded whether the toxicity potential is dependent on the coating alone, 
or whether that is dependent on the combination of the core material and the coating. Th ere-
fore, although the limited data available indicate that charge, size and coating of NPs may be 
important characteristics that determine the developmental toxicity potential of NPs, more 
(systematic) studies are needed to assess how physicochemical characteristics of NPs relate to 
their developmental toxicity potency. Th is information may help to prioritize NPs for in vitro 
and in vivo developmental toxicity testing. 
Th e results of the present study indicate that the positively charged PS-NPs may pose a hazard 
for embryonic development. However, to possibly become a risk for embryonic development, 
NPs need to be able to reach the developing embryo in the in vivo situation. Th erefore, with 
oral exposure, NPs would need to translocate across the intestinal barrier as well as the pla-
cental barrier. Th e bioavailability upon oral exposure has been reported to be low for many 
NPs, because of a limited translocation across the intestinal barrier (Walczak et al. 2014). As 
far as we know, no in vivo study using oral exposure has shown so far that NPs can cause de-
velopmental toxicity. However, in vivo studies using intravenous injection of NPs have shown 
that NPs can cause adverse eff ects to the developing embryo, indicating that NPs can trans-
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locate across the placenta in the in vivo situation (Semmler-Behnke et al. 2008, Yamashita et 
al. 2011, Yang et al. 2012, Qi et al. 2014). In an earlier study, we have assessed the potential of 
the same PS-NPs as used in the present study to translocate across an in vitro barrier of hu-
man placental (BeWo) cells (Kloet et al. 2015). Th e results of these studies indicated that the 
positively charged PS-NPs hardly translocated across the BeWo cell layer, which may indicate 
that fetal exposure of these PS-NPs is low. Th erefore, although the present study indicates the 
potential of positively charged PS-NPs to cause developmental toxicity, concentrations shown 
in the present study to be required to exert these eff ects may not be reached in the in vivo 
situation, because of the low placental transfer. Th erefore, in order to predict which NPs may 
cause developmental toxicity in the in vivo situation, data obtained in the in vitro ES-D3 cell 
diff erentiation assay should be combined with placental translocation data from the BeWo 
model in order to select the NPs that are expected to have the highest potency in vivo. Th ese 
combined data may then be used to select and prioritize NPs that should be assessed in vivo 
for potential developmental toxicity.
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 ABSTRACT 
Specifi cations of food additives like titanium dioxide, iron oxide, silicon dioxide and silver 
do not exclude the material of commerce being present in part in nanoform. Th e aim of the 
present study was to investigate toxic eff ects of the nanoform of these metal (oxide) food 
additives and other nanoparticles (NPs), being manganese oxide, copper oxide, chromium 
oxide, cobalt oxide and nickel oxide NPs, using an in vitro model of macrophage RAW264.7 
cells. Eff ects on cell viability, reactive oxygen species (ROS) production, mitochondrial per-
meability transition pore (MPTP) opening, ATP, and TNF-α were assessed. Th e results indi-
cate that most of the tested NPs show no eff ects on the selected endpoints up to the highest 
concentration tested. Of the food additive related NPs, silicon dioxide and silver NPs were 
most toxic, showing a decrease in cell viability at concentrations of 100 µg/ml and higher. 
Altogether, the present study shows no or limited eff ects of the NP forms of metal (oxide) 
food additives on cell viability, ROS production, MPTP opening, ATP levels and TNF-α pro-
duction in RAW264.7 macrophages. Eff ects were only observed at high concentrations that 
may not be physiologically relevant, indicating that related adverse eff ects upon exposure to 
the respective NPs may be limited.
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INTRODUCTION 
Several food additives, such as titanium dioxide (TiO2) (E171), iron (III) oxide (Fe2O3) (E172), 
silicon dioxide (SiO2) (E551) and silver (Ag) (E174), contain metal or metal oxide particles of 
variable sizes (Athinarayanan et al. 2014, Periasamy et al. 2015). At present the specifi cations 
of these food additives do not exclude the presence of the compounds in their nanoform, be-
cause food additives are excluded from the regulation that states that all ingredients that are 
present in nano-form should be indicated in the list of ingredients as ‘nano’ (2011). A recent 
study investigated the morphology and dimensions of the food additive SiO2 in several com-
mercial food products, showing the presence of spherical SiO2 nanoparticles (NPs) of about 
10-50 nm in size (Athinarayanan et al. 2014). Other studies found that a certain food grade 
TiO2 contained ~25-38% of the TiO2 as NPs smaller than 200 nm (Weir et al. 2012, Faust et al. 
2014). Th ese fi ndings indicate that studies on the health eff ects of nanoforms of current food 
additives are of high interest. At the same time, safety considerations for nanoscale materials 
in food products have not been well developed yet (Bouwmeester et al. 2009). As the health 
eff ects of NPs are largely unknown, toxicity studies with nanomaterials that measure such 
health eff ects are urgently needed. 
Th e aim of the present study was to investigate the toxic eff ects of the nanoform of metal 
(oxide) food additives TiO2, Fe2O3, SiO2 and Ag using an in vitro model consisting of mac-
rophage RAW264.7 cells. Further, the eff ects of other metal oxide NPs of manganese oxide 
(Mn2O3), copper oxide (CuO), chromium oxide (Cr2O3), cobalt oxide (Co3O4) and nickel 
oxide (NiO), to which we may be exposed via products like paints, catalysts, construction 
materials, coatings and batteries were quantifi ed (Siddiqui et al. 2012, Tavares et al. 2014, 
Dang et al. 2015). Th e possible NP-induced adverse eff ects on macrophage RAW264.7 cells 
may indicate possible immunotoxic responses and hazards since macrophages play a major 
role in the innate immune response, providing a fi rst line of defence (Ma et al. 2003, Elsabahy 
et al. 2013). NP-induced macrophage cell toxicity may therefore decrease the innate immune 
response. Also, activation of cytokine production, such as tumor necrosis factor-α (TNF-α), 
by macrophages exposed to NPs is undesired, since this may lead to infl ammatory reactions. 
To assess eff ects of the NPs on the macrophages, cell viability, mitochondria-related parame-
ters and release of the infl ammatory mediator TNF-α were assessed in NP-exposed RAW264.7 
cells. Th is study focussed on the eff ects of the NPs on mitochondria-related parameters, since 
previous research indicated that mitochondria play an important role in NP-induced toxicity 
(Park et al. 2008, Sharma et al. 2011, Shvedova et al. 2012, Bhattacharjee et al. 2013). Espe-
cially cationic NPs have been reported to damage the mitochondria, leading to disturbance of 
intracellular adenosine 5′-triphosphate (ATP) and reactive oxygen species (ROS) production, 
which may trigger apoptotic reactions that ultimately lead to the observed toxicity (Bhat-
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tacharjee et al. 2013). Th erefore, in the present study the eff ects of the metal oxide NPs on 
ROS production, mitochondrial permeability transition pore (MPTP) opening and intracel-
lular ATP levels were assessed, in addition to eff ects on cell viability and production of TNF-α. 
MATERIALS AND METHODS 
Materials 
High glucose Dulbecco´s Modifi ed Eagle Medium (DMEM/F-12), Phosphate Buff ered Sa-
line (PBS), Fetal Calf Serum (FCS), Hank’s Balanced Salt Solution (HBSS) and trypsin-ED-
TA were obtained from Invitrogen (Breda, the Netherlands). Bovine Serum Albumin (BSA), 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and copper sulfate 
were purchased from Sigma Aldrich (Zwijndrecht, the Netherlands). WST-1 Cell Prolifera-
tion Reagent was purchased from Roche (Woerden, Th e Netherlands). Information on size 
and specifi c surface area of the NPs that were used in the present study as provided by the 
manufacturers are presented in table 1. Fe2O3 NPs, TiO2 anatase and TiO2 rutile NPs, and 
Cr2O3 NPs were obtained from US Research Nanomaterials (Houston, Texas, USA). Mn2O3 
NPs were obtained from Auer Remy (Hamburg, Germany). SiO2 NPs and NiO NPs were ob-
tained from Skyspring (Houston, Texas, USA). Co3O4 NPs and CuO NPs were obtained from 
Sigma Aldrich (Zwijndrecht, Th e Netherlands). Ag NPs were obtained from NanoComposix 
Inc. (San Diego, California, USA).
 Preparation of NPs for in vitro studies
All NPs were delivered in powdered form except for Ag NPs which came as a stable 5 mg/ml 
aqueous suspension in nanopure water. Th e working suspensions were prepared according to 
a method described by Zhang et al. (2012). Briefl y, a 5 mg/ml stock suspension in nanopure 
water of each powdered NP was prepared in a sterile glass vial. Th ese suspensions were soni-
cated in a bath sonicator (VWR international, Leuven, Belgium) for 20 minutes. Aft erwards, 
an equal volume of 4% BSA in nanopure water was added to stabilise the suspension. Th ese 
suspensions were left  for one hour at room temperature to equilibrate. Aft er vortexing the NP 
stock suspension, further dilutions were prepared with 2% BSA in nanopure water, except 
for the Ag NP stock suspension which was further diluted in nanopure water. Finally, the 
BSA-coated NP suspensions were 12.5x diluted in cell culture medium containing 10% FCS, 
reaching the fi nal exposure NP concentrations between 0 and 200 µg/ml.
NP characterization
Th e size (hydrodynamic diameter) of the NPs was determined by dynamic light scattering 
(DLS) using a Cobolt Samba 300mW DPSS laser at a wavelength of 532 nm. Measurements 
were performed on freshly prepared NP suspensions at 10 μg/ml in nanopure water and in 
cell culture medium containing 10% FCS. For each sample, twenty measurements were made 
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and the detector intensity data (measured with an ALV/SO SIPD Single Photon Detector with 
ALV Static and Dynamic Fiber optics) were processed with an ALV5000/60X0 external cor-
relator and ALV-5000/E soft ware (all from ALV-GmbH, Germany). Data were analysed with 
the Aft erALV soft ware and mean diameter and polydispersity index (PDI) were determined 
for each NP sample. Additionally the zeta potential of the NPs was measured at a concentra-
tion of 100 µg/ml in both nanopure water and in cell culture medium containing 10% FCS 
using the Malvern Zetasizer 2000 (Malvern Instruments, UK). 
Morphology of the NPs was characterised by scanning electron microscopy (SEM). To this 
end, suspensions of the NPs (10-100 µg/mL) in nanopure water were studied using SEM. Of 
each suspension 25 μl was deposited and left  to dry on a nickel-coated polycarbonate fi lter, 
which was mounted on an aluminium specimen holder. Th e high resolution fi eld emission 
gun scanning electron microscope (FEG-SEM) used in this study was a Tescan MIRA-LMH 
FEG-SEM (Tescan, Brno, Czech Republic). Th e microscope was operated at an accelerating 
voltage of 15 kV, working distance (WD) of 10 mm and spot size of 5 nm. 
Images of cells exposed to 200 µg/ml were captured with an inverted fl uorescence microscope 
(Olympux IX70, USA) equipped with a digital camera (Canon EOS 1000D, Japan).
Table 1. Commercial source information for metal (oxide) NPs used in the present study. Reported size 
was determined by TEM and reported specifi c surface area was calculated using bulk density.  
NP Source Catalogue number Size (nm) Specifi c surface 
area (SSA) 
(m2/g)
TiO2 Anatase US Research Nanomaterials, Inc US3498 30 50 
TiO2 Rutile US Research Nanomaterials, Inc US3520 30 35-60  
Fe2O3 US Research Nanomaterials, Inc US3210 20-40 40-60 
SiO2 Skyspring Nanomaterials, Inc 6810DL 20-60 400-600 
Ag Nanocomposix DAC1612 50 9.8
Mn2O3 Auer Remy 3610FY 30 
Cr2O3 US Research Nanomaterials, Inc US3060 60 14
CuO Sigma Aldrich 544868 <50 20 
Co3O4 Sigma Aldrich 637025 <50 40-70 
NiO Skyspring Nanomaterials, Inc 5410SC 50 >6 
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Cell culture and assessment of cell viability
RAW264.7 cells (LGC, ATCC, Teddington, UK) were cultured at 37°C with 5% CO2 in a hu-
midifi ed atmosphere in 10 ml DMEM supplemented with 10% (v/v) FCS in a 75 cm2 culture 
fl ask (Corning, USA). Cells were subcultured every 3 to 4 days when reaching 80% confl uen-
cy using trypsin-EDTA aft er rinsing with PBS. 
To assess eff ects of the NPs on cell viability, RAW264.7 cells were seeded at 2x104 cells/well 
in 100 µl culture medium with 10% FCS in 96-well plates (Greiner bio-one) and incubated 
at 37°C and 5% CO2 for 24 hours. Aft er this, the medium was removed and cells were sub-
sequently exposed to 100 µl of NP suspensions using concentrations ranging from 0 to 200 
µg/ml in culture medium with 10% FCS. Aft er 24 hours exposure, 10 µl of WST solution was 
added to the medium. Aft er 45 min incubation, the 96-well plate was shaken for 5 minutes 
(protected from light) and subsequently absorbance was measured at 450 and 620 nm (back-
ground) using a SpectraMax M2 Microplate Reader (Molecular Devices LLC, Sunnyvale, CA 
USA). For each experimental condition, formazan formation was expressed as percentage of 
the formazan formation of the solvent control. Ag NPs showed a concentration-dependent 
interference in this WST assay. Th erefore, instead of WST solution, 5 µl of a 5 mg/mL tetra-
zolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution in 
PBS was added to each well in the experiments on Ag NPs and incubated for 1.5 hours. Th e 
exposure media containing MTT was then removed and 100 µL DMSO was added to solu-
bilize the formazan crystals, which was achieved by shaking the plates protected from light 
for 10 min. Th e dissolved formazan was quantifi ed by measuring the absorption at 562 nm 
and 620 nm (background) using a SpectraMax M2 Microplate Reader. For each experimental 
condition, formazan formation was expressed as percentage of the formazan formation of the 
solvent control. Copper sulfate (100 µM) was used as the positive control. 
Assessment of mitochondrial permeability transition pore (MPTP) opening
Th e MPTP opening refers to a change in the inner mitochondrial membrane permeability 
(Bonora et al. 2014). An increase in MPTP opening results in an increase in the mitochon-
drial membrane permeability, leading to rapid loss of the mitochondrial membrane potential, 
a decrease in ATP production, and fi nally to the loss of cell integrity (Ly et al. 2003). Aft er 
24 hours exposure to the NPs under similar conditions as with the cell viability assay, MPTP 
opening was measured using the MitoProbe Transition Pore Assay Kit (Invitrogen, Breda, Th e 
Netherlands, cat nr. M34153). Fluorescence was measured at 485 and 530 nm (background) 
using a SpectraMax M2 Microplate Reader. Ionomycin, which was supplied with the kit, was 
used as the positive control (15 minutes incubation at a concentration of 10 µM). In the assay, 
an increase in MPTP opening causes a decrease in the fl uorescent signal which correlates with 
an increase in the mitochondrial membrane permeability, so with a decrease in the mitochon-
drial membrane integrity.
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Assessment of intracellular ROS production
To determine the eff ects of the NPs on intracellular ROS production, RAW264.7 cells were 
seeded at 2x104 cells/well in 100 µl culture medium with 10% FCS in 96-well plates and in-
cubated at 37°C and 5% CO2 for 24 hours, followed by removal of the medium and addition 
of a solution of 20 µM 2,7-dichlorodihydrofl uorescein diacetate (DCFDA) in medium with 
10% FCS. Aft er 45 minutes the DCFDA solution was removed and cells were exposed for 24 
hours to the NPs under similar conditions as with the cell viability assay. Fluorescence was 
measured using a SpectraMax M2 Microplate Reader at 485 and 538 nm (background) wave-
lengths. H2O2 (10 mM) was used as the positive control. 
Assessment of intracellular ATP levels
Th e eff ects of NPs on intracellular ATP levels was determined. Aft er 24 hours exposure to the 
NPs under similar conditions as with the cell viability assay, the ATP levels were determined 
using the ATP bioluminescent somatic cell assay kit (Sigma Aldrich, Zwijndrecht, Th e Neth-
erlands, cat nr. FLASC) by measuring luminescence using the Luminoscan Ascent (Th ermo 
electroncorporation). 2,4-Dinitrophenol (4 mM) was used as the positive control. 
Assessment of TNF-α production
To determine the eff ects of the NPs on TNF-α production, the sandwich ELISA mouse TNF-α 
kit (Invitrogen, Breda, Th e Netherlands, cat nr. KMC3011C) was used. Aft er 24 hours expo-
sure to the NPs under similar conditions as with the cell viability assay, plates were centri-
fuged (centrifuge model 4k10 from Sigma) at 1200 rpm for 5 minutes at 4°C. Subsequently, 
the supernatants were collected and frozen at -80°C. Samples were thawed and added to mi-
crotiter strips, coated with monoclonal antibodies specifi c for mouse TNF-α. Th e samples 
were diluted twice with standard diluent buff er from the kit and the secondary antibody (bi-
otinylated mouse TNF-α Biotin Conjugate) was added. Aft er 90 minutes of incubation, the 
wells were washed four times with wash buff er (to remove any unbound secondary antibody) 
aft er which a 100 μl solution containing Streptavidin-HRP was added, which binds to the 
biotinylated secondary antibody. Th e plate was covered with a plastic cover and stored for 
30 minutes at room temperature and the wells were subsequently washed four times with 
wash buff er delivered with the kit. Stabilized chromogen was added to each well and the plate 
was stored for 20 to 25 minutes in the dark. Subsequently, a stop solution was added to each 
well and the absorbance of each well was read at 450 nm, using a SpectraMax M2 Microplate 
Reader. A series of TNF-α concentrations were included in duplicate to each 96 wells plate 
in order to defi ne a calibration curve enabling quantifi cation of TNF-α. Lipopolysaccharide 
(LPS, 0.1 μg/ml) was used as the positive control.
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Data analysis
For each study, three or four independent experiments were performed (n= 3-4). In each ex-
periment three technical replicates were included, which were averaged per experiment. Data 
are shown as mean ± standard deviation (SD) of all data points per experiment and plotted 
in graphs using GraphPad Prism® version 5. Statistical analyses among mean values of the 
diff erent treatments were performed by one-way analysis of variance followed by a Tukey’s 
Multiple Comparison Test using GraphPad Prism® version 5.
RESULTS
Physicochemical characterization of the NPs
NP size, zeta potential and morphology were characterized using SEM, DLS and zeta po-
tential analyses. Figure 1 shows the SEM pictures of the diff erent NPs. Ag NPs are rather 
spherical shaped and monodispersed, while the other NPs have variable shapes and form 
agglomerates (Figure 1).
Dynamic light scattering (DLS) measurements were performed to determine the hydrody-
namic diameter of the diff erent NPs in nanopure water and cell culture medium with 10% 
FCS (Table 2). All NPs agglomerated when dispersed in water or cell culture medium with 
Figure 1. SEM pictures (magnifi cation 200 000x) of the NPs used in the present study.
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10% FCS albeit to varying degrees. For all NPs, except Ag NPs, their hydrodynamic size was 
higher in water compared to cell culture medium, indicating more agglomeration in water 
(Table 2). Of all NPs used in the present study only Ag NPs had a hydrodynamic size close to 
the size as given by the manufacturer (Table 1). Th e PDI of the NPs varied between 0.2 and 
0.6. For all NPs except Mn2O3, the PDI was higher for cell culture medium as compared to the 
PDI in water, indicating that the size distribution became wider. Background values measured 
for cell culture medium with 10% FCS and water are 12.1 and 0 nm respectively. 
Th e zeta potential of the NPs was measured as an indication of the charge of the NPs in both 
water and cell culture medium with 10% FCS (Table 2). All NPs had a zeta potential in water 
between -29.6 and -46.1 mV. In cell culture medium the zeta potential of all NPs varied be-
tween -8.9 and -17.1 mV. Background values measured for cell culture medium with 10% FCS 
and water are -6.4  and 3.3 mV respectively.
Table 2. Dynamic light scattering (DLS) (n=3) and zeta potential (n=3) results.        
NP Diameter in nm ± SD (PDI) Zeta potential (mV) ± SD
In water In cell culture medium 
with 10% FCS
In water In cell culture medium 
with 10% FCS
TiO2 anatase 497 ± 290.2 (0.5) 170 ± 65 (0.5) -29.6 ± 1.35 -11.8 ± 0.1
TiO2 rutile 599 ± 512 (0.3) 176 ± 5.8 (0.5) -36.7 ± 3.7 -13.4 ± 0.7
Fe2O3 991 ± 286 (0.3) 423 ± 139 (0.5) -32.3 ± 0.4 -10.1 ± 0.5
SiO2 606 ± 184 (0.3) 246 ± 67 (0.5) -46.1 ± 1.2 - 9.5 ± 0.3
Ag 65 ± 2.0 (0.2) 74 ± 2.2 (0.3) -44.7 ± 3.6 - 8.9 ± 0.7
Mn2O3 662 ± 280 (0.4) 313 ± 107 (0.3) -33.6 ± 2.5 -17.1 ± 2.5
Cr2O3 460 ± 101 (0.3) 153 ± 19 (0.5) -35.6 ± 3.9 -14.3 ± 0.5
CuO 491 ± 334 (0.3) 205 ± 124 (0.5) -36.3 ± 2.5 -15.8 ± 0.4
Co3O4 1285 ± 827 (0.5) 224 ± 113 (0.6) -37.6 ± 0.6 -13.1 ± 0.9
NiO 799 ± 781 (0.3) 222 ± 23 (0.5) -32.9 ± 2.8 -16.1 ± 0.6
None 0 12.1 ± 0.6 (0.4) 3.3 ± 0.2 - 6.4 ± 2.6
Eff ects of metal (oxide) food additive NPs on RAW264.7 cells 
NP forms of food additives Fe2O3, SiO2, Ag and TiO2 anatase and TiO2 rutile NPs were tested 
for their eff ects on cell viability, ROS production, mitochondrial membrane integrity (as mea-
sured by MPTP opening), intracellular ATP levels and TNF-α production in RAW264.7 cells 
upon 24 hours of exposure. Data obtained for the positive controls of the tests are presented 
in the supplementary fi gure 1. When dispersing the NPs in the medium, sedimentation was 
observed using light microscopy at the concentrations of 50 µg/ml and higher (Supplementa-
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ry fi gure 2). Th e results reveal that of the diff erent NP forms of food additives only SiO2 and 
Ag NPs cause a signifi cant concentration-dependent decrease in cell viability (Figure 2A). 
No eff ect on cell viability was noticed when RAW264.7 cells were exposed to the other NPs 
to concentrations up to 200 μg/ml (Figure 2A). Besides aff ecting cell viability, Ag NPs and 
SiO2 NPs also signifi cantly decreased the intracellular ATP levels in a concentration-depen-
dent manner (Figure 2D). SiO2 NPs caused at the highest concentration tested an increase in 
TNF-α production by the cells (Figure 2E). None of the food-related NPs showed statistically 
signifi cant eff ects on mitochondrial membrane integrity (Figure 2C). Only Fe2O3 NPs signifi -
cantly induced ROS production at the highest concentration tested (Figure 2B). 
Eff ects of other (non-food-related) metal oxide NPs on RAW264.7 cells 
To assess possible adverse eff ects of other metal oxide NPs, the eff ects of an additional series 
of metal oxide NPs were characterized on RAW264.7 cells, being Mn2O3, CuO, Cr2O3, Co3O4 
and NiO NPs. Results obtained reveal that only exposure to Mn2O3 and CuO NPs induced sig-
nifi cant eff ects in RAW264.7 cells (Figure 3). No eff ects were found upon exposure to Cr2O3, 
Co3O4 and NiO NPs up to concentrations of 200 µg/ml. Exposure to Mn2O3 and CuO NPs 
resulted in a statistically signifi cant decrease in cell viability (starting from 200 and 50 µg/ml 
respectively; Figure 3A), a decrease of mitochondrial integrity (starting from 100 and 50 µg/
ml respectively; Figure 3C) and a decrease in intracellular ATP levels (starting from 50 and 
100 µg/ml respectively; Figure 3D). Mn2O3 and CuO NPs also caused a signifi cant increase in 
ROS production (Figure 3B). Further, a concentration-dependent increase of TNF-α produc-
tion upon Mn2O3 NPs exposure was found, but these eff ects were not statistically signifi cant 
(Figure 3E). 
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Figure 2.  Eff ects of diff erent NP forms of metal (oxide) food additives on:  A) cell viability, B) ROS pro-
ducti on, C) mitochondrial membrane integrity, D) ATP levels and E) TNF-α production in RAW264.7 
cells. RAW264.7 cells were exposed for 24 hours to increasing concentrations of NPs. TiO2 A = titanium 
dioxide anatase NP; TiO2 R = titanium dioxide rutile NP; Fe2O3 = iron oxide NP; SiO2 = silicon dioxide 
NP; Ag = silver NP.
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Figure 3. Eff ects of other (non-food-related) metal oxide NPs on A) cell viability, B) ROS production, C) 
mitochondrial membrane integrity, D) ATP, and E) TNF-α production in RAW264.7 cells. RAW264.7 
cells were exposed for 24 hours to increasing concentrations of NPs. Mn2O3 = manganese oxide NP; 
CuO = copper oxide NP; Cr2O3 = chromium oxide NP; Co3O4= cobalt oxide NP; NiO = nickel oxide NP.
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DISCUSSION
Th e present study assessed the adverse eff ects of metal (oxide) NPs on macrophages in vitro, 
to study possible hazards of such NPs. To this end the eff ects of a series of food-related and 
other (non-food-related) metal (oxide) NPs on cell viability, ROS production, mitochondrial 
integrity, intracellular ATP levels and TNF-α production in RAW264.7 macrophages were 
assessed. Th e results indicate that of the food additive related NPs, SiO2 and Ag NPs were the 
most toxic, showing a signifi cant decrease of cell viability at concentrations of 100 µg/ml and 
higher, and a decrease of intracellular ATP at 200 µg/ml (Figure 2). In addition, SiO2 NPs in-
duced increased TNF-α production at 200 µg/ml. From the series of other (non-food-related) 
metal oxide NPs, CuO and Mn2O3 NPs were the most toxic, aff ecting mitochondrial integrity, 
ROS production, ATP levels and cell viability at concentrations of 50 µg/ml and higher. Al-
together, the present study shows no or limited eff ects of the NP forms of metal (oxide) food 
additives and related NPs on cell viability, ROS production, mitochondrial integrity, intracel-
lular ATP levels and TNF-α production in RAW264.7 macrophages. 
In the present study, eff ects for most NPs were only detected at high concentrations, if de-
tected at all. At concentrations of 50 µg/ml and higher, metal oxide NP sedimentation was 
observed (supplementary fi gure 2), and it has been reported that toxicity of NPs may be af-
fected by their agglomeration (Oberdorster 2010, Albanese et al. 2011, Zook et al. 2011, Ca-
ballero-Díaz et al. 2013). However, since these NP agglomerations appeared to be co-localized 
with the RAW264.7 marcrophages and since they were not dispersed in the medium, this may 
indicate that these agglomerations are not the result of dispersity problems, but that the mac-
rophages may have internalised the NPs. Th erefore, the toxicity of NPs to the macrophages as 
observed in the present study for SiO2, Ag, CuO and Mn2O3 NPs may be related to a high NP 
uptake, as has been reported before for gold NPs (Zhang et al. 2011). 
It has been hypothesized that oxidative stress is an important mechanism underlying the 
cytotoxicity of NPs, including Mn2O3 and CuO NPs (Carlson et al. 2008, Park et al. 2009, 
Foucaud et al. 2010). NPs’ ability to generate oxidative stress can be due to their high surface 
reactivity (Krug et al. 2011), the presence of transition metal ions in the case of metal oxides 
and metal NPs (Kim et al. 2014), the fact that they can interact with the mitochondrial mem-
brane and disrupt the electron transport chain (Elsaesser et al. 2012), and because they can 
attract macrophages and neutrophils that in response produce ROS (Krug et al. 2011). For 
Mn2O3 NPs and CuO NPs, we indeed found an increase in ROS production upon exposure 
of the cells (Figure 3B), which was accompanied by a decrease in cell viability at high expo-
sure concentrations. Th e increase in ROS production upon Mn2O3 NPs and CuO NPs expo-
sure was clearly associated with a decrease in mitochondrial membrane integrity (Figure 3C) 
and a decrease in ATP levels (Figure 3D) suggesting that the ROS production may originate 
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from impairment of the membrane integrity resulting in uncoupling of the electron transport 
chain. For the other two most cytotoxic NPs tested in the present study, the food-related SiO2 
NPs and Ag NPs, no increased ROS production was found (Figure 2B). Also, no eff ects on 
mitochondrial membrane integrity were observed for these NPs (Figure 2C) and only slight 
eff ects on ATP levels (Figure 2D), which may be a secondary eff ect because of dying cells. Th is 
indicates that the food-related Ag NPs and SiO2 NPs likely have a diff erent mode of action 
underlying their cytotoxicity than the non-food related Mn2O3 NPs and CuO NPs.
Of the NPs used in the present study, Ag NPs and CuO NPs were the most toxic ones. CuO 
and Ag NPs have been reported before as being signifi cantly cytotoxic to A549 cells and Calu-
3 epithelial cells and Raw264.7 macrophages (Karlsson et al. 2008, Haase et al. 2011, Rotoli et 
al. 2012). It is known that ions are released from Ag and CuO NPs at diff erent rates, making 
the understanding of the delivered dose challenging (Ponti et al. 2009, Misra et al. 2012). 
Discussion remains about the role of this ion dissolution in the mode of action underlying 
the toxicity (Karlsson et al. 2008, Adamczyk et al. 2016). Although toxicity of CuO NPs may 
be (partly) caused by dissolution of Cu ions, a study of Karlsson et al. (2008) showed that the 
toxicity of CuO NPs cannot be solely explained by Cu ions released into the cell medium. For 
example, cell viability of A549 cells decreased more when exposed to 40 µg/mL of Cu from 
CuO NPs (50 µg/mL CuO) than when exposed to 40 µg/mL of Cu from CuCl2 (85 µg/mL 
CuCl2) (Karlsson et al. 2008). Regarding Ag NPs, no toxic eff ect was observed when HeLa cells 
were exposed to Ag ions (as silver nitrate) up to 8 µg/mL silver nitrate whereas Ag NPs caused 
toxicity starting from 2.0 µg/mL (Kaba and Egorova 2015). For U937 cells on the other hand, 
Ag ions showed similar toxicity as Ag NPs in a concentration range of 0.5-8 µg/mL (Kaba et 
al. 2015). So although it is known that ions can be released from these NPs, it remains still a 
topic of investigation how these ions contribute to the toxicity observed.   
Our results showed that SiO2 NPs were the most toxic ones among the tested food-related 
NPs. SiO2 NPs are known to exert a decrease in cell viability in primary human monocyte-de-
rived macrophages and MH-S and RAW264.7 cells (Farcal et al. 2015, Di Cristo et al. 2016). 
Exposure to food-related NPs is expected to be mainly via the gastrointestinal tract. Upon 
oral exposure, NP characteristics may change because of gastrointestinal digestion (Rogers et 
al. 2012, Walczak et al. 2015). When food products containing SiO2 were tested in an in vitro 
digestion model, simulating the conditions of the human gastrointestinal tract, it was found 
that SiO2 NPs (5-200 nm) were still present in the intestinal content (Peters et al. 2012). Th is 
indicates that it is most likely that upon consumption of foods containing particulate SiO2, the 
gut epithelium is exposed to SiO2 NPs (5-200 nm) (Peters et al. 2012). To enter the systemic 
circulation, NPs need to be absorbed in the gastrointestinal tract. Intestinal absorption large-
ly depends on the size of NPs, surface charge and hydrophobicity (Bouwmeester et al. 2011, 
Bhattacharjee et al. 2013). In an in vivo study in rats it was shown that 6.6-9.7% of SiO2 NPs 
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of 20 and 100 nm were absorbed into the systemic circulation when orally administered at a 
single dose of 500 and 1000 mg/kg (Lee et al. 2014), indicating that SiO2 NPs can get trans-
located across the intestinal barrier. An in vitro study showed that 50 nm SiO2 NPs were able 
to translocate across an intestinal barrier based on results obtained in a Caco-2 cell transwell 
model system (Sakai-Kato et al. 2014). 
With an estimated daily intake of SiO2 in the nano-size range of 1.8 mg/kg bw/day (van der 
Zande et al. 2014, van Kesteren et al. 2014), the daily intake of a 70 kg person would be 126 
mg. In the adult human the gastrointestinal tract represents a considerable surface area of 
about 200 m2   which has the potential to interact with ingested NPs (Bergin et al. 2013). 
In addition the gastrointestinal tract has localised representations of the adaptive immune 
system in the form of gut-associated lymphoid tissue (GALT) aggregates (Peyer’s Patches) 
(Bergin and Witzmann 2013). Th ese Peyer’s patches account for 1% of the total surface area 
of the gastrointestinal tract (des Rieux et al. 2006). About 9 litres of fl uid pass through the 
GI system each day (Sherwood L. 2014). Th us, upon oral intake of 126 mg SiO2 per day this 
would lead to a concentration of 14 µg/ml, which is lower than the lowest observed adverse 
eff ect concentration of 100 µg/mL in the present study.
If 100% of the estimated daily intake of SiO2 NPs (126 mg) would be transported from the 
intestines into the blood, assuming 5 liters of blood and a 100% clearance per day, a maximal 
concentration of 25 µg/ml would be reached if NPs would not distribute to tissues. Also this 
concentration is lower than the lowest observed adverse eff ect concentration of 100 µg/mL 
defi ned in the present study. Considering that the oral bioavailability is lower than 10% and 
that NPs also distribute to tissues (Lee et al. 2014), concentrations higher than 2.5 µg/mL are 
not likely to be reached in a real-life exposure scenario. Th is concentration is far below the 
concentrations of SiO2 causing in vitro toxicity in the present study, suggesting that in vivo 
toxic eff ects of food additive related SiO2 NPs on macrophages are expected to be limited. Th is 
is all in line with the results from an oral repeated-dose toxicity study in which male Wistar 
rats were exposed to SiO2 NPs via the diet for 28 or 84 days, showing no toxicity at the highest 
dose level tested (2500 mg/kg bw/day) (van der Zande et al. 2014).
It has to be kept in mind that NPs may not only aff ect the gastrointestinal cells directly but 
may also infl uence the microbiome, although the evaluation of eff ects of NPs on the micro-
biome is in its early infancy (Pietroiusti et al. 2015). For example, the cytotoxicity of Ag NPs 
on Escherichia coli as representative for intestinal bacteria was compared with the cytotoxicity 
of Ag NPs on gastrointestinal cells. Th is revealed that Ag NPs aff ected bacteria at lower con-
centrations than those that aff ected gastrointestinal cells, indicating that Ag NPs may cause 
adverse eff ects by selectively aff ecting the gut microbiota (Frohlich et al. 2016). In a study us-
ing an in vitro colon model (Taylor et al. 2015), TiO2 , ZnO and CeO2 NPs induced signifi cant 
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phenotypic changes of the gut microbial community, inlcuding the production of short chain 
fatty acids which are the key metabolites in the control of energy homeostatis and which have 
been implicated in the development of obesity (Schwiertz et al. 2010). For other food related 
metal (oxide) NPs such as SiO2, Fe2O3 and Ag NPs, such eff ects on the gut microbiota and 
related short chain fatty acid production remain to be investigated.
CONCLUSION
In conclusion, the present study shows no or limited eff ects of the NP forms of metal (ox-
ide) food additives on cell viability, ROS production, mitochondrial integrity, ATP levels and 
TNF-α production in RAW264.7 macrophages. Of the food additive related NPs, SiO2 and Ag 
NPs were the most toxic, showing a decrease of cell viability at concentrations of 100 µg/ml 
and higher. Eff ects were only observed at high concentrations that may not be physiologically 
relevant, indicating that related adverse eff ects upon exposure to the respective NPs may be 
limited. 
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SUPPLEMENTARY MATERIALS CHAPTER 5
Supplementary fi gure 2. Microscopic pictures of RAW264.7 cells aft er a 24-hour exposure to metal 
(oxide) NPs at a concentration of 200µg/ml.
Supplementary fi gure 1. Data obtained for the positive controls for the cell viability assay, ROS assay, 
MPTP assay, ATP assay and TNF-α assay using respectively A) 100 µM copper sulfate, B) 10 mM hy-
drogen peroxide, C) 10 µM ionomycin, D) 4mM 2,4-dinitrophenol (DNP), and E) 0.1 μg/ml lipopoly-
saccharide (LPS).
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ABSTRACT
Increasing use of engineered nanoparticles has led to an increased likelihood of their envi-
ronmental release and raises concern for ecosystem and health hazard. Th e volume of sil-
ver nanoparticle (Ag NP)-based products entering the market is relatively high, making the 
risk assessment of Ag NPs a priority. In literature, varying and sometimes confl icting reports 
exists about the physicochemical properties of NPs that are important in infl uencing their 
uptake and eff ects. To address this discrepancy, small and medium sized (20 and 50 nm) Ag 
NPs with diff erent surface coating/charges (chitosan/positive: Ag NP_Chit; bovine serum al-
bumin/negative: Ag NP_BSA, and; polyvinylpyrrolidone/neutral: Ag NP_PVP) were specifi -
cally synthesized and characterized. Macrophage cells (RAW 264.7) were exposed to these Ag 
NPs at 0 – 200 µg/mL, and uptake dynamics, cell viability, inductions of tumor necrosis factor 
(TNF)-α and reactive oxygen species (ROS) were assessed. Generally, adverse eff ects from 
exposure to the tested Ag NPs resulting in reduced overall viability were similar irrespective 
of Ag NP types or sizes. On adenosine triphosphate production and specifi c mechanisms 
of toxicity (TNF-α and ROS production) however, the Ag NPs diff ered signifi cantly. Tests 
targeting specifi c mechanisms of action indicated the highest induction of TNF-α in cells 
exposed to both sizes of the more potent negatively charged Ag NP_BSA (80x higher than 
control). Signifi cant ROS induction was only observed with the 20 nm positively charged Ag 
NP_Chit. Additionally, live microscopic imaging of exposed cells allowed the monitoring of 
the uptake dynamics and subcellular cytoplasmic accumulation of Ag NPs. Th e present study 
provides further evidence of the infl uence of NP properties in driving their toxicity in an in 
vitro model.
13937-kloet-layout.indb   146 28/10/2016   09:29
147
Cellular interacti ons of silver nanoparti cles with systemati c variati on in size and surface coati ng with macrophage 
RAW 264.7 cells
6
INTRODUCTION
Nanotechnology can be considered as one of the fastest growing technologies which has 
revolutionized the industrial sector (Peterson, 2000, Gwinn and Vallyathan, 2006, Kennell, 
2009), bringing about possibilities only imagined a few decades ago. Th is has led to increased 
production and applications of engineered nanoparticles (NPs) for consumer products (Wi-
jnhoven et al., 2009, Wijnhoven et al., 2010). Presently, NPs continue to fi nd applications in 
the design and manufacture of household products, electronics and medical devices, food 
and transport systems, to mention a few (Ahamed et al., 2010, Haider and Kang, 2015). Con-
sequently, the increase in production and use of NPs will likely result in an increased release 
into the environment as industrial waste (or by-product), sewage or waste water, (Geranio et 
al., 2009, Wijnhoven et al., 2009, Benn et al., 2010, Reidy et al., 2013). Such environmental 
release could potentially have harmful impacts.
Currently, silver nanoparticles (Ag NPs) represent the nanomaterial most frequently used in 
products on the market (Wijnhoven et al., 2010, Vance et al., 2015) owing to their well demon-
strated antimicrobial activity (Silver and Phung, 1996, Sondi and Salopek-Sondi, 2004, Lara et 
al., 2010, Hwang et al., 2012, Prabhu and Poulose, 2012, Franci et al., 2015). At the nanoscale 
(1 – 100 nm), the small size and increased surface area of Ag NPs result in novel properties. 
Th ese can be enhanced by stabilization and/or functionalization using biocompatible conju-
gates. Essentially, the type of surface coating and process used in stabilizing engineered NPs 
during synthesis determines their surface charges, solubility and/or hydrophobicity (Evanoff  
and Chumanov, 2005, Abou El-Nour et al., 2010, Bastus et al., 2014, Shenashen et al., 2014). 
Th is in turn infl uences the behavior and environmental fate of NPs, as well as their eff ects on 
organisms (Kreuter, 2004, Roohani-Esfahani et al., 2010, Shoults-Wilson et al., 2011, Cha-
nana and Liz-Marzán Luis, 2012).
Over the last two decades, researchers have attempted to elucidate the fate and eff ect of vari-
ous NPs using both in vivo and in vitro models (Foldbjerg et al., 2012, Yu et al., 2013, van der 
Ploeg et al., 2014a, van der Ploeg et al., 2014b). Although the importance of the physicochem-
ical properties of NPs in infl uencing their fate and toxicity has increasingly been investigated, 
reports in available literature have not been consistent. Important physicochemical properties 
in this regard include size and NPs dispersion (both mono- and polydispersity), shape, zeta 
potential, and agglomeration and dissolution rates (Reidy et al., 2013). While some studies 
have reported eff ects of size (Powers et al., 2011b) or charge (Suresh et al., 2012), others fail to 
detect these (Yang et al., 2012). Additional perspectives on the infl uence of physicochemical 
properties of Ag NPs on their interactions in both in vivo and in vitro models, has been re-
viewed earlier (Johnston et al., 2010, Reidy et al., 2013). From the reviews cited and examples 
mentioned above, one can identify the challenge associated with the regulation of Ag NPs and 
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other NPs in general. Th is is especially so, given the limited data base and the limitations of 
generating in vivo data for all the diff erent forms and types of NPs. 
A better understanding of the properties that infl uence the fate and eff ects of Ag NPs in or-
ganisms therefore, will facilitate appropriate risk assessment which in turn will assist the reg-
ulation of nanomaterials. Using in vitro models in risk assessments of chemicals facilitates 
the setting of priorities for in vivo testing, thereby reducing the number of animals required 
(Braakhuis et al., 2015). By fi rst investigating with in vitro models, insights in the toxicity 
and possible mode of action of NPs are obtained. Such information could be used in a weight 
of evidence approach (Connolly et al., 2015), furthering our understanding of observations 
made under in vivo situations, as well as defi ning priorities for in vivo testing and facilitating 
read-across.
In this study, we systematically investigated the physicochemical properties of Ag NPs infl u-
encing their interactions at cellular level, using an in vitro mammalian cell line model: the 
mouse monocyte macrophage (RAW 264.7). Macrophages are involved in the defense system 
of an organism against infections, and the role of Ag NP properties in initiating infl ammatory 
(TNF-α) and oxidative stress responses in these cells were investigated. Since it appears that 
how a NP is produced infl uences both its fate and eff ect following exposures, specifi cally 
prepared Ag NPs were used in the current study. Th ese were synthesized to diff er in size and 
surface chemistry (charge), two important properties infl uencing NP uptake and eff ect (Reidy 
et al., 2013). Using imaging techniques, we also showed the uptake dynamics of Ag NPs at a 
cellular level. Th e outcome of this study provides further insight into how Ag NP properties 
determine their fate and eff ects at cellular level, thus indirectly shedding light on what the 
outcome may likely be in intact organisms (Landsiedel et al., 2012, Cornelis et al., 2014).
MATERIALS AND METHODS
Experimental design
Th e mouse monocyte macrophage cell line (RAW 264.7) was used as the in vitro model, and 
cells were treated with Ag NPs. Experiments were conducted in three independent exposures 
for each type of Ag NP (n=3) and the data generated were processed with Microsoft  Excel. 
Where appropriate, the data were subjected to one-way analysis of variance (ANOVA) with 
the aid of GraphPad Prism 5.04 for Windows (GraphPad Soft ware, San Diego California US, 
www.graphpad.com), and logistic regression was done using GenStat 17th ed. (17.1.0.14713; 
VSN International, Hemel Hempstead, UK, GenStat.co.uk). A p value of <0.05 was consid-
ered signifi cant.
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Reagents and Instruments
All chemicals, enzymes and reagents were analytical grade and purchased from Sigma-Al-
drich® (Zwijndrecht, NL), unless where stated otherwise. Apart from one commercially ob-
tained Ag NP (Ag NP_NC), all other Ag NPs were synthesized at the Catalan Institute of 
Nanoscience and Nanotechnology (ICN2, Barcelona, ES) by methods described below. End-
point measurements were carried out using SpectraMax M2 Microplate Reader (Molecular 
Devices LLC, Sunnyvale, CA US) for fl uorescence and absorbance, or Luminoskan Ascent 
(Th ermo Scientifi c, 5300172, MA, US) for luminescence.
Synthesis of Ag NPs
Colloidal, dispersed Ag NPs of two diff erent sizes (20 and 50 nm) were prepared separate-
ly, following a kinetically controlled seeded-growth method previously reported (Bastus et 
al., 2014) with slight modifi cations. Th e approach is based on the reduction of silver nitrate 
(AgNO3) in the presence of two competing reducing agents, tannic acid (TA) and trisodium 
citrate hexahydrate (SC) at 100°C. Six diff erent Ag NPs were synthesized by surface-coating 
both sizes with bovine serum albumin (BSA), chitosan (Chit) or polyvinylpyrrolidone (PVP) 
to generate negative Ag NP_BSA, positive Ag NP_Chit and neutral Ag NP_PVP, respectively. 
Details of these procedures are elaborated upon in the electronic supplementary material.
An aqueous suspension of a negatively charged 50 nm PVP-coated Ag NP (Ag NP_NC) was 
obtained from NanoComposix® (San Diego, US) and included in this study for comparison 
with the synthesized Ag NPs. Based on the manufacturer’s information, the Ag NP_NC is 
reported to have mean core- and hydrodynamic diameters of 54.8 ± 10 nm and 72 ± 14.4 nm 
respectively. Th e stock suspension of the pristine Ag NP has a mass concentration of 5.0 mg 
Ag/mL, and a particle number concentration of 5.2 x 1012 particles/mL. Th e surface area was 
9.8 m2/g while surface charge (zeta-potential) was -37.8 mV. Th e DLS and zeta potential in 
both milliQ and DMEM were confi rmed in our laboratory, and details previously provided 
(Makama et al., 2015).
Ag NP Characterization
Prior to exposure experiments, pristine Ag NPs were dispersed in Dulbecco’s modifi ed Eagle’s 
medium, DMEM (Invitrogen Breda, NL), as well as milliQ water and characterized by trans-
mission electron microscopy (TEM), UV-Vis spectroscopy, dynamic light scattering (DLS), 
and zeta-potential measurements (ζ-potential). A combination of diff erent techniques was 
used to characterize the Ag NPs and to monitor their proper coating and stability in the 
diff erent media. Characterization details are given in the electronic supplementary material.
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NPs dispersions
Ag NPs stock dispersions were prepared by fi rst suspending the respective powders in milliQ 
water except for Ag NP_Chit, where 50 mM acetic acid (Merck, Darmstadt, DE) was used 
instead. Ag NP_Chit suspensions were initially prepared in 50 mM acetic acid in order to 
prevent agglomeration while ensuring monodispersity (Zhao et al., 2011, Nadesh et al., 2013). 
Where used, the fi nal acetic acid concentration in the medium at which the cells were exposed 
to was 4 mM (0.02%), and determined to be non-cytotoxic (data not shown). For all Ag NPs, 
the stock dispersions were prepared at 2.5 mg Ag/mL and sonicated in a Sonorex RK100 
(Berlin, DE) water-bath over ice for 15 min. Further dilutions to the desired exposure con-
centration ranges (0.1, 1, 5, 10, 20, 50, 100, and 200 µg Ag/mL) were made in DMEM fortifi ed 
with heat inactivated fetal calf serum (FCS) at 10%.
Ag NPs exposure and Uptake dynamics
A mouse monocyte macrophage cell line, RAW 264.7 (ATCC® TIB-71™; Manassas, VA US) 
was used in this study at passages 16-22. Cells were cultured in DMEM, enriched with FCS 
at 10% (v/v). Sub-culturing and passaging of cells was done every 3 – 4 days when reaching 
80% confl uency by trypsinization aft er rinsing with phosphate buff ered saline (PBS). Before 
exposure to Ag NPs, cells were grown for 24 h in 96-well plates at a seeding density of 105 
cells/well for all assays, and incubated at 37°C in humidifi ed air (plus 5% CO2) to attain above 
80% adherent confl uency. Aft er this initial 24 h of stabilization and growth, Ag NPs exposures 
for all assays with the exception of the Dichlorofl uorescein (DCF) assay for ROS production, 
were conducted over a 24 h duration. For the ROS production assay, exposure to Ag NPs was 
for 6 h, based on an adaptation of a similar method described earlier (Carlson et al., 2008). 
Unless stated otherwise, general incubation conditions were as described above.
Macrophages were imaged by means of confocal microscopy to follow cellular uptake, lo-
calization and accumulation behavior of the diff erent Ag NPs over time. Imaging conditions 
were chosen such as to achieve low photon stress, without any visible loss of vitality aft er 
24 h of exposure and imaging.  Th is was performed for the 50 nm size class only, assuming 
that this large size is generally taken up less rapidly compared to 20 nm (Shang et al., 2014a, 
Shang et al., 2014b). Details on methodology and other results are provided in the electronic 
supplementary material.
Eff ect assessment
Cytotoxicity assays were performed to evaluate the viability of the macrophages aft er expo-
sure to the diff erent Ag NPs. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay (Kloet et al., 2015); ATP content was determined using a bioluminescent somat-
ic cell assay kit (Sigma-Aldrich®, St Louis, MO, US), and; mitochondrial permeability tran-
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sition-pore (MPTP) assays were performed using a commercial kit from Molecular Probes 
(Leiden, NL). Th e productions of ROS as well as the induction of TNF-α were also assessed 
to elucidate specifi c modes of action involved. A 2’,7’-dichlorodihydrofl uorescein diacetate 
(H2DCF-DA) dye from Molecular probes (Carlsbad, CA, US) was used for ROS, while TNF-α 
induction was assessed by a solid phase sandwich Enzyme-Linked Immuno-Sorbent Assay 
(ELISA) using a Mouse TNF-α ELISA kit (InvitrogenTM, Paisley, UK). Protocols for these as-
sessments were based on the manufacturers’ instructions, and details are provided in the elec-
tronic supplementary material.
Controls
Macrophage cells exposed to DMEM, containing equal proportions of milliQ H2O, but no 
NPs served as blanks. For exposures with Ag NP_Chit group, 0.02 % acetic acid (4 mM fi -
nal exposure concentration) was used. Positive controls were prepared in exposure medium 
without NPs and included for each assay. All controls were incubated according to the respec-
tive protocols and results can be found in the supplementary Fig. S1. To check the likelihood 
of particle interference with spectroscopic measurements, diff erent Ag NP concentrations 
were included (in the absence of cells) and measured for all assays. Readings confi rmed no 
interference of the particles with the fl uorescence, absorbance or luminescence readings, and 
all controls were as expected (Supplementary Fig. S1).
RESULTS
Ag NPs Characterization 
Fig. 1 a – c presents representative TEM images and UV-Vis spectra of 50 nm Ag NPs charac-
terization, while information on the 20 nm size group is provided in supplementary Table S1 
and Fig. S2. TEM images below (Fig. 1 a – c) indicate visually that the primary particle sizes 
targeted by the synthesis were achieved and that for all coatings, the morphology of the parti-
cles were preserved aft er coating and lyophilization processes. Average particle sizes obtained 
by analysis of over 250 NPs by TEM were 51.1 ± 5.7, 51.9 ± 6.4 and 51.0 ± 6.1 for Ag NP_BSA, 
Ag NP_Chit and Ag NP_PVP 50 nm size group, respectively (Fig. 2 a – c). For the 20 nm 
group, these values were respectively 19.5 ± 5.4, 18.2 ± 5.1 and 23.8 ± 4.6 nm. 
Th e UV-Vis specter of pre-coated Ag NPs showed SPR peaks centered at 405 nm (Supplemen-
tary Fig. S2 d-f) for the 20 nm size group, and 441 nm (Fig. 1 d-f dashed line) for the 50 nm 
sizes. Also, the hydrodynamic sizes of the 20 nm and 50 nm Ag NPs were determined to be 36 
nm and 55 nm, respectively. Coating the Ag NPs with BSA, PVP and Chitosan led to a slight 
red-shift  in the positions of the SPR peaks, indicating an aﬃ  nity of these molecules for the 
silver surfaces and their spontaneous association. Th e SPR peaks shift ed 6-8 nm in the case of 
Ag NP_BSA, 2-3 nm for the Ag NPs-PVP and 9-10 nm for the Ag NPs-Chit.
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DLS measurements in milliQ water and DMEM showed larger particles sizes (Supplementary 
Table S1) than those obtained from TEM. Th e hydrodynamic sizes for 20 nm/50 nm NPs were 
41.5 ± 1.3/69.9 ± 3.2 and 46.8 ± 0.1/71.3 ± 2.0 for Ag NP_BSA and Ag NP_PVP respectively. 
In accordance with these results, the hydrodynamic sizes of the Ag NPs aft er their surfaces 
were coated also increased by 10-12 nm for the Ag NPs_BSA, 15-20 nm for the Ag NPs_PVP 
and 50 – 100 nm for Ag NP_Chit. Ag NP_Chit formed agglomerates during re-suspension, 
consequently overestimating the average diameter to be around 240 nm for both sizes. Fig. 2 
shows the particle size distribution of Ag NPs as determined by TEM. Th e frequency curves 
shift s from left  to right with increasing particle sizes. Th e surface charges of the 20 nm Ag 
NPs measured in water (and DMEM) showed ζ-potentials (meV) of –37.0 ± 2.0 (–23.0 ± 2.0), 
+7.0 ± 1.0 (–21.3 ± 1.4) and –22 ± 2.0 (–19.3 ± 0.7) for Ag NP_BSA, Ag NP_Chit and Ag 
NP_PVP, respectively. Th e surface charges for the 20 nm particles were similar to their 50 nm 
counterparts (see supplementary material Table S1). Aft er coating, the ζ-potential measured 
indicated changes in the surface charges from –40 to –50 meV corresponding to citrate ions 
on the surface of the pre-coated intermediate product of Ag NP synthesis. Th ese changes were 
between –29 and –37 meV (Ag NP_BSA), –16 and –22 meV (Ag NP_PVP) and +7 to +8 meV 
(Ag NP_Chit). Th e ζ-potential values in DMEM were all negative, although the negatively 
charged Ag NP_BSA had a slightly more negative potential in all measurements.
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Figure 1. Representative Ag NPs characterization results for 50 nm size group. TEM images (a – c) of 
re-suspended Ag NPs showing quasi-spherical particles within the expected size ranges, with overall 
average diameter of 51.3 ± 6.1 nm. UV-Vis also shows SPR peaks within the expected wavelength range 
300 – 600 nm both in milliQ water and in cell culture medium (d – f and g – i, respectively). Th e UV-Vis 
SPR curves of coated and non-coated Ag NPs nicely overlaps (d – f), with the post-coating SPR curves 
exhibiting a red-shift  indicative of the eff ect of Ag NPs coating. DMEM: Dulbecco’s modifi ed Eagle’s 
medium.
Figure 2. Particle size distribution of Ag NP_BSA (a), Ag NP_Chit (b) & Ag NP_PVP (c) showing fre-
quency counts as determined by transmission electron microscopy (TEM). Th e frequency curves shift s 
from left  to right with increasing particle sizes: 20 nm (solid lines); 50 nm (broken lines).
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Confocal localization and uptake dynamics of Ag NPs
Fig. 3 shows a time series of macrophages imaged in tz intervals for 2.5 h during exposure to 5 
µM Ag NP_BSA, indicating Ag NPs as red dense regions in the cytoplasm of cells. Additional 
imaging results are provided in the electronic supplementary material.
Figure 3. Frames of a time series of macrophages imaged in tz intervals for 2.5 h during exposure to 5 
µM Ag NP_BSA. Maximal intensity z-projections were made of optical sections in the 7-14 µm mid-
range, representing the maximal fl uorescent signal of individual time-points. Ag NPs are visible as red 
dotted regions in the cytoplasm of cells (white arrows), while the non-confocal bright fi eld image is 
displayed in grey levels (BW). Displaced clusters show how cells move in the xy plane over time (0-9000 
sec). Th ese frames were captured from the supplemental movie MOV_Ag NPs.avi.
Eff ect assessments
MTT Assay
Th ere was a concentration-dependent decrease in mitochondrial function assessed by the 
MTT viability assay, with smaller Ag NPs (20 nm) presenting lower EC50 values compared 
to their larger (50 nm) counterparts (Fig. 4 a – d; Table 1). Exposure of the cells to the Ag 
NP_BSA results in a statistically signifi cant decrease in MTT, already at low exposure con-
centration of 10 µg/mL for the 20 nm Ag NPs. Further statistical analyses however, did not 
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present any signifi cant diff erence between the EC50 values obtained for the diff erent sizes (20 
nm vs 50 nm) nor types (surface-coating/charge) of Ag NPs. Except for Ag NP_Chit 50 nm 
for which the EC50 value exceeded the highest exposure concentration (Table 1).
Table 1. Table of EC50s (µg/mL) for assays, representing the eff ective concentration of Ag NPs required 
to produce the eff ect (increase/decrease) by 50%.
Ag NP_BSA Ag NP_Chit Ag NP_PVP Ag NP_NC
Assay 20nm 50nm P-value 20nm 50nm P-value 20nm 50nm P-value 50nm
MTT 11.7 58.9 0.224 10.3 125.9 0.553 14.8 37.6 0.438 40.7
ATP 28.4 114.7 0.005 93.0 >200 0.006 66.8 104.2 0.333 182.0
MPTP 23.3 114.3 0.197 14.5 24.3 0.112 56.3 109.2 0.301 137.3
ROS 77.6 31.6 0.073 >200 >200 <0.001 80.2 >200 0.588 89.5
TNF-α 1.1 5.0 0.156 49.9 15.1 0.002 nc 14.2 0.038 93.6
Signifi cant when p<0.05; nc, not converged.
Mitochondrial permeability transition pore (MPTP) Assay
Results indicated a signifi cant opening of the MPTP with increasing Ag NP exposure concen-
tration. A slight right-shift  of the Ag NPs 50 nm dose-response curves was observed when 
compared to the curves obtained aft er exposure to the 20 nm Ag NPs (Fig. 4 e – h). Data 
showed that higher exposure concentrations of the 50 nm Ag NPs were needed to elicit the 
same loss in MPTP integrity as was obtained with the 20 nm Ag NPs, indicating a more ef-
fi cient induction of opening of the MPTP by the smaller Ag NPs. Th ese diff erences however 
were not statistically signifi cant. Th e EC50s for the 20 and 50 nm sizes were only within 1-fold 
diff erence for chitosan- and PVP-coated NPs (Table 1). Th e EC50 for the 50 nm Ag NP_BSA 
exceeded the highest exposure concentration of 200 µg/mL.
Adenosine Triphosphate (ATP) Assay
With increasing exposure concentration, the amount of ATP measured in the cells decreased 
in a concentration dependent manner, suggesting a loss in viability since ATP is rapidly de-
graded or lost from the cells as they die (Eguchi et al., 1997). For Ag NP_Chit and Ag NP_
BSA, there was a signifi cant eff ect of size in addition to exposure concentration, with p values 
of 0.006 and 0.005 respectively when comparing the EC50s for the respective 20 and 50 nm 
particles. Th ere was no eff ect of size for the Ag NP_PVP. Similar to the 50 nm Ag NP_PVP, Ag 
NP_NC (also 50 nm, PVP-coated, but negatively charged), ATP was signifi cantly depleted at 
the highest exposure concentrations, and EC50 values for both types of Ag NPs exceeded the 
highest concentration of exposure (Fig. 4 i – l; Table 1).
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Figure 4. Representative Cytotoxicity of 20 and 50 nm NPs (Ag NP_BSA, Ag NP_Chit, Ag NP_PVP) 
and 50 nm Ag NP_NC to mouse monocyte macrophage cells (RAW 264.7 cell line) assessed by MTT 
(a – d), MPTP (e – h) and ATP (i – l) assays; and by assays for reactive oxygen species (ROS) production 
(m – p) and TNF-α  production (q – t). Results are expressed as percentages (mean ± standard deviation, 
n=3) relative to the blank, set at 100%. Dotted lines and fi lled diamond (20 nm); solid lines and empty 
circle (50 nm). Statistical signifi cance compared to control is indicated by * (p ≤ 0.05); ‡ (p ≤ 0.01); # (p ≤ 
0.001). Cytotoxicity (MTT, ATP and MPTP assays) showed a similar pattern for all tested Ag NPs, with 
viability decreasing with increasing exposure concentrations and minimal diff erences between NPs of 
diff erent sizes. On mechanisms of action (ROS production and TNF-α induction) however, there were 
eff ects of NP type and size (ROS production, 3n), while surface coating of Ag NPs with BSA appeared to 
result in a potent TNF-α induction (3q).
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Intracellular Reactive Oxygen Species (ROS) generation; H2DCF-DA Assay
Ag NP_Chit 20 nm were the only NPs observed to increase ROS aft er 6 h exposure (Fig. 4 m – 
p). For these NPs, a 1.5x increase in ROS was observed at the highest exposure concentration 
(Fig. 4 n). Th e “uncharged” Ag NP_PVP 20 nm, also showed an initial increase in ROS until 
10 µg/mL beyond which the curve steepens downwards. For the 50 nm NPs, no increase in 
ROS was observed for any type of Ag NPs tested (Fig. 4 m – p). Estimates of the EC50s indi-
cated lower values for the 20 nm size Ag NPs, and only the Ag NP_Chit showed signifi cant 
diff erences between the two sizes tested (Fig. 4 n). Comparing the diff erent 20 nm Ag NPs, 
the EC50 estimated for ROS generation for Ag NP_Chit was signifi cantly higher than those of 
the other types (Fig. 4 n).
TNF-α induction
Ag NP_BSA were most potent in inducing TNF-α, presenting marked increase relative to 
the control (Fig. 4 q). Th e other NP types initially appeared to induce some TNF-α, but this 
dropped below the reference (control) with increasing concentration, coinciding with the 
onset of cytotoxicity (Fig. 4 q – t). An opposite size-dependent eff ect with chitosan- and 
PVP-coated Ag NPs can be noted, where some marginal induction of TNF-α was shown more 
by the 50 nm than the 20 nm Ag NPs (Fig. 4 s). An interesting observation was made with 
the two diff erent types of PVP-coated Ag NPs, where for TNF-α induction they gave diff erent 
results (Fig. 4 s and t) even though for all other assays they behaved similarly (Fig. 4). Also, 
there were signifi cant diff erences in eff ects produced by the diff erent sizes of Ag NP_Chit and 
Ag NP_PVP (p = 0.002 and 0.038 respectively), though TNF-α induction was relatively low 
(1.5 – 2 fold increase) compared to the induction observed with Ag NP_BSA (Fig. 4 q – t).
DISCUSSION
In this present study, we focused on two very important properties; size and surface coating/
charge, identifi ed from literature to be important in infl uencing the outcome of exposure to 
NPs. Here we present a more appropriate comparison of the infl uence of these NP properties 
by using synthesized Ag NPs from the same stock, designed to diff er at specifi c properties of 
interest. Our study showed similar cytotoxicity patterns for all tested Ag NPs, diff ering only 
at specifi c modes of action. Additionally, we present further evidence of the cellular uptake 
dynamics of diff erent Ag NPs.
NP Synthesis, Dispersion and Characterization
By varying the reaction parameters (temperature, seeding concentration and amount of pre-
cursor added), the desired Ag NP size ranges 20 and 50 nm were achieved. Th e average NP 
sizes as determined by TEM were found to be within expected ranges, and depending on the 
surface coating used, negative, positive and “neutral” charges were obtained. While coating 
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with BSA and PVP is spontaneous and easy to monitor by the characterization techniques 
described above, that with chitosan resulted in Ag NPs aggregation. Th is may likely be due to 
the interaction of the negatively charged citrate Ag NP, an intermediate/pre-coated product 
of Ag NPs synthesis, with the positively charged chitosan (Gnanadhas et al., 2013, Bastus et 
al., 2014). To overcome this eff ect, a fast mixing of relatively small volumes of Ag NPs and an 
excess amounts of chitosan was used, resulting in a fast coating of the NPs.
Before coating, the particles showed SPR peaks and hydrodynamic sizes in accordance with 
expected results for the three diff erent sizes (Bastus et al., 2014). A slight shift  in the SPR peak 
was observed by UV-Vis spectroscopy aft er incubating the NPs for 24 h with the respective 
coating molecules. Th is shift  is related to modifi cations in the close environment of the NPs 
and proves the aﬃ  nity of the BSA, PVP and chitosan molecules for the silver surfaces and 
their spontaneous association (Bastus et al., 2014). Th e shape of the SPR peaks were pre-
served in both milliQ water and DMEM (Fig. 1 d – f and g – i, respectively), which means 
that the particles were dispersed and stable under these conditions. Th e DLS measurements 
in both milliQ water and DMEM however, systematically resulted in larger sizes than those 
obtained before lyophilization. Th is could be indicative of a few agglomerates formed during 
the re-suspension of the powdered Ag NPs. Despite the large hydrodynamic diameter seen 
in the particles coated with chitosan, we observe well dispersed particles by TEM (Fig. 1 b).
Dispersed Ag NP_Chit formed some aggregates in the suspensions media, and these may 
have led to an overestimation of the hydrodynamic sizes during the DLS measurements, re-
sulting in rather high NP diameters (Supplementary Table S1). Because the DLS operates 
on Rayleigh’s approximation principle of light scattering by particles where the intensity of 
scattering is proportional to the sixth power of the particle’s radius, DLS technique is very 
sensitive to particle agglomerates and/or any aggregation in NP suspensions (Hagendorfer 
et al., 2012). Hence, the occurrence of even minute amounts of agglomerates may skew the 
results. Th is aggregation observed with Ag NP_Chit for instance, represents a small fraction 
of the NPs, otherwise the SPR peaks would not be preserved (Fig. 1 d – i), and it would also be 
noticeable in the TEM images. Hence, the results indicate the formation of some aggregates 
but the majority of the Ag NPs appear to be single NPs, even for Ag NP_Chit.
Following dispersion in DMEM, the surface charges changed to negative values in all Ag NPs. 
Positively charged particles were likely coated by negatively charged proteins in the media, 
and may explain the negative ζ-potentials measured for all Ag NPs. A Z-potential measure-
ment in a medium like DMEM containing an abundance of charged protein molecules is 
greatly infl uenced by the electrostatic interactions in the matrix. Th is was demonstrated by 
others (Pavlin and Bregar, 2012, Shannahan et al., 2013). Similarly, we observed more nega-
tive ζ-potentials values (Supplementary Table S1) when Ag NPs were re-suspended in water, 
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with minimal eff ect on hydrodynamic sizes regardless of the dispersant used. Lyophilization 
of the samples did not result in particle aggregation or surface modifi cations, and except for 
Ag NP_Chit, they could be easily dispersed in water as TEM images above show (Fig. 1 a – c) 
and DMEM. Th e SPR peaks and the surface charges were preserved as well.
Ag NPs localization and Uptake dynamics
Uptake of the negatively charged Ag NP_BSA was rapid and most signifi cant based on an 
arbitrary unit (AU) of quantifi cation. Due to agglomeration in the suspension and growth 
medium, it was not possible to assess uptake of Ag NP_Chit by the cells.  Supplementary Table 
S2 shows that the mean cellular uptake of Ag NP_BSA was twice that of Ag NP_PVP at sim-
ilar exposure concentrations and time, though the uptake eﬃ  ciency of individual cells does 
vary a lot. Several cells showed fast uptake, with up to 80% of the Ag NPs observed to be taken 
up within the fi rst 30 min of exposure (not shown). Aft er 2.5 h however, cytoplasmic fl uores-
cence intensity levels reached a plateau for the diff erent Ag NPs tested (Table S2). In fact, there 
was no signifi cant increase in the mean fl uorescent intensity in the macrophages aft er 24 h 
exposure (Supplementary Table S2). Th is rapid Ag NP uptake indicates that the 6 h exposure 
duration used for the assessment of ROS production is suﬃ  cient for cells to internalize the Ag 
NPs. With increasing exposure concentrations, the mean AU plateau value increased nonlin-
early for all Ag NPs. Fresh re-exposure at the same concentration and for an additional 24 h 
did not signifi cantly increase the plateau value either. Even at the lower exposure ranges, it can 
be seen that the uptake aft er 2 h is already reaching a plateau for the diff erent Ag NPs (Table 
S2) and this may suggest that cells loose their uptake capacity over time.
Cellular vitality was monitored during uptake assays by intercellular dynamics and presence 
of membrane protrusions, the latter being typical for functional macrophages (Vonna et al., 
2007, Venter et al., 2014). Over a period of 48 h, no apparent cell death or abnormalities were 
observed while visualizing the subcellular bio-distribution of the Ag NPs.  Subcellular dynam-
ics remained visible during standardized imaging, as well as aft er 48 h exposure to 5 µg/mL of 
50 nm Ag NP_BSA (Supplementary Fig. S4). Th e density of membrane protrusions however, 
slowly decreased over time (2.5 – 24 h, not quantifi ed). Only aft er prolonged local imaging 
were loss of membrane protrusions, amorphic membrane blebbing and cell fusion events trig-
gered, indicating photon stress. We also demonstrated the uptake dynamics of Ag NP_BSA 
sticking to a macrophage surface membrane protrusion, and consequently being transported 
to the cell body within 30 seconds. Th e time series shows the dynamics of individual vesicles 
of various sizes in the cytoplasm (Fig. 3 and MOV_Ag NPs.avi). Both dispersed small vesicles 
as well as vesicles with clustered accumulated Ag NPs, occurred for all Ag NPs. We cannot 
exclude the likelihood that free Ag NPs were also present in the cytoplasm (Supplementary 
Fig. S4). Over time, more clustered vesicles appeared, indicating vesicle fusion. Multiple large 
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endosomes or lysosomes with many Ag NPs clustered together were observed, suggesting that 
uptake was not by diff usion. Th ere are diff erent types of active endocytotic pathways such as 
receptor mediated endocytosis (clathrin or caveolin mediated) and macropinocytosis, but the 
current study did not discriminate between those.
Vesicle density varied over the cytoplasmic domain, but Ag NPs were never observed in the 
nucleoplasms (Fig. 3 and Supplementary Fig. S4). Th e absence of 50 nm Ag NPs in the nuclei 
was expected since nuclear pores have an eff ective diameter of 9 – 10 nm. Aft er 24 h loading, 
cells were still viable and healthy as judged by the dynamics from the cells themselves as well 
as from the organelles within. Th e dynamic movements of the Ag NPs within membrane do-
mains indicate that accumulation does not imply clustering (MOV_Ag NPs.avi).
Eff ect Assessment
Th e smaller 20 nm Ag NPs tend to induce earlier eff ects than the 50 nm sizes in almost all as-
says reported here (Fig. 4 and Table 1). However, the diff erences were minimal and for all Ag 
NPs tested, MTT reduction and MPTP opening did not diff er signifi cantly (p<0.05) between 
diff erent sizes (20 nm vs 50 nm) and surface-coatings or charges. A concentration dependent 
decrease in MTT reduction was observed, with the 20 nm NPs showing lower EC50 values 
than the 50 nm NPs (Fig. 4 and Table 1). Ag NP_BSA NPs appear to elicit the most eff ect. 
With the exception of Ag NP_Chit 50 nm where the EC50 exceeded the highest exposure con-
centration, EC50s were between 10 and 15 µg/mL and 35 and 40 µg/mL for the 20 nm and 50 
nm size groups respectively (Table 1). Th e infl uence of NP size on its ability to induce toxic 
eff ects has been demonstrated previously, (Liu et al., 2010, Park et al., 2011) for instance. Our 
fi ndings partially agree with the proposition that size does matter as could be seen with ATP 
production, where the 20 nm Ag NPs were more potent than the 50 nm for both Ag NP_BSA 
and Ag NP_Chit (Fig. 4 i – l; Table 1).
ATP assay results indicated a signifi cant decrease at low exposure concentrations of 10 µg/
mL, at which the mitochondrial respiratory systems were also impaired (Fig. 4). Th is eff ect 
may likely be due to mitochondrial damage (AshaRani et al., 2009). Interestingly and contrary 
to the cited report in which ATP depletion in the tested cells was observed only aft er 48 h, 
ATP was depleted aft er 24 h exposure in our current study. Th e surface coating used for the 
Ag NPs in the cited study was starch, and may have interacted diff erently with the cells, poten-
tially delaying the onset of toxicity. We found an increased opening of the mitochondrial tran-
sition pore with increasing exposure concentration, leading to a rapid change in permeability. 
Th is is likely followed by membrane depolarization, release of intra-mitochondrial ions and 
metabolic intermediates amongst other eff ects (Lemasters et al., 1998). Normally, the MPTP 
remains closed unless under conditions of stress as found in for instance hypoxia, oxidative 
stress, and exposure to a calcium ionophore. Ag NPs of all sizes and surface coating tested 
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demonstrated ability to cause the MPTP to open, leading to the quenching of the signal from 
the calcein which is now accessible to the CoCl2. In our study however, we could not demon-
strate ROS production for most Ag NPs tested (Fig. 4 m-p). Th us, other factors including 
increased accumulation of intracellular fatty acids and lysophosphatidase, as well as glutathi-
one oxidation (Lemasters et al., 1998), may also be responsible for activating MPTP opening.
Intracellular ROS generation is an outcome of normal cellular metabolism and these radicals 
may be cleared by the cell’s scavenging processes. Increase in ROS production however, is 
considered to be an early phase response to toxicants (Aranda et al., 2013), and has been 
reported as one of the likely mechanisms of toxicity following exposure to Ag NPs as well 
as other NPs (Asharani et al., 2011, Foldbjerg et al., 2011, Jeong et al., 2011). In this current 
study, ROS production was only slightly increased with 20 nm Ag NP_Chit which showed a 
1.5 times increase in ROS relative to the control at the highest exposure concentration (Fig. 4 
n). Also, 20 nm Ag NP_PVP showed an initial increase in ROS, then a decrease as exposure 
concentration increases. Th is decrease in ROS production is associated with the onset of cyto-
toxicity (Fig. 4), and perhaps other cytotoxic processes are initiated or progressing faster than 
ROS generation. For example, the opening of the MPTP may lead to partial mitochondrial 
depolarization, which depending on Ca2+ concentrations, could result in a decrease in ROS 
production (low Ca2+) or an increase (high Ca2+) as reported earlier (Akopova et al., 2011).
Th e initial increase in ROS generation at lower exposure concentrations (Fig. 4 m-p) agrees 
with the fi ndings of others where it was suggested that cytotoxic eff ects were as a result of ROS 
production, particularly at low exposure concentrations and short incubation times (Carlson 
et al., 2008, Suresh et al., 2012, Foldbjerg et al., 2015). It may be that the cytotoxic eff ect of the 
Ag NPs overwhelms the cell’s capacity to generate ROS as a response, and rather progresses 
to cell death following other routes as suggested above. Again, positively charged NPs tend 
to interact more readily with cells due to the negative cell membrane charges (Nafee et al., 
2009). Th is may enhance the exposure of cells to positively charged NPs, likely explaining the 
increased ROS production observed with the 20 nm positively charged Ag NP_Chit (Fig. 4n) 
where there was a signifi cant diff erence between the two sizes tested (p<0.001). Interestingly, 
ROS was rather decreased in macrophage cells with increasing exposure concentrations of the 
50 nm size Ag NP_Chit, similar to the other Ag NP types tested. With increasing exposure 
concentrations, the resulting distortion in metabolic activity coupled with an open MPTP, 
may eventually lead to ATP depletion and cell death. Th is process has also been associated 
with mitochondrial respiratory system impairment following oxidative stress (AshaRani et 
al., 2009). In this current study, ROS production appears to have been inhibited as Ag NPs 
exposure concentration increases relative to the control. Considering the early onset of cyto-
toxicity based on MTT, MPTP and ATP assay results however, the downward plunge of the 
ROS curves could result from the inability of injured cells to produce oxidative radicals, since 
their viability has been impaired. 
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Ag NPs have been reported to cause immunogenic response in cells, characterized by induc-
tion of cytokines like TNF-α, macrophage inhibitory protein, interleukins, etc. (Carlson et al., 
2008, Park et al., 2011). For the Ag NPs tested in this current study, the negatively charged 
Ag NP_BSA showed the most induction with both sizes resulting in an 80-fold increase be-
tween exposure concentrations 10 and 50 µg/mL. Higher concentrations showed a downward 
plunge of the curves below the reference (control), coinciding with cytotoxicity (Fig. 4 a, e, 
i, and q). Th ere were no signifi cant diff erences in the eff ects induced by the diff erent sizes of 
Ag NP_BSA (Fig. 4 q). Interestingly, even when coated with similar biomolecules, the behav-
ior of NPs may still diff er as can be seen with the 50 nm PVP-coated Ag NPs commercially 
produced (negatively charged) and the synthesized one (uncharged). Although both behaved 
similarly for all other assays tested, the case was diff erent with TNF-α induction (Figs. 3 s 
and t) where Ag NP_PVP was a signifi cantly higher TNF-α inducer than Ag NP_NC (p = 
0.002). Th is could likely be due to the type of synthesis procedure applied for making not only 
the NPs (Powers et al., 2011a, Samberg et al., 2011), but also the bioconjugate (Bastus et al., 
2014). Th e type or composition of the coating agent infl uences the outcome of exposure, cor-
roborating previous fi ndings (Aadil et al., 2016) where the infl uence of lignin concentration, 
incubation temperature and time in the synthesis of Ag NPs were assessed. Also, the pH of 
the solution during the synthesis was important in determining the surface charge of the NPs, 
with acidic pH resulting in negatively charged NPs while basic pH leads to positively charged 
NPs. Th is phenomenon is important not only during synthesis of NPs, but also during expo-
sure (Deng et al., 2016).
Th e greater the NP’s relative surface area, the greater the potential for reactivity. Since the 
relative surface area is determined by the particle size, smaller NPs may interact more with 
the macrophages (Johnston et al., 2010, Reidy et al., 2013) when administered on an equal 
mass-basis as was done in the current study. Moreover, surface coatings and their interactions 
with biomolecules can infl uence dissolution rates of Ag NPs (Yen et al., 2009, Yang et al., 
2012), leading to toxicities. Based on this, one could hypothesize that the synthesized Ag NPs 
tested in this study were quite stable under the experimental conditions reported here. Longer 
exposure durations of 48 – 72 h may likely present diff erent outcomes.
Also, some studies have shown an opposite eff ect of size for e.g. with PVP-coated Ag NP 
(Powers et al., 2011a) where the larger particles produced larger eff ect. In the present study, 
this was observed with Ag NP_Chit and Ag NP_PVP in TNF-α induction assay, with the 50 
nm sizes having lower EC50 values (Table 1). For the tested Ag NPs in this study, cytotoxicity 
patterns were similar irrespective of types and size of the Ag NPs. Looking at ROS and TNF-α 
induction on the other hand revealed diff erences between the diff erent types of Ag NPs. Th is 
is indicative of varying mechanisms of action involved, corroborating what has been opined 
by others (Johnston et al., 2010, Reidy et al., 2013). Th ese authors suggested that a combina-
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tion of diff erent physicochemical properties of Ag NPs is more likely responsible in inducing 
the observed toxicities, rather than only size or particle dissolution for instance, as the release 
of ions would be expected to be greater for smaller particles.
CONCLUSION 
Our study used well established in vitro assays to investigate the infl uence of the physico-
chemical properties of a specifi cally designed set of diff erent types of Ag NPs systematically 
synthesized to vary the properties of interest. Th e role of surface coating/charge in infl uencing 
TNF-α induction was demonstrated by the negatively charged Ag NP_BSA. Eff ect of size was 
less prominent under our experimental conditions, showing mostly minimal diff erences that 
were not statistically signifi cant. Overall, the negatively charged Ag NP_BSA appears to be 
more potent in inducing adverse eff ects on the macrophages. Th e complexity in determining 
the fate and toxicity of Ag NPs (also other NPs) using in vitro or in vivo models is as yet a 
challenge that needs further evaluation. Live confocal imaging of exposed cells allowed the 
monitoring of Ag NPs uptake dynamics and subcellular cytoplasmic accumulation. 
A combination of several factors likely play a role in determining the outcome of exposure. 
Th ese include the processes involved in the NP syntheses, presence and type of coating agents 
resulting in various physicochemical properties (size, charge, hydrophobicity, etc.), as well 
as the toxicity tests models used and end-points studied. Th is has been observed in earlier 
reviews (Johnston et al., 2010, de Lima et al., 2012, Reidy et al., 2013), and still remains a 
hindrance for conclusive risk assessment evaluation of Ag NPs. Taken together, the results 
from MTT, ATP and MPTP assays shows that adverse eff ects from exposure to the tested Ag 
NPs were similar irrespective of type or size. However, for ROS and TNF-α induction, we do 
fi nd signifi cant toxicity diff erences with variations in the physicochemical properties of the 
Ag NPs tested.
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SUPPLEMENTARY MATERIALS CHAPTER 6
MATERIALS AND METHODS
Synthesis of Ag NPs
MilliQ water (18.2 MΩ/cm) was used for all Ag NPs syntheses. Colloidal, dispersed Ag NPs of 
two diff erent sizes (20 and 50 nm) were prepared separately, following a kinetically controlled 
seeded-growth method previously reported (Bastus et al. 2014) with slight modifi cations. Th e 
approach is based on the reduction of silver nitrate (AgNO3) in the presence of two competing 
reducing agents, tannic acid (TA) and trisodium citrate hexahydrate (SC) at 100°C. In order 
to produce large amounts (grams) of Ag NPs in the present study, a 10 L batch reactor was 
used and the concentration of the AgNO3 (Ag NP precursor) was increased by a factor of 10, 
while all other parameters remained the same with that reported previously (Bastus et al. 
2014). 
First, early nucleated Ag NP seeds were formed by injecting 5 mL of 2 M AgNO3 into a boil-
ing solution containing SC (5 mM) and TA (0.025-0.075 mM), under continuous vigorous 
stirring. Th ese seeds were further grown to the desired sizes by injecting more of the silver 
precursor dropwise to avoid formation of new seeds. During the growth phase of the seeds, 
the temperature of the solution was reduced to 90ºC, while slowly adding up to 15 mL of the 
2 M AgNO3 into the reactor. Under these conditions, 10-20 L of a stable, highly monodisperse 
and colloidal Ag NP solutions (0.25-0.5 g/L or 2.3 – 4.6 mM) were produced for each size.
Th e solutions containing the synthesized Ag NPs were concentrated to about 6% of their 
original volume by ultrafi ltration using a tangential fl ow fractionation (TFF) system (KrosFlo® 
Research II TFF Systems, Spectrum® Laboratories Inc.). Negative, positive, and neutral Ag 
NPs were obtained by subsequently mixing about 200 mL each of the concentrated solutions 
of Ag NPs with either 0.01 mM bovine serum albumin (BSA), 0.08 mM chitosan (Chit) or 
0.05 mM polyvinylpyrrolidone (PVP) to generate negative Ag NP_BSA, positive Ag NP_Chit 
and neutral Ag NP_PVP, respectively. To prevent corrosion and facilitate easy transport, the 
Ag NPs were lyophilized, layered over with argon and kept under dark conditions until use. 
Th us, six diff erent Ag NPs were synthesized consisting of three types based on surface coat-
ing/charge, each at two diff erent sizes.
An aqueous suspension of a negatively charged 50 nm PVP-coated Ag NP (Ag NP_NC) was 
obtained from NanoComposix® (San Diego, US) and included in this study for comparison 
with the synthesized Ag NPs. Based on the manufacturer’s information, the Ag NP_NC is 
reported to have mean core- and hydrodynamic diameters of 54.8 ± 10 nm and 72 ± 14.4 nm 
respectively. Th e stock suspension of the pristine Ag NP has a mass concentration of 5.0 mg 
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Ag/mL, and a particle number concentration of 5.2 x 1012 particles/mL. Th e surface area was 
9.8 m2/g while surface charge (zeta-potential) was -37.8 mV. Th e DLS and zeta potential in 
both milliQ and DMEM were confi rmed in our laboratory, and details have been presented 
earlier (Makama et al. 2015).
Ag NP Characterization
Prior to exposure experiments, pristine Ag NPs were dispersed in Dulbecco’s modifi ed Ea-
gle’s medium, DMEM (Invitrogen Breda, Th e Netherlands), as well as milliQ water and char-
acterized by transmission electron microscopy (TEM), UV-Vis spectroscopy, dynamic light 
scattering (DLS), and zeta-potential measurements (ζ-potential). A combination of diff erent 
techniques was used to characterize the Ag NPs and to monitor proper coating of NPs surfac-
es and their stability in the diff erent media.
TEM images were acquired with a FEI Magellane 400L SEM electron microscope operating at 
scanning TEM (STEM) mode and low accelerating voltage (20 kV) and a JEOL 1010 electron 
microscope operating at an accelerating voltage of 80 kV. Samples for TEM were prepared by 
drop casting onto carbon-coated TEM grids. Th e grids were left  to dry at room temperature. 
Images were acquired in diff erent parts of the grid at diff erent magnifi cations. More than 250 
particles were computer-analyzed and measured to calculate the size distribution of each type 
of Ag NPs.
UV-Vis spectroscopy is a very common and well-known analytical technique (Evanoff  and 
Chumanov 2005; Pan 2015), and a Shimadzu UV-2400 spectrophotometer was used to mea-
sure the localized surface Plasmon resonance (SPR) peak. Here, 1 mL of the Ag NPs suspen-
sion was placed in a cuvette and the spectrum (UV-Vis) acquired in the 300-800 nm range. 
Several metallic NPs, such as gold and silver, exhibit a characteristic absorbance maximum 
in the visible range (SPR peak). Th is characteristic wavelength is highly sensitive to the ENP 
size, surface modifi cations and aggregation and thus a useful tool to characterize the state of 
the NPs in solution. 
Hydrodynamic sizes of the Ag NPs were estimated by DLS, while particle surface charges 
(ζ-potentials) were measured using Malvern Zetasizer Nano ZS (Malvern Instruments, UK). 
A light source wavelength of 532 nm and a fi xed scattering angle of 173° were set for DLS 
measurement. Ag NPs suspensions (1 mL) were dispensed in a cuvette and the instrument 
was set with the specifi c parameters of refractive index and absorption coeﬃ  cient of the ma-
terial and the viscosity of the solvent. All measurements were conducted at least three times. 
Ag NPs characterization was done in both milliQ water and DMEM since the exposure was 
carried out in the cell culture medium. 
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Eff ect assessment: 
MTT Assay
At the end of the 24hr exposure, 10 µL of the tetrazolium salt 3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution at 5 mg/mL in PBS was added 
to each well and incubated under the same conditions as described above for 90 min. Th e 
exposure medium containing MTT was then removed and 100 µL pure dimethyl sulfoxide, 
DMSO (Acros Organics, Geel, BE) was added to solubilize the crystals of formazan salts. Th is 
was followed by shaking the plates in the dark for 10 min. Th e dissolved formazan produces 
a purple color and its absorbance was measured at 562 nm spectrophotometrically (Kloet et 
al. 2015).
Adenosine Triphosphate (ATP) Assay
A bioluminescent somatic cell assay kit (Sigma-Aldrich®, St Louis, MO, US), was used to de-
termine the ATP content of mouse macrophage cells aft er exposure. In this assay, ATP is the 
limiting reagent and the light emitted and measured is proportional to the amount of ATP 
released from the cells, which is in turn determined by the number of viable cells present. Ex-
posure to Ag NPs for this assay was conducted in white 96-well plates (Packard White plates, 
Perkin-Elmer®), using DMEM without phenol red, but with penicillin/streptomycin (Gibco®) 
1% (v/v). Aft er exposure, cell culture media was removed and replaced with 25 µL each of 
fresh medium and somatic cell ATP releasing agent from the kit. Th e plates were placed on 
a shaker for 10 mins in the dark, then transferred to the luminometer where the ATP assay 
working mix (containing luciferin, luciferase and MgSO4) was added automatically to each 
well before measuring the luminescence.
Mitochondrial permeability Transition-Pore (MPTP) Assay
A commercial kit from Molecular Probes (Leiden, NL), MitoProbeTM Transition Pore (MPTP) 
Assay kit (M34153) was used for this assay. Aft er exposure, the culture medium in all wells 
was replaced by Hank’s balanced salt solution, HBSS (Invitrogen, Breda NL), containing cal-
cium but without serum, phenol red or NaHCO3. Cells in all except the positive control wells 
were loaded with a mixture of cobalt chloride (CoCl2) and an acetoxymethyl ester form of a 
calcein dye (Calcein AM) at 1 mM and 5 µM respectively, followed by a 15 min incubation. 
Calcein AM passively diff uses into cells and accumulates in the mitochondria, where it is 
de-esterifi ed by intracellular esterases to liberate the highly fl uorescent calcein. Subsequently, 
calcein does not cross the mitochondrial or plasma membrane in appreciable amounts over 
short periods of time, making it conducive for selective marking of the mitochondria (Martel 
et al. 2012). Th is selectivity is achieved by adding CoCl2 which quenches the cytosolic fl uores-
cence, while mitochondrial fl uorescence is maintained in intact mitochondria since CoCl2 is 
incapable of entering this organelle.
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Th e cells in positive control wells were treated during this loading step with an ionophore 
(ionomycin) at 10µM, which was dissolved in the Calcein AM/CoCl2 mixture above. Iono-
mycin allows the entry of Ca2+ into the mitochondria in excess, triggering the opening of the 
mitochondrial permeability transition pore (MPTP). Th is results in the loss of calcein fl uo-
rescence into the cytosolic compartment where it is quenched. Fluorescence was measured 
at λ 485/530 nm. Th e relative intensity of fl uorescence compared to the blank control (100%) 
is indicative of the integrity of mitochondrial permeability transition pore aft er exposure to 
Ag NPs.
Intracellular Reactive Oxygen Species (ROS) generation; DCF-Assay
Th e generation of intracellular ROS was determined using a slightly modifi ed method earlier 
described (Hussain et al. 2006). Cells were preloaded with 20 µM 2’,7’-dichlorodihydrofl uo-
rescein diacetate (H2DCF-DA) dye from Molecular probes (Carlsbad, CA, US) for 45 min. 
Aft er this, the medium containing the dye was removed and the cells were exposed to the var-
ious concentrations of Ag NPs for 6h. Fluorescence was measured at λ 485/520 nm at the end 
of the exposure and expressed as percentages relative to the blank control (optimal healthy 
cell ROS value set at 100%).
TNF-α induction
At the end of the 24h exposure period, 80 µL supernatants containing cytokines were collect-
ed from each well and stored at -80 °C until analyzed for secreted levels of TNF-α by a solid 
phase sandwich Enzyme-Linked Immuno-Sorbent Assay (ELISA) using a Mouse TNF-α ELI-
SA kit (InvitrogenTM, Paisley, UK). Analysis was conducted according to the manufacturer’s 
instruction, running calibration and other standards for every 12 x 8 strip-well plates. Briefl y, 
samples were added onto microtiter strip wells pre-coated with specifi c monoclonal TNF-α 
antibodies. Next, a polyclonal biotinylated conjugate was added as a second antibody and 
the plates were incubated at room temperature for 90 min. During incubation, any secreted 
TNF-α in the samples will form a sandwich with these antibodies. Aft er a washing step to get 
rid of excess antibodies, streptavidin-peroxidase was added to complete the four-member 
sandwich by binding to the biotinylated antibody during another 30 min incubation. A wash 
step gets rid of all unbound enzymes before a substrate solution is added to be acted upon by 
the bound enzymes to produce a color whose optical density at 450 nm is directly proportion-
al to the concentration of TNF-α in the sample.
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Controls of Assays
E ect assessment controls
Figure S1. Controls for eff ect assessment experiments – MTT (cell viability), MPTP opening, ATP pro-
duction, ROS generation, and TNF-α induction assays. Results are expressed as percentages (mean ± 
standard deviation, n=3) relative to the blank, set at 100%. Statistical signifi cance compared to control 
is indicated by *** (p ≤ 0.001). Positive controls showed clear eff ects, while exposure to acetic acid (AA) 
at 4 mM was similar to the blank control. DNP, dinitrophenol; IMCN, ionomycin; LPS, lipopolysaccha-
ride.
Ag NPs Characterization 
Table S1. Ag NP characterization showing the hydrodynamic sizes of Ag NPs measured by dynamic 
light scattering (DLS), surface Plasmon Resonance (SPR) peaks and ζ-potentials. Measurements were 
performed before and aft er surface coating of NPs
BSA (negative) Chitosan (positive) PVP (neutral)
20 nm 50 nm 20 nm 50 nm 20 nm 50 nm
TEM Size nm 19.5 ± 5.4 51.1 ± 5.7 18.2 ± 5.1 51.9 ± 6.4 24.0 ± 4.6 51.0 ± 6.1
Sizea nm 41.5 ± 1.3 65.3 ± 0.1 247.8 ± 2.1 241.8 ± 5.1 46.8 ±0.1 68.4 ± 0.6
Sizeb nm 69.9 ± 3.2 86.3 ± 1.0 209.1 ± 1.4 234.5 ± 1.2 63.0 ± 0.2 71.3 ± 2.0
ζ-potentiala meV -29.0 ± 2.0 -37.0 ± 2.0 +8.0 ± 2.0 +7.0 ± 1.0 -16 ± 2.0 -25.0 ± 2.0
ζ-potentialb meV -25.5 ± 2.3 -23.0 ± 2.0 - 16.4 ± 2.3 - 21.3 ± 1.4 -16.2 ± 2.3 -19.3 ± 0.7
UV-vis SPR peaksc nm 405 441 405 441 405 441
UV-vis SPR peaksa nm 413 448 413 449 408 443
UV-vis SPR peaksb Nm 412 447 414 450 408 444
meV, milli-electron volts; c, before coating; b and c, aft er coating in H2O or DMEM respectively.
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Figure S2. Ag NPs characterization results for 20nm size group. TEM images (a – c) of re-suspended Ag 
NPs showing quasi-spherical particles within the expected size ranges, with overall average diameter of 
20.6 ± 5.0 nm. UV-Vis also shows SPR peaks within the expected wavelength range 300 – 600 nm both 
in milliQ water and in cell culture medium (d – f and g – i, respectively). Th e UV-Vis SPR curves of 
coated and non-coated Ag NPs nicely overlaps (d – f), with the SPR curves of the coated NPs exhibiting 
a red-shift  indicative of the eff ect of Ag NPs coating. When Ag NP_Chit and Ag NP_PVP were diluted 
in Dulbecco’s modifi ed Eagle’s medium (DMEM), some agglomerations appear to set in as indicated by 
the changes in the SPR curves (Fig. 2e-f compared with 2h-i).
Confocal localization and uptake dynamics of Ag NPs
RAW 264.7 cells were seeded in a glass bottom 8-well µ-Slides (Ibidi® GmbH, Martinsried, 
DE) at a density of 5 x 105 cells/mL growth medium, and incubated at 37°C in humidifi ed air 
(plus 5% CO2) to attain ~80% adherent confl uency. Ag NPs exposures were performed only 
with the 50 nm Ag NP_BSA and Ag NP_PVP at 0.1 – 5 µg/mL, and characterized aft er 2.5 
and 24 h of exposure. Th e exposure was carried out immediately before microscopic mea-
surements.
Imaging was done on a Confocal Laser Scanning LSM 510-META on an Axiovert 200M mi-
croscope (Carl Zeiss, Jena, DE) equipped with a 40x/1.3 Oil DIC Plan Neofl uar or 63x/1.4 Oil 
DIC Plan Apochromat objective. Localizations were obtained with optical xy- planes of 1.0 
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um depth (z) in adhered cells with 40% of a 1 mW 543 nm diode laser excitation using LP560 
and standardized zoom and exposures (scan speed 6) and gain settings (839) for all acquisi-
tions. By screening the fl uorescence spectra of Ag NPs aft er excitation by a 488nm, 514nm or 
543nm laser with a multi array of detectors in the META channel, it appeared that the 543 nm 
absorption and strong LP560 fl uorescence provided the most sensitive and specifi c confi gu-
ration to be used for imaging.  Controls and exposed cells were imaged in the same way, with 
no background signal in the controls. Uptake dynamics were obtained by image acquisitions 
in time series over 2.5 and 24 h periods. Images were similarly processed with Zeiss ZEN soft -
ware and ImageJ v.1.49o (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, 
Maryland, US, http://imagej.nih.gov/ij/, 1997-2015).
In this study, Ag NPs taken up by macrophages could be excited with 40% of a 1mW 543 nm 
laser and detected with a long pass (LP) 560 nm fi lter.  Using a multi-detector array (i.e. the 
META detector in lambda channel mode of a Zeiss LSM510-M), emission wavelengths that 
could induce the most bright fl uorescence were analyzed. Base on this, the most sensitive 
channel mode imaging confi guration, without any auto fl uorescent signal from the cells was 
chosen. To obtain sensitive and specifi c detection of Ag NPs, several laser/fi lter confi gura-
tions were tested, and signals obtained were most bright at 543 nm. A multi-detector array 
(560-750 nm) showed that  emission photons induced aft er 543 nm excitation, originated 
from 560-600 nm emissions (~80% of output) decreasing towards higher wavelengths. Since 
macrophage intrinsic fl uorescence was not detected with these settings, we used a channel 
mode with 560 LP detection to localize the Ag NPs. Due to the relatively slow point scanning 
speed, the Ag NPs were best detected during and aft er cellular uptake since reduced dynamics 
increases signal detection.  A dose dependent signal increase was observed (Table S2, Fig. S3) 
with diff erent Ag NPs tested, similar to earlier reports (Zucker et al. 2013).
Table S2.Uptake of diff erent types of Ag NPs by RAW264.7 cells exposed for 2.5 and 24 h to diff erent 
concentrations of Ag NPs
Concentration µg/mL
/Duration
Ag NP_BSA Ag NP_PVP
2.5 h 24 h 2.5 h 24 h
0.1 12.2 ± 3.4 10.6 ± 1.6 6.5 ± 1.6 6.3 ± 1.1
0.5 n.m. n.m. 7.7 ± 1.1 6.5 ± 0.5
1 9.8 ± 1.5 10.9 ± 1.3 8.7 ± 1.6 6.3 ± 1.3
5 25.9 ± 6.6 26.5 ± 6.9 13.6 ± 3.2 12.2 ± 4.2
n.m., not measured
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Th e fl uorescence signals correlating to the Ag NPs were quantifi ed based on mean pixel in-
tensity of fi elds of view of representative cytoplasmic domains (Fig. S3 and S4), and were 
expressed as arbitrary units (AU). At identical exposures as well as imaging and processing 
conditions, these fl uorescence intensity values refl ect uptake of the diff erent Ag NPs by mac-
rophage cells. To allow Ag NP uptake comparisons, quantifi cations of cytoplasmic dense re-
gions from randomly selected cells with similar cellular confl uency (70 – 80%) and z-depths 
were made (Fig. S3). Th e selection of representative cytoplasm dense regions was based on 
the visual images. Th is selection was then applied to the fl uorescence signal, and the AU 
quantifi ed. In this way, regions analyzed were selected based on the occurrence of cytoplasm, 
without the bias of occurrence of silver signal. Based on the AUs estimated, the uptake of the 
negatively charged Ag NP_BSA was rapid and most signifi cant. Due to agglomeration in the 
suspension and growth medium, it was not possible to assess the uptake of Ag NP_Chit and 
will not be discussed further. Th e cellular uptake of Ag NP_BSA was twice that of Ag NP_
PVP at similar exposure concentrations and time (Table S2), although the uptake eﬃ  ciency of 
individual cells does vary a lot.
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Figure S3. Confocal microscopic images of Ag NP uptake observed in RAW264.7 macrophage cells 
aft er 2.5 and 24 h exposure to 5 mg/mL Ag NPs. Upper row: Ag NP_BSA; lower row: Ag NP_PVP. Left  
column 2.5 h of exposure; Right column 24 h of exposure. Left  panes: signals from Ag NPs; Right panes: 
bright-fi eld micrographs of the same fi eld. Size of all squares: BSA: 225*225 µm; PVP: 112.5*112.5 µm.
Figure S4. A subset of a z-series of a 15 µm diameter macrophage with Ag NPs clusters in red through-
out the cytoplasm (white arrows), excluding the nucleus. Cells were exposed for 22 h with negatively 
charged Ag NP_NC. Images display 1 µm optical slices of Ag NP fl uorescence as overlay on a (non-con-
focal) transmission image.
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General discussion, future perspectives and conclusions
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GENERAL DISCUSSION
Th e production of nanoparticles (NPs) has increased in the last decades and the number of 
products in which NPs are being incorporated is still growing. Th e rapid increase of nano-
technology has several benefi ts for society, yet there is an increasing concern that exposure 
to NPs may result in signifi cant adverse health eff ects (Oberdorster et al. 2007, Hussain et al. 
2015). Insight into the potential human health risks posed by NPs is essential for sustainable 
development and safe use of innovative products based on these materials. In the food sec-
tor NPs are used in food packaging materials and in food itself, including food supplements 
(Athinarayanan et al. 2015). Since NPs are incorporated in a variety of consumer products, it 
is likely that the general population gets exposed to NPs, via NP-containing products such as 
food and food packaging materials but also personal care products, textiles and medicines. 
In order to assess whether exposure to these NPs may pose a human health risk, NPs should 
be assessed for their safety. Testing all these NPs using in vivo animal experiments is undesir-
able for scientifi c, ethical and societal reasons. In order to reduce in vivo testing, alternative 
methods for testing of chemicals are currently being developed and validated (Eisenbrand et 
al. 2002, Van der Jagt et al. 2004, Stokes 2015). It would be desirable that the safety and risk 
assessment of NPs could be largely based on studies using in vitro models instead of in vivo 
models as this would reduce costs and time required to test the large numbers of NPs. Use 
of in vitro models may also help to defi ne structure activity relationships and facilitate read-
across within classes of NPs. Previous research has indicated that NP toxicity can be related to 
a certain extent to their physicochemical properties (Fourches et al. 2010). It would be of great 
value to get more insight in such relationships, to be able to set priorities for safety testing. 
Th e aim of the present thesis was to investigate the potential of in vitro testing strategies to 
detect hazards of NPs, focusing on toxicokinetic as well as toxicodynamic endpoints. Toxi-
cokinetic studies focused on translocation of NPs in in vitro models of the placental barrier, 
while toxicodynamic studies were directed at two endpoints that represent potential hazards 
of NPs that have not yet been well characterized including developmental toxicity and immu-
notoxicity. In the present thesis diff erent types of NPs were used. Polystyrene nanoparticles 
(PS-NPs) were selected because of their commercial availability, with high quality and a wide 
variety of available physicochemical properties like surface charge, and fl uorescent labeling 
enabling easy detection in toxicokinetic (translocation) studies. Several metal (oxide) NPs 
were selected as well, of which some are possible constituents of food additives like TiO2, 
Fe2O3, SiO2 and Ag. Other metal oxide NPs that were selected were Mn2O3, CuO, Cr2O3, CoO 
and NiO to which we may be exposed via products like paints, catalysts, construction mate-
rials, coatings and batteries. 
Chapter 1 introduced the aim of the thesis and the various in vitro models and NPs used in 
the studies performed. Literature data indicate that translocation of NPs is possible across 
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the gut, lung and skin barriers, related to oral, inhalation and dermal exposure, respectively 
(Landsiedel et al. 2012). In order to estimate the in vivo internal exposure, several in vitro 
models have been developed to study NP translocation across the lung, gut, skin and placental 
barrier (Mahler et al. 2012, Prow et al. 2012, George et al. 2015, Poulsen et al. 2015). Chap-
ter 2 of the present thesis provided a review about the performance of such in vitro models 
for studies on toxicokinetics of NPs. Th e chapter described models that mimic the diff erent 
barriers of the human body, with a focus on the lung, gut, skin and placental barrier, thus 
providing an overview of the state-of-the-art of using in vitro model systems, ranging from 
single cell-type monolayer to multi-cell (3D) models, to characterize the translocation of NPs 
across these diff erent barriers. In this chapter it was concluded that at the current state-of-
the-art, the in vitro models do not yet allow to predict the absolute transfer rates but they do 
support the defi nition of relative transfer rates and can thus help to reduce animal testing by 
setting priorities for subsequent in vivo testing. Th e use of in vitro models is very promising 
since they are currently further improved to mimic the in vivo situation more closely by, for 
example, using co-cultures of diff erent cell types and implementing them in a microfl uidic 
chip format. When these models are further validated by testing exactly the same NPs in an in 
vivo set-up and in the in vitro model, they could be even used to determine the internal expo-
sure (bioavailability) of NPs in an absolute way, besides to set priorities for NP toxicity testing. 
Since part of the toxicodynamic studies of the present thesis were directed at developmen-
tal toxicity testing of NPs, an important toxicokinetic aspect studied in the present thesis in 
chapter 3 was placental translocation of NPs. In order to obtain insight in toxicity and trans-
location of NPs across the placental barrier, cytotoxicity and translocation was studied for one 
positively and two negatively charged PS-NPs of 50 nm in an in vitro model of the placenta. 
Th e model consisted of BeWo b30 cells, derived from a human choriocarcinoma grown on a 
transwell insert forming a cell layer that separates an apical from a basolateral compartment. 
PS-NPs were characterized with respect to size, surface charge, morphology and protein co-
rona. In this study it appeared that in spite of similar size, surface charge and type of proteins 
in the protein corona, the diff erently charged NPs displayed a remarkable diff erence in cyto-
toxicity, with only the PS-NPs with an original positive charge inducing cytotoxicity. Th e rel-
atively higher cytotoxicity of positively as compared to negatively charged NPs was reported 
before for tri-block copolymer NPs (Bhattacharjee et al. 2012) but also for other type of NPs 
like gold NPs (Liu et al. 2013) and silicon NPs (Bhattacharjee et al. 2013). 
Translocation of PS-NPs appeared not to be related to PS-NP charge alone. A remarkable 
diff erence in translocation was found between the two 50 nm negatively charged PS-NPs that 
were obtained from diff erent manufacturers. For the PS-NPs from Polysciences, the appar-
ent permeability coeﬃ  cient (Papp) was slightly higher than that of amoxicillin, a compound 
that is known to be translocated over the in vitro BeWo b30 placental barrier and the ex vivo 
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placental barrier to only a limited extent (Li et al. 2013), with a Papp value of 13 x 10-6 cm/s. 
When testing the negatively charged PS-NPs from Magsphere, no PS-NPs could be detect-
ed in the basolateral compartment upon adding a concentration of 10 µg/ml to the apical 
compartment and 24 hours incubation. Th is remarkable diff erence in translocation of the 
two similar sized negatively charged PS-NPs across the BeWo b30 placental barrier is in line 
with the 30-fold diff erence that was found in translocation of these two negatively charged 
PS-NPs across a Caco-2 monolayer in a similar transwell model system (Walczak et al. 2014). 
Since none of the characterized parameters, including size, surface charge and protein corona 
revealed remarkable diff erences between the two negatively charged NPs, the diff erence may 
originate from the chemical groups on the surface of the NPs generating the negative charge. 
Th e general conclusion from this study was that the in vitro BeWo b30 model can be used as 
a fast method to get an initial qualitative impression about the capacity of NPs to translocate 
across the placental barrier and to set priorities for further in vivo studies on translocation of 
NPs to the fetus. 
Chapter 4 investigated whether the same PS-NPs as tested in chapter 3 for placental translo-
cation, are able to cause in vitro developmental toxicity in the ES-D3 cell diff erentiation assay 
of the embryonic stem cell test (EST) focusing also on the eff ect that charge may have. Th e 
study showed that the two negatively charged PS-NPs did not show any eff ect in the ES-D3 
cell diff erentiation assay up to the highest concentration tested while the positively charged 
PS-NP showed a concentration-dependent inhibition of ES-D3 cell diff erentiation. However, 
eff ect concentrations in the ES-D3 cell diff erentiation assay are close to cytotoxic concentra-
tions, which indicated that the inhibition of the ES-D3 cell diff erentiation may be due to cyto-
toxic eff ects of the positively charged PS-NPs. Th is indicated that the inhibition of the ES-D3 
cell diff erentiation by the positively charged PS-NPs may be caused by non-specifi c eff ects. 
Th e ES-D3 cell diff erentiation assay is a useful tool to determine whether chemicals and NPs 
can pose a hazard for the embryonic development. However, to possibly become a risk for 
embryonic development, NPs need to be able to reach the developing embryo in the in vivo 
situation. Th erefore, upon oral exposure, NPs would need to translocate across the intesti-
nal barrier as well as the placental barrier. Th e bioavailability of many NPs upon oral ex-
posure has been reported to be low, because of a limited translocation across the intestinal
barrier (Walczak et al. 2014). However, in vivo studies using intravenous injection of NPs 
have shown that NPs can cause adverse eff ects to the developing embryo, indicating that NPs 
can translocate across the placenta in the in vivo situation (Hougaard et al. 2015). As indicat-
ed above in chapter 3, the potential of the same PS-NPs as tested in the EST was assessed to 
translocate across an in vitro placental barrier of human placental (BeWo) cells. Th e results 
of these studies indicated that the positively charged PS-NPs were hardly translocated across 
the BeWo cell layer, which could indicate that fetal exposure of these PS-NPs is expected to be 
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low. Th erefore, although the EST data indicated the potential of positively charged PS-NPs to 
cause developmental toxicity, such concentrations may not be reached in the in vivo situation 
because of the low placental transfer. On the other hand, the negatively Polysciences PS-NPs 
which did translocate across the BeWo barrier albeit to a limited extent, appeared not to cause 
an adverse eff ect in the in vitro developmental toxicity assay, also pointing to a limited hazard 
all together. Th ese examples show that in order to predict which NPs may cause developmen-
tal toxicity in the in vivo situation, data obtained in the in vitro ES-D3 cell diff erentiation 
assay could be combined with placental translocation data from the BeWo model in order to 
select the NPs that are expected to have the highest potency in vivo. Th ese estimations may 
then be used to select NPs that could be assessed for potential developmental toxicity in vivo. 
Combining the results from Chapter 3 and 4 allows the combination of kinetic considerations 
with the in vitro developmental toxicity assay to improve the prediction of the in vivo hazards 
as done previously by Li et al. (Li et al. 2015, Li et al. 2015) for a series of azoles, for which 
the correlation of the prediction of in vivo developmental toxicity improved from R2=0.57 to 
R2=0.95 when the ES-D3 cell diff erentiation data were combined with the relative transport 
rates obtained in the BeWo model.  
A literature search was performed on the reported potencies of other NPs in the ES-D3 cell 
diff erentiation assay, in order to assess whether eff ects of NPs in the ES-D3 cell diff erentiation 
assay may also be related to physicochemical properties other than surface charge, such as size 
or coating. Although the experiments in chapter 3  of the present thesis showed that positively 
charged PS-NPs are more toxic than negatively charged PS-NPs, it appeared that this may not 
be generalizable to other NPs. Th is follows from the fact that SiO2, Ag and TiO2 NPs that were 
reported to inhibit ES-D3 cell diff erentiation were negatively charged, while the negatively 
charged PS-NPs of the present study did not aff ect ES-D3 cell diff erentiation. Th is implies 
that the negative charge did not arise from serum proteins which may aff ect the NP charge, 
as observed in the present study when NP charge was measured in medium with FCS. To 
obtain better insight in the role of NP surface charge on developmental toxicity more studies 
are required that assess the eff ects of NPs with diff erent charge that are made of the same core 
material. Th e analysis of the available literature also indicated that the in vitro developmen-
tal toxicity potency of NPs may also largely depend on the coating applied. However, from 
the available data it cannot be concluded whether the toxicity potential is dependent on the 
coating alone, or whether it is also dependent on the combination of the core material and the 
coating. Th erefore, although the limited data available indicate that charge, size and coating 
of NPs may be important characteristics that determine the developmental toxicity potential 
of NPs, more (systematic) studies are needed to assess how physicochemical characteristics of 
NPs relate to their developmental toxicity. Th is information may help to prioritize NPs for in 
vitro and in vivo developmental toxicity testing.
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In chapter 5, toxic eff ects of a series of metal (oxide) NPs were tested in macrophage RAW264.7 
cells in order to obtain insight in eff ect of these NPs on cells of the innate immune response. 
In these macrophage RAW264.7 cells the eff ects of the metal (oxide) NPs were characterized 
on cell viability, TNF-α production and mitochondria-related parameters like production of 
reactive oxygen species (ROS), mitochondrial permeability transition pore (MPTP) opening, 
and intracellular ATP levels, since previous research indicated that mitochondria play an im-
portant role in NP-induced toxicity (Park et al. 2008, Sharma et al. 2011, Shvedova et al. 2012, 
Bhattacharjee et al. 2013). Th e results obtained indicated that TiO2, Fe2O3, Cr2O3, CoO and 
NiO NPs showed no eff ects on the selected endpoints up to the highest concentration tested 
(200 µg/ml), and that SiO2 and Ag NPs caused concentration-dependent adverse eff ects in the 
RAW264.7 cells. 
Th e results showed that SiO2 NPs were the most toxic ones among the tested food-related 
NPs. Exposure to food-related NPs is expected to be mainly via the gastrointestinal tract. 
When food products containing SiO2 were tested in an in vitro digestion model, simulating 
the conditions of the human gastrointestinal tract, it was found that SiO2 NPs (5-200 nm) 
were still present in the intestinal content (Peters et al. 2012). Th is indicates that it is most like-
ly that upon consumption of foods containing particulate SiO2, the gut epithelium is exposed 
to SiO2 NPs (5-200 nm) (Peters et al. 2012). To enter the systemic circulation, NPs need to be 
absorbed in the gastrointestinal tract. In an in vivo study in rats it was shown that 6.6-9.7% of 
both SiO2 NPs of 20 and 100 nm were absorbed into the systemic circulation, with no signifi -
cant eff ect of the particle size, when orally administered at a single dose of 500 and 1000 mg/
kg (Lee et al. 2014), indicating that SiO2 NPs can get translocated across the intestinal barrier. 
With an estimated daily intake of SiO2 in the nano-size range of 1.8 mg/kg bw/day (van der 
Zande et al. 2014, van Kesteren et al. 2014), the daily intake of a 70 kg person would be 126 
mg. In the adult human the gastrointestinal tract represents a considerable surface area of 
about 200 m2  which has the potential to interact with ingested NPs (Bergin et al. 2013). In ad-
dition the gastrointestinal tract has localised representations of the adaptive immune system 
in the form of gut-associated lymphoid tissue (GALT) aggregates (Peyer’s Patches) (Bergin 
and Witzmann 2013). Th ese Peyer’s patches account for 1% of the total surface area of the 
gastrointestinal tract (des Rieux et al. 2006). About 9 litres of fl uid pass through the gastro-
intestinal tract each day (Sherwood L. 2014). Th us, upon oral intake of 126 mg SiO2 per day 
this would lead to a concentration of 14 µg/ml, assuming full distribution of the NPs over the 
entire intestinal content, which is lower than the lowest observed adverse eff ect concentration 
of 100 µg/mL in the present study. Only when using a worst case assumption of only limited 
dilution of an oral dose of 126 mg SiO2 NPs in the human intestine, local concentrations can 
be expected to reach the eff ect levels observed in vitro.
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Furthermore, if 100% of the estimated daily intake of SiO2 NPs (126 mg) would be transported 
from the intestines into the blood, assuming 5 liters of blood and a 100% clearance per day, a 
maximal concentration of 25 µg/ml would be reached if NPs would not distribute to tissues. 
Also this concentration is lower than the lowest observed adverse eff ect concentration of 100 
µg/mL defi ned in the present thesis. Considering that the oral bioavailability is lower than 
10% and that NPs also distribute to tissues (Lee et al. 2014), concentrations higher than 2.5 
µg/mL are not likely to be reached in a real-life exposure scenario. Th is concentration is far 
below the concentrations of SiO2 causing in vitro toxicity in the present study, suggesting that 
in vivo toxic eff ects of food additive related SiO2 NPs on macrophages, are expected to be 
limited. Th is is in line with the results from an oral repeated-dose toxicity study in which male 
Wistar rats were exposed to SiO2 NPs via the diet for 28 or 84 days, showing no toxicity even 
at the highest dose level tested (2500 mg/kg bw/day) (van der Zande et al. 2014). 
It has to be kept in mind that NPs may not only aff ect  the gastrointestinal cells directly but 
may also infl uence the microbiome although the evaluation of eff ects of NPs on the micro-
biome is in its early infancy (Pietroiusti et al. 2015). For example, the cytotoxicity of Ag NPs 
on Escherichia coli as representative for intestinal bacteria was compared with the cytotoxicity 
of Ag NPs on gastrointestinal cells. Th is revealed that Ag NPs aff ected bacteria at lower con-
centrations than the gastrointestinal cells indicating that Ag NPs may cause adverse eff ects 
by selectively aff ecting the gut microbiota (Frohlich et al. 2016). In a study using an in vitro 
colon model (Taylor et al. 2015), exposure to TiO2 , ZnO and CeO2 NPs induced signifi cant 
phenotype changes of the gut microbial community, including eff ects on the production of 
short chain fatty acids which are the key metabolites in the control of energy homeostasis and 
have been implicated in the development of obesity (Schwiertz et al. 2010). For SiO2  and other 
food-related NPs, however, the occurrence of such eff ects remains to be investigated.
Altogether, results obtained in chapter 5 showed no or limited eff ects of the NP formulations 
of metal (oxide) food additives on cell viability, ROS production, MPTP opening, ATP levels 
and TNF-α production in RAW264.7 macrophages. Eff ects were only observed at high con-
centrations that may not be physiologically relevant, indicating that related adverse eff ects 
upon exposure to the respective NPs in vivo may be limited. 
Of the NPs tested in chapter 5, Ag NPs were among the NPs showing most eff ects. Th e vol-
ume of Ag NPs-based products entering the market is relatively high, making the risk as-
sessment of Ag NPs a priority. Th erefore to elucidate the factors that drive Ag NPs’ potential 
to pose health risks, chapter 6 assessed the eff ects of specifi cally synthetized Ag NPs with 
two diff erent sizes (20 and 50 nm) and with three diff erent surface coatings (chitosan: Ag 
NP_Chit, bovine serum albumin: Ag NP_BSA, polyvinylpyrrolidone: Ag NP_PVP) in the 
same in vitro RAW264.7 model. Th e eff ect of surface charge and size of NPs was character-
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ized on cell viability, TNF-α production, ROS production, MPTP opening, and intracellular 
ATP levels. Decreased cell viability was observed for all Ag NPs tested. Th e results from MTT, 
ATP and MPTP opening assays showed that adverse eff ects from exposure to the tested Ag 
NPs on these endpoints were similar irrespective of type or size. However, the role of surface 
coating/charge in infl uencing TNF-α induction was demonstrated by the fact that only neg-
atively charged Ag NP_BSA induced TNF-α production (80x higher than control). Further, 
signifi cant ROS induction was only observed with the 20 nm positively charged Ag NP_Chit. 
Eff ect of size was less prominent under the experimental conditions, showing only minimal 
diff erences that were not statistically signifi cant. Overall, the negatively charged Ag NP_BSA 
appeared to be most potent in inducing adverse eff ects on the macrophages. Th is toxicity of 
the negatively charged Ag NPs is the opposite of what was found in chapter 3 for the PS-NPs, 
since the positively charged PS-NPs appeared to be the most cytotoxic to BeWo cells. So this 
points again to the direction that the eff ect of surface charge may vary with the type of NPs 
investigated, indicating that more studies with other NPs with diff erent core material and 
with diff erent charges are required. One has to keep in mind that Ag NPs are known to release 
ions which can also contribute to toxicity even if the Ag NPs has a negative surface charge, 
and in general the smaller the Ag NP the higher the ion release (Johnston et al. 2010, Reidy 
et al. 2013). Given this ion release, the PS-NPs used in chapter 3 and 4 seem to be a better 
model to evaluate the eff ect of charge or size since they do not present these additional factors 
leading to toxicity.
Taken together, the present thesis provided further evidence of the infl uence of physicochem-
ical properties of NPs in driving toxicity in an in vitro model. However, the determination of 
the fate and toxicity of NPs using in vitro or in vivo models is a challenge that needs further 
evaluation. A combination of several factors likely play a role in determining the outcome 
of exposure including factors like NP core material and presence and type of coating agents 
resulting in various physicochemical properties (size, charge, etc.), as well as the toxicity test 
models used and end-points studied. Th is has been observed in earlier reviews (Johnston et 
al. 2010, Reidy et al. 2013) and appears to hamper conclusive evaluation of the role of physi-
cochemical characteristics of NPs in the modes of action underlying their potential hazards 
and risks so far. 
Th e results obtained do show however that in vitro assays can detect diff erences in potential 
hazards posed by NPs. Th erefore it is concluded that the results of the work presented in this 
thesis will contribute to the further development and use of non-animal based testing strat-
egies for safety testing of NPs providing insight into selected potential hazards of the tested 
NPs.
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FUTURE PERSPECTIVES
Although the present thesis has extended the understanding and prediction of  potential haz-
ards of diff erent NPs, several issues remain to be elucidated to fully understand the hazards of 
NPs to human health and the environment. Th e current section presents some considerations 
on future topics of importance in this fi eld. Th ese topics include:
 - Use of alternative testing strategies and especially the EST to detect developmental 
toxicity.                    
 - Physicochemical characterization of NPs
 - Predictive toxicology:  Nano-QSAR models
 - Dosimetry
 - Th e role of the microbiome
Use of alternative testing strategies and especially the EST to detect developmental toxicity. 
Given the high number of NPs for which at present in vivo toxicity data are missing the po-
tential to use alternative in vitro testing methods to detect possible health hazards of NPs, is 
of high importance to set priorities in future safety testing and also to support development of 
safer NPs. An important endpoint to include in these activities is developmental toxicity since 
this is an endpoint requiring relatively large numbers of experimental animals (Rovida et al. 
2009). In the present thesis the ES-D3 cell diff erentiation assay of the EST was used. Th e main 
advantage of this assay over other alternative assays for developmental toxicity testing is that 
it does not require the use of any animals because it uses an immortal cell line isolated from 
a mouse blastocyst. Th e EST is also relatively easy to carry out and the endpoints used in the 
assay do not require extensive knowledge on morphologic development (de Jong et al. 2011).
However, the diff erentiation of the stem cells into beating cardiomyocytes as only endpoint 
might not be suﬃ  cient for determination of all possible embryotoxic eff ects (zur Nieden et 
al. 2004). With the EST, only the eff ects on mesodermal development are recorded. But some 
substances and also NPs might have embryotoxic eff ects on specifi c cell-types other than 
cardiomyocytes. Th is may lead to false negative results if the test compound aff ects cell types 
other than the myocardium. Th erefore, also the diff erentiation into neural and endothelial 
cells, chondrocytes and osteoblasts should be investigated (Buesen et al. 2004).
Other alternative assays for in vivo developmental toxicity are the rat Whole Embryo Culture 
(WEC) and the limb bud micromass (MM) test (Genschow et al. 2000, Augustine-Rauch et 
al. 2010). Th e WEC is used to assess the eff ects of chemicals on the development of the com-
plete embryo within its intact visceral yolk sac outside the uterus, during a critical phase in 
organogenesis (de Jong et al. 2011). Th e test makes use of mammalian embryos, but both the 
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exposure and the assessment of eff ects occur in vitro (Piersma et al. 2008). Th erefore, WEC 
systems off er the most complete in vitro alternative for animal testing for developmental tox-
icity. Th e test does require animal material, but has the advantage of representing embryo-
genesis in full complexity from cellular proliferation and diff erentiation to pattern formation 
(Piersma 2004). 
In the MM test, chondrogenesis of mesenchymal cells of limb buds of rat embryos is studied 
(Kistler 1987). Th e test involves exposing cultured chick, mouse or rat embryo midbrain or 
limb cells to test agents for varying times and estimating the inhibition of cell diff erentiation 
in these cultures. Th e MM assay reported that when cells from the undiff erentiated mesen-
chyme of early chick embryo limbs are cultured in small volumes at high density, they formed 
numerous small aggregates (foci) of cells of diff erentiating chondrocytes within a background 
of apparently undiff erentiated cells (Flint 1993). In principle, the MM developmental toxicity 
test is based on detecting the ability of a particular compound to inhibit the formation of foci. 
Embryotoxic compounds will reduce the number of foci or the number of cells within foci 
(Spezia et al. 2013). Both the WEC and MM assay rely on a constant source of embryonic 
tissues from pregnant animals. However the MM assay is considered most useful for iden-
tifying strongly embrytotoxic compounds (Genschow et al. 2004) since the predictivity for 
non-embryotoxic compounds and the precision for weakly embryotoxic compounds were 
judged to be insuﬃ  cient.  
Another in vitro test for embryotoxicity is the so-called chick embryotoxicity screening test 
(CHEST) assay. Th e main endpoints assessed using the CHEST are mortality, malformations, 
embryo development, blood vessel development and blood vessel coloration. Th e test com-
pounds can easily be administered to the eggs and eff ects on the developing embryo can be 
investigated. However, the CHEST has been criticised for not being able to distinguish general 
toxicity from specifi c developmental eff ects and the absence of mammalian maternal-foetal 
relations (Jelinek et al. 1985).  
A fi nal possible method to study in vitro developmental toxicity is the Zebrafi sh Embryo-
toxicity Test (ZET). Th is test uses non-mammalian embryos. Th e eff ects of compounds are 
tested on the development of embryos of the zebrafi sh. In principle, the fertilized fi sh eggs are 
exposed to diff erent concentrations of a test substance. At diff erent time points, the exposed 
developing fi sh embryos are observed and scored for lethal and embryotoxic eff ects. Th e ZET 
has been used for testing embryotoxiciy of Ag NPs (van Aerle et al. 2013, Yoo et al. 2016), 
ZnO, SiO2, Al2O3, Pt and Au NPs (George et al. 2011) and TiO2 NPs (Brundo et al. 2016, 
Shih et al. 2016). Yoo et al. 2016 investigated embryotoxicity eff ects of 10 nm Ag NPs during 
zebrafi sh development, using the following parameters: abnormal morphology, mortality, 
hatching rate and heart rate. Th e hatching rate diff ered not signifi cantly between the exposure 
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groups while the Ag NP exposed group showed increased mortality (11%) and teratogenicity 
(15%) at 72 h compared to the control group for which these values amounted to 2% and 0% 
respectively. Th e heart rate of Ag NP exposed embryos tended to be lower than that of the 
control group but diff erences were not statistically signifi cant (Yoo et al. 2016). Van Aerle et 
al. (2013) investigated the eff ects of exposure to bulk Ag, 10 nm Ag NPs or ionic Ag to ze-
brafi sh embyros using a Next Generation Sequencing approach. All treatments aff ected gene 
expression and those genes associated with oxidative phosphorylation and protein synthesis 
overlapped strongly between the three treatments indicating similar mechanisms of toxicity 
for the three forms of silver studied (van Aerle et al. 2013). 
One study investigated a batch of commercial metal/metal oxide NPs both for their cytotoxic 
potential in vitro using automated epifl uorescence microscopy on mammalian BEAS-2B and 
RAW 264.7 cells and in vivo using the zebrafi sh (George et al. 2011). Th e automated epifl uo-
rescence procedure measures sub-lethal (e.g. intracellular Ca2+fl ux and mitochondrial pertur-
bations) and lethal (cell death with increased membrane permeability) responses. Among the 
NPs analyzed, Pt, Ag, SiO2, Al2O3, and Au NPs triggered sub-lethal eff ects without cytotoxic-
ity. Quantum Dots (QDs) and ZnO NPs triggered sub-lethal eff ects and cytotoxicity. In order 
to compare the in vitro with the in vivo response outcomes in zebrafi sh embryos, NPs were 
tested for their impact on mortality rate, hatching rate, cardiac rate, and morphological de-
fects. While QDs, ZnO and Ag NPs induced morphological abnormalities or interfered with 
embryo hatching, Pt and Ag NPs exerted inhibitory eff ects on cardiac rate at the sub-lethal 
dose of 15 μg/mL. Ag NP-treated embryos developed bent spines, short body sizes, pericar-
dial edema, submandibular edema and bent tails at 120 hrs, while the majority of ZnO-treat-
ed embryos remained unhatched and embryos treated with QDs died early and underwent 
complete dissolution within 24 hrs. Ag NP was clearly more toxic in zebrafi sh embryos than 
towards mammalian cells in vitro (George et al. 2011). 
Physicochemical characterization of NPs
Th e ability to create NPs with a wide variety of characteristics with respect to   chemistry, 
shape, size and surface properties led to attention for the nanotoxicological aspects regarding 
of the physicochemical characteristics of NPs (Westmeier et al. 2016). It is well known that the 
biological activity of NPs depends on their physicochemical parameters including size, shape, 
surface area, surface charge, crystal structure, chemical composition and surface chemistry 
(Fadeel et al. 2015). Generally, by using the currently available methods, it is only possible 
to measure a single or several characteristic(s) of NPs but not all (Bouwmeester et al. 2011). 
Investigations of the NPs behaviour in physiological media are very important to interpret the 
toxicological results. As an example the formation of a protein corona formation can cause 
changes in charge, size and surface chemistry of a certain NP thereby impacting on its uptake 
and cellular fate (Corbo et al. 2016). Th erefore, physicochemical characteristics and biological 
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eff ects should preferably be measured under the same experimental conditions (Meissner et 
al. 2009). 
In this thesis NPs were characterized in the medium used for the respective assay using SEM 
and dynamic light scattering (DLS) for size and zeta potential (for surface charge). Chapter 3 
pointed out that only size and charge characterization of PS-NPs were not enough for inter-
preting the results. Translocation of the diff erent PS-NPs across the BeWo cell layer was not 
found to be related to PS-NP charge and a remarkable diff erence in translocation was found 
between the two 50 nm negatively charged PS-NPs from diff erent manufacturers, where one 
did not translocate at all to the basolateral compartment. Th erefore the protein corona was 
also assessed using SDS-PAGE.  Biomolecules rapidly adsorb to NPs as they have a high sur-
face energy, leading to the formation of the protein corona which critically aff ects the NPs 
biological identity (Cedervall et al. 2007). Th e protein corona formation can infl uence the 
delivery properties of NPs, as well as their toxicity (Tenzer et al. 2013) and plays a critical 
role in cellular uptake (Pelaz et al.,2015), accumulation, biodegradation and clearance of NPs 
(Saptarshiet al., 2013). Protein corona analyses of the 3 diff erent PS-NPs in chapter 3 re-
vealed diff erences in the amount but not the nature of the proteins in the corona of the three 
diff erent PS-NPs. Since none of the characterized parameters, including size, zeta potential 
and protein corona revealed remarkable diff erences between the two negatively charged NPs, 
it was argued that the diff erence may originate from the chemical groups on the surface of 
the NPs generating the negative charge. Previously it was demonstrated that three diff erent 
positively charged tri-block copolymer nanoparticles showed diff erent cellular uptake and 
toxicity in spite of a similar overall size and zeta potential, and that only a diff erent shielding 
of the charge due to subtle diff erences in the charge generating surface moiety infl uenced 
the cellular uptake and toxicity (Bhattacharjee et al. 2011). Such observations indicate that 
by characterising size, zeta potential and protein corona, even when done in the relevant 
medium or body fl uid, may prove insuﬃ  cient for full characterization of the NP parameters 
that direct the biological eff ects and potential toxicity. Obviously this also hampers defi ni-
tion of (Q)SARs and read-across and suggests that at the current state-of-the-art parameters 
generally used to characterise NPs physicochemical characteristics may prove insuﬃ  cient to 
understand the diff erences in their toxicity.
Although techniques for characterization of NPs have progressed greatly over the past 10 
years, further improvements are highly recommended. For example it would be advantageous 
to modify current standards such as DLS and TEM/SEM in order to perform them with a 
higher sensitivity and in a more relevant biological environment (Hussain et al. 2015). Limita-
tions of the DLS method include that the particle size is correlated with the light scattered and 
the presence of a few large particles, for example from the culture medium or relevant bio-
logical fl uid, could mask the presence of a high number of small particles (Handy et al. 2008). 
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Establishing nano-QSARs linking NP/corona properties to (patho)physiological responses 
remains a still distant goal despite the achievements of the past years. It is clear that charac-
terizing the nano-cellular interactions is a critical step in the development of a fundamental 
understanding of nanotoxicology. International guidelines for physicochemical characteriza-
tion are needed for regulatory purposes, and the methods used for characterization need to 
be standardized and validated  (Fadeel et al. 2015).
Predictive toxicology: Nano-(Q)SAR models  
Because of the high costs and time involved in toxicological in vivo and in vitro studies, there 
has been considerable interest in computer based strategies defi ning alternative computa-
tional methods, like the application of (quantitative) structure-activity relationship ((Q)SAR) 
models. (Q)SAR models are theoretical models that relate the structure or physicochemical 
characteristics of compounds to their biological activities. (Q)SAR models could be a useful 
screening tool, eliminating the need to test every single NP on an individual basis (Oksel et al. 
2015). Considering the large number of factors that diff er from conventional chemicals and 
that are likely to infl uence the biological activity of NPs, it might also be concluded that tradi-
tional (Q)SAR approaches need serious reconsiderations in order to be applied to NPs (Oksel 
et al. 2015). Th e simple application of classic (Q)SAR approaches based on the representation 
of various substances by the structure of their molecules is impossible for the majority of 
NPs (Toropova et al. 2016). Because of the high structural complexity and diversity of NPs, 
it is diﬃ  cult to develop quantitative parameters capable of characterizing the structural and 
chemical properties of NPs. In addition, systematic studies that assess physicochemical and 
structural properties in relation to biological eff ects of NPs are scarce, making the develop-
ment of predictive computational models and their validation diﬃ  cult, since these procedures 
require relatively large amounts of data (Fourches et al. 2010).  Moreover, due to the fact that 
large datasets are not available for a large part of the NPs one might need to develop a meth-
odology that provides predictions based on smaller datasets. Few studies have reported on 
the  development of nano-(Q)SARs. Recently, an approach was published to develop a (Q)
SAR for fullerene NPs based on a small dataset (Toropova et al. 2016). In this study a QSAR 
was developed based on several data (conditions) related to (i) dose (g/plate); (ii) metabolic 
activation (with or without mix S9); and (iii) illumination (dark or irradiation) as a tool to 
predict mutagenicity of fullerene NPs in bacterial strains. Th ese computational experiments 
have shown that the described approach, based on a list of several conditions and not on mo-
lecular structure as is usually done in the classical approach, can be a tool to build up models 
for the prediction of mutagenicity of fullerene NPs under diff erent conditions, based on a 
small dataset. 
Burello et al. 2011, have proposed a theoretical framework to predict the oxidative stress po-
tential of oxide NPs based on the available electronic energy levels in the NPs (Burello et al. 
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2011).  Fourches et al. 2010 investigated the potential of (Q)SAR modelling to establish statis-
tically signifi cant relationships between measured biological activity profi les of NPs and their 
physical, chemical, and geometrical properties, either measured experimentally or computed 
from the structure of NPs (Fourches et al. 2010). Th ey studied a fi rst dataset of 51 NPs with 
diff erent metal cores which were tested in four cell lines (monocytes, hepatocytes, endothelial 
and smooth muscle cells) in four diff erent assays (ATP levels, reducing equivalents, caspase 
mediated apoptosis and mitochondrial membrane potential). It was demonstrated that NPs 
with similar biological activity can be also recognized as similar by their type of metal core, 
since NPs in one cluster featured the same metal core, independently of their surface modi-
fi ers. In a second dataset they studied 109 NPs with the same core but with diff erent surface 
modifi cations for their cell uptake activity. Here the structure of organic small molecules con-
jugated to the NP surface was the only diff erence between the 109 NPs. Factors that correlated 
with cellular uptake were: lipophilicity, molecular refractivity, specifi c Van der Waals surface 
area and electrostatic descriptors. Th ese fi ndings imply that the cellular behaviour of a NP 
dataset based on a common core can be predicted using (Q)SAR analysis of the surface mod-
ifying ligands (Fourches et al. 2010).
At the moment the research for nano-(Q)SAR models continues. Th ere remains the need for 
thorough testing and validation of (Q)SAR methodologies, and there are still barriers that 
need to be overcome to establish predictive, reliable, and legally acceptable nano-(Q)SAR 
models. A main issue is the scarcity of consistent and high-quality experimental data which 
are needed to develop a robust and predictive nano-(Q)SAR model (Oksel et al. 2015). Th e 
scarcity of such data is mainly caused by diﬃ  culties in standardizing nanotoxicity testing 
methodologies and characterization conditions. High quality data are required, which are 
consistent and systematically obtained for NPs that have been comprehensively character-
ised under relevant exposure conditions prior to toxicological testing (Oksel et al. 2015). It 
is therefore suggested that, due to high variability in the molecular structures and diff erent 
mechanisms of toxicity, individual classes of NPs should be modelled separately (Puzyn et al. 
2009). Th e establishment of standard protocols is essential to enable accurate measurements 
of physicochemical and biological properties of NPs (Oksel et al. 2015). 
Dosimetry
Another challenge is to arrive at a consensus about which dose metric is best to be used in 
nanotoxicological studies, for example mass, particle number or surface area  (Hussain et al. 
2015). Dosimetry is the accurate description of the dose or the amount of NPs that comes into 
contact with the biological target. It is an important aspect to take into account when predict-
ing risks but it should be measurable and it should be possible to incorporate it in regulations. 
Currently the dose is oft en defi ned as the nominal dose, so the amount of NPs introduced 
into the culture medium expressed in mass per volume (µg/ml). However, it is also possible 
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to measure the intracellular or deposited doses (Fadeel et al. 2015). It has been suggested that 
the NP surface area could be more relevant in nanotoxicology studies than the mass unit 
(Oberdorster et al. 2007). Braakhuis et al. have demonstrated that for short-term inhalation 
of Ag NPs, the total surface area of Ag NPs that reach the alveoli seems the most suitable dose 
descriptor for the acute eff ects of Ag NPs in a range of sizes (Braakhuis et al. 2016). Th is is 
because the alveoli are the site of the observed toxicity and Ag NPs can release Ag ions, which 
possibly cause the observed eff ects. Th e release of Ag ions increases with decreasing particle 
size due to their relative larger surface area (Braakhuis et al. 2016). Th is indicates that for oth-
er types of NPs that do not release ions the suitable dose descriptor could be diff erent. Th ere 
is probably no one-size-fi ts-all dose metric for NPs and various approaches depending on the 
type of NP and type of toxicological testing system might be needed to apply. 
So dosimetry in nanotoxicological studies is complicated by additional topics which are 
unique for NPs. For example NPs such as Cu and Ag release ions over time thereby introduc-
ing a second factor of interaction with the cells. In addition, NPs that are insoluble may have 
an infl uence on biokinetic behavior, since there is an increase potential for bioaccumulation, 
which makes it diﬃ  cult to estimate a delivered dose at specifi c tissues or cells. Insoluble NPs 
may cause a diverse range of chronic eff ects and have the potential to reside for years in the 
respiratory tract (Bakand et al. 2016). Also the fact that the properties of NPs may vary sig-
nifi cantly between cell culture media and physiological fl uids may infl uence the dose metric 
that most adequately describes the exposure. For example, the protein corona that forms on 
NP surface when in it comes in contact with biological fl uids such as serum, mediates the in-
teractions with cells and could aff ect the cellular uptake of NPs. A study found that SiO2 NPs 
exposed to cells in the absence of serum have a stronger adhesion to the cell membrane and a 
higher uptake in cells, compared to SiO2 NPs exposed to cells in medium containing serum, 
when a preformed corona is present on their surface (Lesniak et al. 2012). Th is indicates the 
importance of proper performance and description of the physicochemical characterization 
of nanoparticles in every experiment. 
 e role of the microbiome 
Th e gut microbiome consists of trillions of microorganisms located in our gastrointestinal 
tract (Tsai et al. 2009). Th e gut microbiome plays a major role in infl uencing the health status 
of the host. Th ere is a complex interaction between the gut microbiome, diet, genetics, envi-
ronmental infl uence, host health and neurotransmitters and metabolites (Ghaisas et al. 2015, 
Pietroiusti et al. 2015). Gut bacteria play a major role in immune modulation and develop-
ment of the nervous system and are the main source of vitamin K and B complex. Alterations 
in the microbiome have been suggested to play a role in several diseases like irritable bowel 
syndrome (IBS), ulcerative colitis, Alzheimer’s disease, Parkinson’s disease, type-2 diabetes, 
multiple sclerosis and autism (Althani et al. 2015, Ghaisas et al. 2015). 
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Th e evaluation of eff ects of NPs on the microbiome is in its early infancy. Altough data are 
limited, available experimental data suggest that diff erent types of NPs including carbon 
nanotubes (CNTs), TiO2, CeO2, ZnO, SiO2 and Ag NPs, may aff ect the microbiome in a way 
that may result in adverse health eff ects. It is speculated that this may then result in clinical 
disorders such as colitis, obesity and immunological dysfunctions (Pietroiusti et al. 2015). 
For example in a study using an in vitro colon model (Taylor et al. 2015) which included the 
microbial community taken from a young healthy donor, exposure to TiO2 and ZnO NPs in-
duced changes in various phenotypic traits of the colonic bacteria, including the production 
of short chain fatty acid which are the key metablolites in the control of energy homeostasis 
and have been implicated in the development of obesity (Schwiertz et al. 2010). Development 
of colitis associated to gut microbiota alterations was reported in mice which were exposed 
to ambient particulate matter containing carbon based NPs (Kish et al. 2013). Given the few 
studies done so far on possible microbiome-NP interactions, there is a need for more in vitro 
and in vivo studies. In these studies the potential degradation of ingested NPs by the microbi-
ome could be investigated as well (Pietroiusti, Magrini et al. 2015).
OVERALL CONCLUSION
Overall, the work presented in this thesis showed that in vitro assays can contribute to the 
development and use of non-animal based testing strategies for safety testing of NPs and 
provide insight into selected potential hazards of the tested NPs and a means to set priorities 
in future in vivo tetsing. Use of in vitro models may also help to defi ne nano-(Q)SAR meth-
odologies. Th e work presented in this thesis also showed that the role of surface charge varies 
with the type of NP and the endpoint of interest. So this would mean that case-by-case testing 
is needed to which in vitro assays will form an important contribution. 
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SUMMARY
Th e production of nanoparticles (NPs) has increased in the last decades and the number of 
products in which NPs are being incorporated is still growing. Th e rapid increase of nano-
technology has several benefi ts for society, yet there is an increasing concern that exposure to 
NPs may result in signifi cant adverse health eff ects. Since NPs are incorporated in a variety 
of consumer products, it is likely that the general population will be exposed to NPs, via 
NP-containing products such as personal care products, food and food packaging materials, 
textiles and medicines. It would be desirable that the safety and risk assessment of NPs could 
be largely based on studies using in vitro models instead of in vivo models as this would 
reduce the use of test animals, costs and time required to test the large numbers of NPs. Th e 
aim of the present thesis was to investigate the potential of in vitro testing strategies to detect 
hazards of NPs, focusing on toxicokinetic as well as toxicodynamic endpoints. Toxicokinetic 
studies focused on translocation of NPs in in vitro models of the placental barrier, while toxi-
codynamic studies were directed at two endpoints that represent potential hazards of NPs that 
have not yet been well characterized including: developmental toxicity and immunotoxicity. 
Chapter 1 introduced the aim of the thesis and the various in vitro models and NPs used 
in the studies performed. In the present thesis diff erent types of NPs were used. Polysty-
rene nanoparticles (PS-NPs) were selected because of their commercial availability, with high 
quality and a wide variety of available physicochemical properties like surface charge, and 
fl uorescent labeling enabling easy detection in toxicokinetic (translocation) studies. Several 
metal (oxide) NPs were selected as well, of which some are possible constituents of food ad-
ditives like TiO2, Fe2O3, SiO2 and Ag. Other metal oxide NPs that were selected were Mn2O3, 
CuO, Cr2O3, CoO and NiO to which we may be exposed via products like paints, catalysts, 
construction materials, coatings and batteries. 
Chapter 2 of the present thesis provided a review about the performance of in vitro models 
for studies on toxicokinetics of NPs. Th e chapter described models that mimic the diff erent 
barriers of the human body, with a focus on the lung, gut, skin and placental barrier, thus 
providing an overview of the state-of-the-art of using in vitro model systems, ranging from 
single cell-type monolayer to multi-cell (3D) models, to characterize the translocation of NPs 
across these diff erent barriers. In this chapter it was concluded that at the current state-of-
the-art, the in vitro models do not yet allow prediction of absolute transfer rates but they do 
support the defi nition of relative transfer rates and can thus help to reduce animal testing by 
setting priorities for subsequent in vivo testing. Th e use of in vitro models is very promising 
since they are currently further improved to mimic the in vivo situation more closely by, for 
example, using co-cultures of diff erent cell types and implementing them in a microfl uidic 
chip format. When these models are further validated by testing exactly the same NPs in an in 
13937-kloet-layout.indb   202 28/10/2016   09:29
203
Summary
8
vivo set-up and in the in vitro model, they could be even used to determine the internal expo-
sure (bioavailability) of NPs in an absolute way, besides to set priorities for NP toxicity testing. 
Chapter 3 showed the results of placental translocation of NPs as an important toxicokinetic 
aspect, since part of the toxicodynamic studies of the present thesis were directed at devel-
opmental toxicity testing of NPs. In order to obtain insight in toxicity and translocation of 
NPs across the placental barrier, cytotoxicity and translocation was studied for one positively 
and two negatively charged PS-NPs of 50 nm in an in vitro model of the placenta. Th e model 
consisted of BeWo b30 cells, derived from a human choriocarcinoma grown on a transwell 
insert forming a cell layer that separates an apical from a basolateral compartment. PS-NPs 
were characterized with respect to size, surface charge, morphology and protein corona. In 
this study it appeared that in spite of similar size, surface charge and type of proteins in the 
protein corona, the diff erently charged NPs displayed a remarkable diff erence in cytotoxicity, 
with only the PS-NPs with an original positive charge inducing cytotoxicity. Translocation of 
PS-NPs appeared not to be related to PS-NP charge alone. A remarkable diff erence in translo-
cation was found between the two 50 nm negatively charged PS-NPs that were obtained from 
diff erent manufacturers. For the negatively charged PS-NPs from Polysciences, the apparent 
permeability coeﬃ  cient (Papp) was slightly higher than that of amoxicillin, a compound that 
is known to be translocated over the in vitro BeWo b30 placental barrier and the ex vivo hu-
man placental barrier to only a limited extent. When testing the negatively charged PS-NPs 
from Magsphere, no PS-NPs could be detected in the basolateral compartment upon adding 
a concentration of 10 µg/ml to the apical compartment and 24 hours incubation. Since none 
of the characterized parameters, including size, surface charge and protein corona revealed 
remarkable diff erences between the two negatively charged NPs, the diff erence may originate 
from the chemical groups on the surface of the NPs generating the negative charge. Th e gen-
eral conclusion from this study was that the in vitro BeWo b30 model can be used as a fast 
method to get an initial qualitative impression about the capacity of NPs to translocate across 
the placental barrier and to set priorities for further in vivo studies on translocation of NPs 
to the fetus. 
Chapter 4 investigated whether the same PS-NPs as tested in chapter 3 for placental translo-
cation, are able to cause in vitro developmental toxicity in the ES-D3 cell diff erentiation assay 
of the embryonic stem cell test (EST) focusing also on the eff ect that charge may have. Th e 
study showed that the two negatively charged PS-NPs did not show any eff ect in the ES-D3 
cell diff erentiation assay up to the highest concentration tested while the positively charged 
PS-NP showed a concentration-dependent inhibition of ES-D3 cell diff erentiation. However, 
eff ect concentrations in the ES-D3 cell diff erentiation assay were close to cytotoxic concen-
trations, which indicated that the inhibition of the ES-D3 cell diff erentiation may be due to 
cytotoxic eff ects of the positively charged PS-NPs. Th is indicated that the inhibition of the ES-
D3 cell diff erentiation by the positively charged PS-NPs may be caused by non-specifi c eff ects. 
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A literature search was done on the reported potencies of other NPs in the ES-D3 cell diff er-
entiation assay, in order to assess whether eff ects of NPs in the ES-D3 cell diff erentiation assay 
may also be related to physicochemical properties other than surface charge, such as size or 
coating. Although the experiments in chapter 3 of the present thesis showed that positively 
charged PS-NPs are more toxic than negatively charged PS-NPs, it appeared that this may 
not be generalizable to other NPs. Th is  follows from the fact that SiO2, Ag and TiO2 NPs 
that were reported to inhibit ES-D3 cell diff erentiation were negatively charged, while the 
negatively charged PS-NPs of the present study did not aff ect ES-D3 cell diff erentiation. To 
obtain better insight in the role of NP surface charge on developmental toxicity more studies 
are required that assess the eff ects of NPs with diff erent charge that are made of the same core 
material. Although the limited data available indicate that charge, size and coating of NPs may 
be important characteristics that determine the developmental toxicity potential of NPs, more 
(systematic) studies are needed to assess how physicochemical characteristics of NPs relate to 
their developmental toxicity. Th is information may help to prioritize NPs for in vitro and in 
vivo developmental toxicity testing.
In chapter 5, toxic eff ects of a series of metal (oxide) NPs were tested in macrophage RAW264.7 
cells in order to obtain insight in eff ect of these NPs on cells of the innate immune response. 
In these macrophage RAW264.7 cells the eff ects of the metal (oxide) NPs were characterized 
on cell viability, TNF-α production and mitochondria-related parameters like production of 
reactive oxygen species (ROS), mitochondrial permeability transition pore (MPTP) opening, 
and intracellular ATP levels. Th e results showed that SiO2 and Ag NPs were the most toxic 
ones among the tested food-related NPs and that TiO2, Fe2O3, Cr2O3, CoO and NiO NPs 
showed no eff ects on the selected endpoints up to the highest concentration tested (200 µg/
ml). Altogether, results obtained in chapter 5 showed no or limited eff ects of the NP formula-
tions of metal (oxide) food additives on cell viability, ROS production, MPTP opening, ATP 
levels and TNF-α production in RAW264.7 macrophages. Eff ects were only observed at high 
concentrations that may not be physiologically relevant, indicating that related adverse eff ects 
upon exposure to the respective NPs in vivo may be limited. 
Of the NPs tested in chapter 5, Ag NPs were among the NPs showing most eff ects. Th e volume 
of Ag NPs-based products entering the market is relatively high, making the risk assessment 
of Ag NPs a priority. Th erefore to elucidate the factors that drive Ag NPs’ potential to pose 
health risks, chapter 6 assessed the eff ects of specifi cally synthetized Ag NPs with two dif-
ferent sizes (20 and 50 nm) and with three diff erent surface coatings (chitosan: Ag NP_Chit, 
bovine serum albumin: Ag NP_BSA, polyvinylpyrrolidone: Ag NP_PVP) in the same in vitro 
RAW264.7 model. Th e eff ect of surface coating and size of NPs was characterized on cell 
viability, TNF-α production, ROS production, MPTP opening, and intracellular ATP levels. 
Decreased cell viability was observed for all Ag NPs tested. Th e results from MTT, ATP and 
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MPTP opening assays showed that adverse eff ects from exposure to the tested Ag NPs on 
these endpoints were similar irrespective of surface coating or size. However, for ROS pro-
duction and TNF-α induction, signifi cant diff erences were found with variations in the phys-
icochemical properties of the tested Ag NP. Th e role of surface coating/charge in infl uencing 
TNF-α induction was demonstrated by the fact that only negatively charged Ag NP_BSA 
induced TNF-α production (80x higher than control). Further, signifi cant ROS induction was 
only observed with the 20 nm positively charged Ag NP_Chit. Overall, the negatively charged 
Ag NP_BSA appeared to be most potent in inducing adverse eff ects on the macrophages. Th is 
toxicity of the negatively charged Ag NPs is the opposite of what was found in chapter 3 for 
the PS-NPs, since the positively charged PS-NPs appeared to be the most cytotoxic to BeWo 
cells. So this points again to the direction that the eff ect of surface charge may vary with the 
type of NPs investigated, indicating that more studies with other NPs with diff erent core ma-
terial and with diff erent charges are required.
Finally chapter 7 of the thesis presented a general discussion and some future perspectives 
for use of in vitro models in defi ning hazards of NPs. It was concluded that taken together, 
the present thesis provided further evidence of the infl uence of physicochemical properties 
of NPs in driving toxicity in in vitro models. However, the determination of the fate and 
toxicity of NPs using in vitro or in vivo models is a challenge that needs further evaluation. 
A combination of several factors likely play a role in determining the outcome of exposure 
including factors like NP core material and presence and type of coating agents resulting in 
various physicochemical properties (size, charge, etc.). Th is appears to hamper conclusive 
evaluation of the role of physicochemical characteristics of NPs in their potential hazards and 
risks so far. Th e results obtained do show however that in vitro assays can detect diff erences 
in potential hazards posed by NPs. Th erefore it is concluded that the results of the work pre-
sented in this thesis will contribute to the further development and use of non-animal based 
testing strategies for safety testing of NPs providing insight into selected potential hazards of 
the tested NPs. 
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